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Summary 
 
Dorsal closure of the Drosophila embryo represents the best characterized example of epithelial 
movement and fusion. This is due to the advanced genetics which allowed the identification of 
numerous genes that participate in dorsal closure. A deeper knowledge of the molecular 
mechanisms that drive dorsal closure leads also to a better understanding of other similar 
epithelial closure events such as wound healing and other processes that involve cell shape 
changes in general. 
The small Rho GTPases Drac1 and Dcdc42 are essential regulators of actin cytoskeleton 
dynamics and therefore are also key players in dorsal closure. To identify novel signaling 
components of Drac1 and Dcdc42 that potentially act during dorsal closure, we performed a 
genetic screen. To this end, we misexpressed dominant negative forms of either Drac1 or 
Dcdc42 (Drac1N17 or Dcdc42N17) specifically in the eye by using the Gal4/UAS-system. As a 
consequence, the resulting tester flies displayed eyes with a disrupted structure ("rough eye" 
phenotype) that was used as a starting point for a gain-of-function screen. Approximately 10'000 
flies with random insertions of a UAS-containing enhancer promoter (EP) element were crossed 
to the Drac1N17 or Dcdc42N17 tester flies and the F1 generation was screened for modification of 
the rough eye phenotype. We selected modifiers that improved eye structure, i.e. suppressed 
the rough eye phenotype. Modification of the rough eye phenotype is supposed to be caused by 
EP dependent transcription of a nearby gene. These genes thus encode potential Drac or 
Dcdc42 signaling components. 
The decision to screen for eye (instead of dorsal closure) phenotype modifications was 
motivated, first, by the viability of the corresponding tester lines that made it possible to screen 
the F1 generation and, second, by the relative ease to examine the subtle eye phenotype 
modifications – to score for a partial suppression of the severe dorsal closure phenotypes 
caused by Drac1N17 or Dcdc42N17 embryonic overexpression was supposed to be too demanding 
and time consuming for this kind of large scale screening. 
This approach led to the identification of 17 genes, none of which has been previously reported 
to interact with Drac1 or Dcdc42. Their potential role in dorsal closure has not yet been 
investigated except for one suppressor gene: falafel. Loss-of-function mutations in falafel were 
generated that indeed resulted in various defects in dorsal closure besides other phenotypes. 
Thus this genetic approach identified at least one novel gene implicated in dorsal closure that 
probably would not have been picked up in conventional loss-of-function screens as its mutant 
phenotype is pleiotropic. 
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falafel encodes a novel RanBP domain containing protein that is evolutionary conserved. 
Mutations in orthologous genes in Caenorhabditis elegans and yeast were described to result in 
stress hypersensitivity. Furthermore, the yeast and human Falafel orthologs function in a 
conserved protein phosphatase 4 (PPP4) complex, which, at least in yeast, is sensitive to the 
anticancer agent cisplatin. In the course of this work, we could also demonstrate that loss of 
falafel function resulted in hypersensitivity to cisplatin, indicating a role in DNA damage 
response.  
Altogether, the 17 identified suppressor mutations represent a heterogenous group of genes with 
diverse functions. I suggest a common function for six of the 17 genes in mediating Rac/Cdc42 
dependent regulation of homeostasis of reactive oxygen species (ROS). This may be relevant, 
since Cdc42 and especially Rac have well documented roles in the regulation of NADPH 
oxidase that produces ROS. The six genes with a proposed role in ROS signaling are Trf2, 
ATP7, CG6700, CG30421, pfrx and SelD. 
ROS mediated DNA damage leads to cell cycle arrest. Interestingly, two identified suppressors 
of Dcdc42N17 correspond to well known cell cycle regulators: string (cdc25) and Rbf. This finding 
additionally supports a role for Dcdc42 in cell cycle checkpoint regulation in response to ROS. 
Moreover, Falafel's putative function in DNA damage response may also be in line with the 
herein proposed new function of Drac1 and Dcdc42 in the regulation of ROS, response to DNA 
damage and cell cycle progression. 
 
 
 
 
 
 
 - 2 -  
Zusammenfassung 
 
Die Schliessung der dorsalen Epidermis (dorsal closure) während der Embryonalentwicklung 
von Drosophila ist eines der best untersuchten Beispiele der Bewegung und Fusion von Epithel-
Zellschichten. Dank der fortgeschrittenen Drosophila-Genetik wurden bereits zahlreiche Gene 
identifiziert, welche eine Rolle bei der dorsal closure spielen. Die weitere Erforschung der 
molekularen Mechanismen, welche diesen Prozess steuern, kann auch zu einem besseren 
Verständnis von ähnlichen Epithelschliessungs-Prozessen wie der Wundheilung oder von 
anderen Zellbewegungsabläufen führen. 
Die kleinen Rho GTPasen Drac1 und Dcdc42 sind essentielle Regulatoren des Actin-Zellskeletts 
und damit auch wichtig für die Zellbewegungen, die während der dorsal closure geschehen. Um 
neue Komponenten der Drac1- und Dcdc42-Signalwege zu identifizieren, haben wir darum 
einen genetischen "Screen" durchgeführt. 
Zu diesem Zweck exprimierten wir dominant negative Versionen der Drac1- oder Dcdc42-
Proteine (Drac1N17 oder Dcdc42N17) spezifisch im Auge mittels des Gal4/UAS-Systems. Die 
darausfolgenden "Tester"-Fliegen haben einen "rauhe-Augen-Phänotyp", welcher durch eine 
unregelmässige Anordnung und Verflachung der Ommatidien gekennzeichnet war. Dieser 
Phänotyp wurde in der Folge als Ausgangspunkt für einen Überexpressions-Screen benutzt. 
Über 10000 Fliegen mit zufälligen Insertionen eines "enhancer promoter" (EP) Elementes 
wurden mit den Drac1N17- or Dcdc42N17-Tester-Fliegen gekreuzt. Daraufhin wurden die F1-
Nachkommen auf eine Veränderung des rauhe-Augen-Phänotyps hin untersucht. Es wurden 
diejenigen Fliegen ausgewählt, welche eine Verbesserung der Augenstruktur, d.h. eine 
Unterdrückung (Suppression) des rauhe-Augen-Phänotyps, aufwiesen. Es wurde jeweils 
angenommen, dass solch eine Verbesserung der Augenstruktur durch die vom EP-Element und 
von den darin enthaltenen UAS-Sequenzen abhängige Transkription eines der Insertion 
angrenzenden Genes verursacht wurde. Solche Gene kodieren darum für potentielle neue 
Komponenten der Drac1- und Dcdc42-Signalwege. 
Der Grund für einen Augen- (statt dorsal closure-) Screen lag einerseits in der Lebensfähigkeit 
der Drac1N17- und Dcdc42N17-Tester-Fliegen, welche eine Untersuchung schon der F1-
Generation möglich machte, und andererseits in der Schwierigkeit, subtile Veränderungen eines 
schweren dorsal closure  Defektes in grossem Massstab zu untersuchen. 
Im Laufe des Screens wurden 17 Gene identifiziert, welche bisher nicht im Zusammenhang mit 
Drac1 oder Dcdc42 beschrieben wurden. Die  potentielle Funktion im Prozess der dorsal closure  
wurde bisher für eines der 17 Gene untersucht: falafel. Wir erzeugten Mutationen im falafel-Gen, 
welche, nebst anderen Phänotypen, tatsächlich eine defekte dorsal closure zur Folge hatten. 
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Somit war dieser genetische Ansatz, ein Überexpressions-Screen für Augenphänotyp-
Veränderungen, in mindestens einem Fall erfolgreich, um neue dorsal closure Gene zu 
identifizieren, welche in konventionellen loss-of-function-Screens möglicherweise nicht entdeckt 
worden wären. 
falafel kodiert für ein neuartiges, evolutiv stark konserviertes Protein mit einer Ran-bindenden 
Domäne (RanBP). Verschiedene Studien konnten zeigen, dass orthologe Gene in Fadenwurm, 
Hefe und Mensch sensitiv für verschiedene Stressbedingungen sind. Ausserdem wurden die 
menschlichen und die in der Hefe orthologen Proteine als Bestandteil eines Protein-
Phosphatase-4 (PPP4) Komplexes beschrieben, welcher sensitiv für das krebshemmende 
Medikament Cisplatin ist. In dieser Arbeit konnten wir zeigen, dass auch Funktionsverlust von 
falafel zu Hypersensivität für Cisplatin führt. Da Cisplatin ein DNA-schädigendes Molekül ist, 
zeigen diese Resultate, dass Falafel und der PPP4-Komplex eine Rolle bei Prozessen spielen 
könnten, die in Folge von DNA-Schädigungen geschehen. 
Die 17 in dieser Arbeit identifizierten Suppressor-Gene stellen eine heterogene Gruppe von 
Genen dar, welche verschiedenste Funktionen ausüben. Für sechs dieser 17 Gene gibt es 
allerdings Hinweise für eine gemeinsame Funktion, und zwar bei der Regulation von Sauerstoff-
Radikalen (reactive oxygen species, ROS), bzw. von deren Konzentration und Signalwirkungen 
in der Zelle. Diese sechs Gene sind Trf2, ATP7, CG6700, CG30421, pfrx und SelD. 
Interessanterweise haben Cdc42 und vor allem Rac eine gut dokumentierte Funktion in der 
Regulation der NADPH-Oxidase, einem Enzym-Komplex, welches Sauerstoffradikale produziert.  
Sauerstoff-Radikale können auch die DNA schädigen, welches in der Folge zu einem Zellzyklus-
Stopp führen kann. Interessanterweise entsprechen zwei der identifizierten Dcdc42N17-
Suppressoren bekannten Regulatoren des Zellzyklus: string (cdc25) und Rbf. Die Identifizierung 
dieser zwei Zellzyklus-Regulatoren, der sechs potentiellen ROS-Regulatoren und von Falafel als 
Interaktoren von Drac1 und Dcdc42 legt somit folgende zusätzliche Funktionen dieser zwei Rho 
GTPasen nahe: Regulation des Zellzyklus und die Koordination der Antworten (Reparatur bis 
Zelltod) auf DNA-Schädigungen, möglicherweise in Abhängigkeit von Sauerstoff-Radikalen.  
 
 
 
 
 
 
1. Introduction 
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1.1. Dorsal closure 
 
Dorsal closure (DC) is the morphogenetic movement at the end of Drosophila embryogenesis 
whereby a naturally occurring epithelial hole on the dorsal side gets closed. This hole closure 
process requires cytoskeletal reorganization, cell shape changes, cell migration, supracellular 
contraction of entire tissues, and adhesion guided by filopodia and lamellipodia. This process 
shows obvious parallels to other morphogenetic processes such as embryonic wound healing in 
Drosophila and vertebrates (Grose and Martin, 1999; Stramer et al., 2005), thorax closure in 
Drosophila (Martin-Blanco et al., 2000), neural tube closure in vertebrates (Xia and Karin, 2004), 
ventral enclosure in Caenorhabditis elegans (Simske and Hardin, 2001) and epiboly in zebrafish 
(Koppen et al., 2006). Moreover, there appears to be also a significant conservation of the 
molecular mechanisms, since many of the proteins important for DC are also implicated in other 
epithelial closure events (see below).  
Drosophila DC represents the best characterized example of epithelial movement and fusion. 
This is due to the advanced genetics which allowed the identification of more than 30 genes that 
participate in DC (Harden, 2002). Live imaging of embryos expressing GFP-fusion proteins 
further unraveled the dynamic behaviour of cells and their cytoskeleton during the process 
(Edwards et al., 1997; Jacinto et al., 2000). All this makes Drosophila DC an excellent model 
system in which to study the regulation of cell migration and cell shape changes. 
 
In the Drosophila embryo, gastrulation is followed by retraction of the germ band, which leaves 
the dorsal-most portion of the embryo covered by the large, flat cells of the amnioserosa (Fig. 1).  
Within approximately five hours the amnioserosa sinks internally where it undergoes apoptosis 
while the two migrating flanks of the epidermis move towards the dorsal midline, completely 
sealing the hole 13 hours after egg laying (AEL), by stage 15 (Campos and Hartenstein, 1985). 
Movement of these epithelial layers depends exclusively on cell shape changes and does not 
require cell division or cell recruitment (Martinez Arias, 1993).  
The dynamics of dorsal closure can be visualized in living embryos with the use of green 
fluorescent protein (GFP) transgenes that label the actin cytoskeleton (Fig. 1). 
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Figure 1. Dynamics of DC can be followed in live embryos expressing GFP-tagged proteins 
Imaging of live embryos expressing either GFP-tagged Moesin, which binds cortical F-actin, (A) or GFP-
tagged actin (B) reveals a thick actin cable and dynamic filopodia (arrows) at the leading edge (LE). Upon 
heat shock a temporary ubiquitous expression of hs-GFP::Moesin is obtained, shown in (A). A more 
restricted expression of UAS-GFP::actin is obtained with the enGal4 driver (B). In this situation the very 
thin and dynamic filopodia become visible above non fluorescent dark regions, especially the 
amnioserosa. In (C) a schematic embryo around stage 13/14 is shown. The contributions of different 
forces that drive DC are indicated by arrows (cell elongation of lateral epithelia, black arrows, and 
amnioserosa contraction, blue arrows) and by the red actomyosin purse-string (red arrows) and filopodia 
at the LE.  
 
The entire process has been divided into four overlapping phases (Jacinto et al., 2002b):  
1) Initiation of dorsal closure starts prior to the completion of germ band retraction, at stage 12, 8 
hours after egg laying (AEL), as soon as the anterior region of amnioserosa and adjacent 
leading edge (LE) has been revealed by the moving germ band. At this first stage, hole closure 
is rather slow and seems to involve mainly amnioserosa cell contraction leading to movement of 
the attached leading edge cells (Kiehart et al., 2000).  
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2) At stage 13, 9 hours AEL, the lateral epithelial cells start to elongate dorsally (Jacinto et al., 
2002b; Riesgo-Escovar and Hafen, 1997b). Furthermore, the first row of cells at the front 
accumulate at the dorsal edge a thick bundle of F-actin and non-muscle myosin heavy chain II 
(hereafter referred to as myosin) which seems to form a supracellular contractile cable around 
the entire dorsal hole (Jacinto et al., 2002a; Young et al., 1993). This actomyosin cable 
potentially operates like a “purse-string” to draw the epithelial hole closed (Kiehart, 1999; Young 
et al., 1993). The cable also seems to organize the scalloped epithelial edge into the uniform 
advance front, thereby preventing individual cells from migrating forward on their own (Jacinto et 
al., 2002a). The cable seems to be anchored by E-cadherin-mediated adherens junctions at the 
LE, thereby joining the cells to form a contiguous purse-string (Danjo and Gipson, 1998). 
3) Dynamic filopodial and lamellipodial protrusions of the leading edge cells are characteristic for 
the third phase of dorsal closure, starting at stage 14, 11 hours AEL. These actin protrusions 
extend from each LE to actively zipper the epithelial sheets together, i.e., when the opposing LE 
cells meet at the dorsal midline, these filopodia interdigitate and prime the formation of adherens 
junctions (Jacinto et al., 2000) as it happens in cultured keratinocytes that assemble into an 
organized epithelial sheet (Vasioukhin et al., 2000). 
Filopodia also seem to support the correct matching of the opposing embryonic segments since 
specific mutants that lack filopodia frequently display mismatched segments (Jacinto et al., 
2000). A sensing mechanism analogous to that of axon growth cone filopodia has been 
postulated. The molecular nature of this mechanism is unknown however. During ventral 
enclosure in C. elegans, the axonal repellent Semaphorin-2A is required to prevent ectopic 
contacts between migrating cells (Roy et al., 2000). Thus it has been suggested that similarly 
during DC a repellent could be expressed from some cells of the LE, possibly by the segment 
border cells (see below), thereby restricting filopodia-guided migration of the LE cells into 
discrete paths. 
4) During the last phase of dorsal closure, at stage 15, 13 hours AEL, the opposing epithelia 
meet at the midline and stop to migrate. The transient adhesions that have been formed 
between interdigitating filopodial protrusions convert into tight and permanent adherens 
junctions. The cells of the amnioserosa are then completely internalized and undergo apoptosis. 
In the end, there is an invisible midline and a completely sealed hole. 
In summary, DC seems to be driven mainly by contraction of both the amnioserosa and the 
supracellular „purse string“. Filopodia and lamellipodia are required to zip the opposing leading 
edges together. A recent report also implicates, in addition to the amnioserosa, a second 
extraembryonic tissue, the yolk sac, to contribute to DC (Reed et al., 2004). 
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1.2. Genes involved in dorsal closure 
 
Genes that affect dorsal closure can be grouped into at least five classes and are summarized in 
Table 1 (reviewed by Harden 2002). Mutations in genes involved in either the Jun amino-
terminal kinase (JNK) cascade, the transforming growth factor beta (TGF-ß) signaling pathway 
or the Wingless (Wg) signaling pathway can disrupt dorsal closure. Furthermore genes involved 
in the Rho GTPase-mediated signaling pathway, and genes encoding cytoskeletal proteins and 
membrane-associated molecules involved in cell adhesion are required for DC. 
Some dorsal closure genes do not fit into one of the five classes and are not described here. 
Only the below mentioned genes are listed in Table 1. For example, Ras signaling will not be 
discussed, neither extracellular proteins as type IV collagen that have been shown to play a role 
during dorsal closure. For a more complete picture of dorsal closure genes see reviews by 
Harden (2002) and Martin and Parkhurst (2004). 
  
DC gene classes DC mutants role in DC 
JNK (chapter 1.2.1.) msn, slpr, hep, bsk, DJun,  
DFos (kayak) 
initial signal in LE, regulation of 
actin/myosin cytoskeleton, required 
for filopodia formation 
TGF-ß (1.2.2.) dpp, put, tkv, mad, shn, pnr expansion of signal, regulation of 
cytoskeleton at segment border 
cells 
Wg (1.2.3.) wg, arm (ß-catenin), dTCF regulation of JNK, link to adherens 
junction? 
cytoskeletal and 
membrane-associated 
proteins (1.2.3.) 
scb, mys (integrins); actin, 
myosin; arm (ß-catenin), shg 
(E-cadherin); abl, ena 
cytoskeleton and signaling 
Rho GTPase family 
(1.2.4.) 
RhoA, Drac1/2, mtl, Dcdc42 regulation of cytoskeleton dynamics 
and of gene expression 
 
Table 1. Dorsal closure genes classified into five groups  
 
1.2.1. JNK 
 
Coincident with the first cell shape changes of the lateral epidermis, there is an upregulation of 
the JNK pathway in the LE cells whereas in the opposing amnioserosa JNK activity is 
downregulated. This boundary of JNK activity is established in response to the early 
dorsoventral patterning system, involving the Dpp gradient, and subsequent inductive signaling 
between the amnnioserosa and the adjacent epidermis (Reed et al., 2001; Stronach and 
Perrimon, 2001).  
JNK cascades consist of a set of sequentially activated serine/threonine kinases closely related 
to the extracellular regulated protein kinases (ERK) that transmit cytoplasmic signals to the 
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nucleus (Goberdhan and Wilson, 1998). In mammalian cells, JNKs are regulated by various 
cellular stresses and growth factors and have been implicated in the regulation of many diverse 
biological processes, such as cell shape changes, immune responses and apoptosis (Davis, 
2000). 
In Drosophila these kinases are encoded by the slipper/DJNKKK (slpr) (Stronach and Perrimon, 
2002), hemipterous/DJNKK (hep) (Glise et al., 1995) and basket/DJNK (bsk) (Riesgo-Escovar et 
al., 1996; Sluss et al., 1996) genes. A Ste20-related kinase, Misshapen (Msn), is the putative 
JNKKKK (Davis, 2000; Su et al., 1998) and functions upstream of Slpr, Hep and Bsk in the 
dorsal closure process. The transcription factor Djun is activated by DJNK (Hou et al., 1997; 
Kockel et al., 1997; Riesgo-Escovar and Hafen, 1997a). In addition to Djun, two other 
transcription factors have been identified that act in the JNK pathway during DC —the 
Drosophila homolog of Fos, DFos (Riesgo-Escovar and Hafen, 1997a; Zeitlinger et al., 1997), 
and the ETS-domain protein anterior open Aop/Yan (Riesgo-Escovar and Hafen, 1997b). Both 
DJun and DFos act as positive regulators, probably through the formation of a heterodimer 
termed AP-1, whereas Aop functions as a negative regulator in the process. 
Mutations in any of these JNK pathways components result in DC defects. The embryos 
eventually die with a characteristic dorsal open phenotype which is easily identified in cuticle 
preparations (compare to Fig. 5 C and E, Chap. 2.2.2.) (Martinez Arias, 1993; Nusslein-Volhard 
et al., 1985; Perrimon et al., 1989; Wieschaus et al., 1984). 
A more detailed analysis revealed that loss of JNK signaling is characterized by disruption of the 
actin and myosin cytoskeleton at the LE, subsequent failure of cell elongation and missing 
filopodia (Jacinto et al., 2000). 
The transcriptional targets of JNK include at least one cytoskeletal component, encoded by 
chickadee (Jasper et al., 2001). Chickadee is the Drosophila homolog of Profilin which regulates 
actin assembly, and there is genetic evidence for an essential role of chickadee in DC (Jasper et 
al., 2001). Furthermore, the dual-specific phosphatase encoded by puckered is activated by the 
JNK cascade in the leading edge cells (see below Fig. 2, puc-lacZ enhancer trap line) and acts 
in a negative feedback loop by dephosphorylating and thereby inactivating Bsk (Martin-Blanco et 
al., 1998). puckered mutant embryos have thus elevated JNK activity. Intriguingly, this leads to a 
somewhat unrestricted movement and overcontraction of the advancing epidermis. 
Furthermore, expression of scab and myospheroid, two Drosophila integrins, have been shown 
to be activated by JNK signaling (Homsy et al., 2005). 
A recent review on the role of the JNK pathway in dorsal closure is given by Xia and Karin 
(2004). 
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1.2.2. Dpp/TGF-ß 
 
Another important output of JNK signaling is the induction of Decapentaplegic (Dpp, a TGF-ß 
homolog) expression in the LE cells (Glise and Noselli, 1997; Hou et al., 1997; Jackson and 
Hoffmann, 1994; Riesgo-Escovar and Hafen, 1997b; Sluss and Davis, 1997; St Johnston and 
Gelbart, 1987; Stronach and Perrimon, 2002; Zeitlinger et al., 1997). Involvement of a TGF-ß 
signaling pathway operating during DC was demonstrated by showing that mutations in the 
genes punt (put) (Letsou et al., 1995; Ruberte et al., 1995) and thick veins (tkv) (Affolter et al., 
1994; Brummel et al., 1994; Nellen et al., 1994; Penton et al., 1994), which encode type-II and 
type-I TGF-ß receptors respectively, cause DC defects. Furthermore, overexpression of both 
Dpp or an activated form of the Dpp receptor Tkv rescues substantially the DC defects of JNK 
pathway mutants (Chen et al., 2002; Hou et al., 1997; Riesgo-Escovar and Hafen, 1997b; Sluss 
and Davis, 1997; Su et al., 1998). Mothers against Dpp (Mad), a Drosophila Smad, signals 
downstream of Dpp to induce gene transcription. Embryos deficient in Mad show DC defects. 
Two other transcription factors that are also required for DC are Schnurri (Shn) that has been 
shown to interact directly with Mad in a Dpp-dependent manner (Udagawa et al., 2000), and 
Pannier (Pnr) (Calleja et al., 2000; Herranz and Morata, 2001). One of the target genes of Dpp 
signaling in the LE is zipper (zip), which encodes the heavy chain of non-muscle myosin II 
(Arquier et al., 2001). 
The DC defects of Dpp pathway mutant embryos are distinct to the JNK pathway mutant 
phenotype. Despite the lack of myosin synthesis at the LE in tkv mutant embryos, assembly of 
the actomyosin cytoskeleton does not require functional Dpp signaling (Ricos et al., 1999; 
Riesgo-Escovar and Hafen, 1997a). This can probably be explained by sufficient maternally 
produced myosin (Young et al., 1993).  
The exact role of Dpp signaling in DC is not clear yet. It was proposed that while Drac1 (see 
below) and JNK signaling assemble cytoskeletal components and other proteins (Dpp, Puc, and 
DPAK) in the LE cells to initiate cellular migration, Dpp-activated signaling would control the 
dynamics of epidermal migration, via Dcdc42 (see below) (Ricos et al., 1999). Dpp secretion 
from already elongating LE cells possibly triggers more laterally located cells to adopt the same 
elongation behaviour. Another role of Dpp and Dcdc42 signaling in regulating the LE 
cytoskeleton specifically at the segment borders is discussed below. 
Thus, JNK activity leads to transcription of further regulators of DC and of cytoskeletal 
components that are required for the cell shape changes occurring during DC. However, there 
seems to be a transcription-independent role for some components of the JNK pathway. For 
example, Bsk/DJNK possibly regulates cytoskeleton dynamics through direct interaction with 
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p150-Spir that belongs to the Wiscott-Aldrich syndrome protein (WASP) homology domain 2 
(WH2) family of proteins involved in actin reorganization (Otto et al., 2000). 
 
1.2.3. JNK regulation, cytoskeleton and adherens junction 
 
There are several other proteins that also induce transcription of dpp and puc at the LE, either 
by activating the JNK cascade or through another JNK independent route. Thus dpp and puc are 
widely used to measure JNK activity either by doing in situ hybridization of dpp transcripts or by 
assaying β-galactosidase activity from a lacZ enhancer trap insertion in puc (Ring and Martinez, 
1993) (Fig. 2). 
 
 
 
Figure 2. Levels of puckered-lacZ expression in the leading edge cells as indicator for JNK activity 
puc-lacZ expression during (A) and at the end (B) of dorsal closure. The advancing epidermis is stained 
only in the leading edge (LE) cells which eventually form the dorsal midline (B) 
 
Mutations in genes that lead to altered dpp or puc expression at the LE often show DC 
phenotypes. For example, mutations in the non-receptor tyrosine kinases Src42A, Tec29 and 
Shark show reduced dpp and puc transcription at the LE and various DC defects (Tateno et al., 
2000). 
Good candidates to act further upstream are integrins. Indeed, two Drosophila integrins, scab 
and myospheroid, encoding α and β subunits, respectively, show dorsal holes when mutated 
(Hutson et al., 2003; Narasimha and Brown, 2004; Stark et al., 1997). The view that integrins 
serve only as passive mechanical links between exracellular matrix (ECM) molecules and the 
cell membrane is out of date. Integrin signaling mediates cell adhesion, migration, and invasion 
during development, tissue repair, tumor invasion, and metastasis. However, it is unlikely that 
integrins signal through exclusive, integrin-specific pathways. Instead, they appear to cooperate 
with other cell-surface receptors to influence a variety of signaling pathways (Porter and Hogg, 
 - 11 -  
1998). Homsy et al. recently suggested that scab and myospheroid rather act downstream of 
JNK signaling (Homsy et al., 2005). Notch signaling appears to inhibit JNK mediated 
transcription of dpp and puc, and complete loss of Notch also results in DC defects. 
Furthermore, two adherens junction proteins, Canoe and ZO1 are required for dorsal closure, 
also by activating the JNK pathway. Thus, besides the proposed function for adherens junctions 
in anchoring the actin-myosin cable, they also appear to assemble signaling complexes that 
regulate DC. 
Enabled (Ena), a modulator of actin dynamics, localizes to adherens junctions and is regulated 
by the nonreceptor tyrosine kinase Abelson (Abl). abl and ena mutant embryos exhibit defects in 
several morphogenetic processes including DC. The effect on DC is further enhanced by 
mutations in two other genes encoding adherens junction proteins, armadillo (arm) and shotgun 
(shg), the Drosophila homologs of β-catenin and E-cadherin, respectively (Grevengoed et al., 
2001). The requirement for Arm during DC has been reported previously (McEwen et al., 2000). 
Arm binds α-catenin and E-cadherin, and regulates assembly of F-actin at adherens junctions 
(Grevengoed et al., 2001; Takahashi et al., 2005). Arm has a second well defined role in 
Wingless (Wg) signaling where it localizes to the nucleus to activate gene transcription 
(DasGupta et al., 2005). Intriguingly, Wingless itself as well as Dsh, a Wg signaling component, 
are also required to activate dpp and puc expression via the JNK pathway and to coordinate cell 
shape changes during dorsal closure (McEwen et al., 2000). However, considering the stronger 
DC phenotype of arm compared to Wg mutant embryos, Arm may contribute to DC in a Wg-
independent fashion through its role in adherens junctions (McEwen et al., 2000). 
 
1.2.4. Rho GTPases 
 
Small GTPases of the Rho subfamily have been shown in various systems to be key regulators 
of the actin cytoskeleton and upstream activators of JNK cascades (Bishop and Hall, 2000). 
Thus, they are good candidates to control the cytoskeletal re-arrangements required for the cell 
shape changes that occur during DC. Indeed, five of the six Drosophila Rho GTPases are 
involved in DC: the Drosphila Rac proteins Drac1, Drac2, and Mtl, the Drosophila Cdc42 protein 
Dcdc42, and the Drosophila Rho protein RhoA (also called Rho1). The particular functions of 
each Rho GTPase for DC are not completely understood yet, but they seem to have only 
partially overlapping functions and most likely regulate different aspects of DC. These include 
the regulation of the actin/myosin cytoskeleton at the LE, formation of signaling complexes and 
assembly of F-actin at adherens junctions, formation of filopodia and lamellipodia, as well as 
regulation of the JNK and Dpp pathways. A sequential activation of Dcdc42, Drac1 and RhoA 
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has been described in fibroblasts (Nobes and Hall, 1995) and macrophages (Allen et al., 1997). 
However, they appear to function in parallel during DC (Harden et al., 1999).  
Whether any of the Drosophila Rho GTPases regulates JNK signaling during DC remains a 
controversial issue. Several studies using dominant negative and constitutively active 
transgenes implicated Drac1 and Dcdc42 as operating upstream of JNK signaling in DC (Glise 
and Noselli, 1997; Harden et al., 1996; Harden et al., 1995; Harden et al., 1999; Stronach and 
Perrimon, 2002). For example, expression of constitutively active DJun can partially rescue the 
DC defects induced by dominant negative Drac1 (Hou et al., 1997). 
On the other hand, embryos expressing dominant negative versions of Drac1 (Drac1N17) or 
Dcdc42 (Dcdc42N17), or a negative regulator of Drac1, RotundRacGAP, maintain dpp and puc-
lacZ expression at the LE (Raymond et al., 2001). The same is true for Dcdc42 mutant embryos 
(Genova et al., 2000). However, a recent study investigated the Drac1/Drac2/mtl triple mutant 
embryos with respect to JNK activity (Woolner et al., 2005). In these embryos dpp expression at 
the LE is reduced and DFos was no longer localized to the nucleus, indicating that JNK signaling 
is indeed regulated by Drac. Moreover, expression of a constitutively active form of JNKK, 
hemipterous (UAS-hepCA), partially rescues the Drac1 mutant phenotype (Woolner et al., 2005). 
Ricos et al. (1999) showed that embryos mutant for Dpp pathway genes resembled the embryos 
in which Dcdc42N17 is overexpressed. In these embryos, DPAK is lost in the LE cells, which are 
subsequently pulled towards the segment borders, thereby causing a bunching of the epidermis. 
This bunching phenotype is probably due to excessive contraction of the LE only at the segment 
borders. The serine/threonine kinase DPAK has been suggested to prevent these 
overcontractions by locally loosening the actin cytoskeleton (Harden et al., 1996; Ricos et al., 
1999). 
Drac1N17 overexpression leads to a similar phenotype as JNK pathway mutants that is clearly 
distinct from the Dcdc42N17/Dpp phenotype. Drac1N17 overexpression disrupts formation of the 
leading edge actomyosin purse-string and impairs cell elongation (Harden et al., 1995; Harden 
et al., 1999) as it happens in JNK pathway mutant embryos. Analysis of the triple Rac mutant 
embryos confirm these results (Hakeda-Suzuki et al., 2002). In addition, there is a gross 
reduction of filopodia and lamellipodia at the LE. Live imaging demonstrated that these actin 
protrusions were also missing in hep mutant embryos and the resulting phenotype includes a 
severe misalignment of opposite segments along the zippering seam (Jacinto et al., 2000). 
Altogether, these data suggest that Rac signaling indeed functions upstream of the JNK 
cascade. 
Cdc42 has been implicated in the regulation of filopodia (Nobes and Hall, 1995), and this seems 
to be the case also during DC, since expression of Dcdc42N17 blocks filopodia formation leading 
 - 13 -  
to a segmental misalignment phenotype similar to that of hep mutant embryos (Jacinto et al., 
2000). Cell culture studies implicated the Wiskott-Aldrich protein (WASP), profilin and the Arp2/3 
complex downstream of Cdc42 to mediate de novo actin polymerization in filopodia (Takenawa 
and Miki, 2001). Drosophila WASP, however, does not seem to be essential for DC (Ben-
Yaacov et al., 2001; Tal et al., 2002). Dcdc42 (or Drac) may still act through profilin in driving 
filopodia formation, as mutations in the Drosophila profilin, chicadee, lead to loss of filopodia at 
the LE (Jasper et al., 2001).  
However, the role of Dcdc42 in DC remains ambiguous. The simplest interpretation puts Dcdc42 
downstream of Dpp. This is supported, first, by the above mentioned phenotypic similarity of Dpp 
pathway mutant and Dcdc42N17 expressing embryos, and second, by the ability of a 
constitutively active form of Dcdc42 to partially rescue the DC phenotype of a mutation in thick 
veins, which encodes the Dpp receptor (Ricos et al., 1999). 
RhoA is also important for DC. It appears to be required for the contractility of the purse-string. 
Embryos expressing a dominant negative form of RhoA and embryos mutant for RhoA show 
loss of myosin from the LE (Harden et al., 1999; Magie et al., 1999). Furthermore, zipper, 
encoding the Drosophila non muscle myosin-II heavy chain, interacts genetically with RhoA 
(Halsell et al., 2000), Drosophila Rho-associated kinase (Drok) and the myosin-binding subunit 
(DMBS) of myosin phosphatase (Mizuno et al., 2002). Drok overexpression as well as mutations 
in DMBS result in excessive phosphorylation of the myosin regulatory light chain (MRLC) and 
aberrant cable assembly at the LE, leading to failure in DC (Mizuno et al., 2002). 
A closer look at RhoA mutant embryos reveals that loss of myosin occurs only at the segment 
boundaries. Therefore the cells with normal myosin levels show anterior-posterior contraction, 
while the segment border cells fail to contract and tend to splay out (Harden et al., 1999; Magie 
et al., 1999). The overall effect is an uneven constriction of the LE along the A/P axis. 
Recent evidence suggests that this phenotype may not only be a consequence of unevenly 
distributed myosin but also a result of an altered adhesive property of RhoA mutant cells. That 
is, cells at the segment borders form ectopic contacts with their lateral neighbors (Bloor and 
Kiehart, 2002; Magie et al., 1999). A role for the Rho and Rac small GTPases in cadherin-
dependent cell-cell contact formation has been reported for cultured vertebrate cells (Braga, 
2000; Braga et al., 1997). Interestingly, Drosophila RhoA accumulates at sites of cadherin based 
adherens junctions at the LE, and DE-cadherin and α-catenin localization is disrupted in RhoA 
mutant embryos (Magie et al., 2002). Moreover, RhoA binds directly to α-catenin and to 
p120catenin (p120ctn) in vitro (Magie et al., 2002). p120ctn is suggested to recruit RhoA to sites of 
cadherin based adherens junctions. Thus the DC defects of RhoA mutants could also be the 
result of aberrant adherens junction formation. Rho signaling in response to the above 
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mentioned predicted repellent could thereby induce differential adhesion properties of cell 
populations. In this model, segment border cells are likely candidates to express different 
adhesion molecules that would not be “recognized” by filopodia of cells inbetween the segment 
borders. 
It is not clear whether RhoA is required for activation of the JNK pathway. RhoA mutant embryos 
exhibit normal levels of dpp mRNA and puckered-lacZ expression in the LE cells (Magie et al., 
1999). Embryos expressing dominant negative RhoA, however, show some ectopic activation of 
JNK dependent transcription in the lateral epidermis (Bloor and Kiehart, 2002). 
 
In summary, the LE cells are induced by signaling in the adjacent amnioserosa to activate the 
JNK pathway and to accumulate F-actin and myosin at their dorsal end. Adherens junctions are 
important in both anchoring the actomyosin cable and assembling signaling complexes that 
regulate cytoskeletal rearrangements as well as JNK dependent transcription. The JNK cascade 
is regulated by numerous proteins, including non-receptor tyrosine kinases, the Rho GTPase 
Drac1, Notch and members of the Wg pathway. JNK signaling in the LE leads to secretion of 
Dpp, which regulates DC in one way through Dcdc42 and DPAK. DPAK function is possibly 
needed to both loosen and strengthen the cytoskeleton depending on the position along the 
anterior/posterior axis. RhoA seems to regulate both myosin activity and adhesive properties of 
LE cells. JNK signaling, the three Drosophila Racs, Drac1, Drac2 and Mtl, and probably also 
Dcdc42 are required for the formation of filopodia and lamellipodia. These actin protrusions 
appear to be responsible for the correct matching of opposing LEs at the dorsal midline, possibly 
by sensing the RhoA-mediated differential adhesive properties of LE cells. 
Figure 3 summarizes the signaling events occurring during DC. Various further proteins that 
participate in DC have not been mentioned here and are not included in the figure (for a more 
complete picture of DC proteins see review Harden 2002). 
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Figure 3. Schematic diagram of signaling events occurring in LE cells.  
Central is the JNK cascade, represented by the Slpr, Hep and Bsk proteins, that is regulated in many 
ways. The effects of subsequent TGF-β/Dpp signaling are less clear but may involve instruction of more 
ventrally located cells to acquire the same cell shape changes as the LE cells. Rho GTPases regulate 
various components of the cytoskeleton. In addition Drac1 and possibly the two other related Drac2 and 
Mtl probably activate the JNK pathway. Adherens junctions anchor the cytoskeleton and assemble 
signaling complexes. 
 
1.2.5. DC is similar to other morphogenetic processes in both mechanistic and 
molecular aspects  
 
The spreading and fusion of epithelia, and the accompanying phenomena like polarized F-actin 
accumulation, supracellular purse-strings, filopodia-mediated adhesion, occur in various 
morphogenetic processes. Although these processes remain much less well characterized than 
Drosophila DC, it is becoming apparent that they require many of the same proteins participating 
in DC. For example, wound healing in Drosophila also requires JNK signaling (Ramet et al., 
2002) and Rho family small GTPase function (Stramer et al., 2005). Wound healing in 
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vertebrates requires TGF-β signaling and Rho family small GTPase function (Jacinto et al., 
2001). During eyelid closure in mammals TGF-β activates the JNK pathway (Zhang et al., 
2003a). Closure of the neural tube (Sabapathy et al., 1999) and optic fissure in vertebrates also 
require JNK (Weston et al., 2003; Xia and Karin, 2004), and hmp2/β-catenin and other adherens 
junction proteins participate in ventral enclosure in C. elegans (Simske and Hardin, 2001). 
We have now more than a basic understanding of the cytoskeletal changes and the complex 
network of signaling pathways that are necessary to promote Drosophila DC. This is due to the 
advanced genetics and the ability to investigate the dynamic cellular behaviours in live embryos. 
Thus DC appears as an ideal model system for epithelial closure events that occur during 
normal development and possibly more generally for pathological conditions, where cell 
migration is misregulated, such as in metastasis. 
 
The aim of this work was to genetically identify novel genes that potentially are involved in DC. A 
deeper knowledge of the morphologic and molecular mechanisms that drive dorsal closure also 
leads to a better understanding of other similar epithelial closure events such as wound healing 
and may as well elucidate the genetics of dynamic cell behaviour in general. 
To complement conventional loss-of-function screens we decided to perform a gain-of-function 
screen. We screened for genes that, upon P-element-mediated overexpression, interacted with 
Drac1 or Dcdc42. We identified several genes not implicated in dorsal closure so far. However, 
their role in this process remains to be shown. For one of these genes loss-of-function mutations 
were generated that indeed show various defects in dorsal closure besides other phenotypes. 
Further analysis revealed that the gene encodes a subunit of a phosphatase complex. 
In addition, the results of this thesis additionally suggest new functions for Rac and Cdc42 
signaling in body size control, ROS homeostasis, and DNA damage repair. 
 
2. Genetic screen to identify novel potential regulators of dorsal 
closure 
 
 
2.1. Gain-of-function screen for Drac1 and Dcdc42 interactors 
 
In order to identify novel components that are required for DC we have performed a genetic 
screen. Specific mutations in Drac1 and Dcdc42 were used as a starting point. Drac1 mutants 
are viable and fertile and display axon guidance and, to a lesser extent, axon branching defects 
(Ng et al., 2002). Only triple Rac (Drac1, Drac2 and mtl) mutants display dorsal closure defects. 
Dcdc42 homozygous mutant embryos fail to retract the germband and subsequently die before 
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the onset of dorsal closure (Genova et al., 2000). We therefore decided to misexpress dominant 
negative forms of Drac1 and Dcdc42 specifically in the eye to obtain viable flies displaying a 
clear rough eye phenotype. This phenotype was used as a basis to screen for modifying 
mutations. The viable tester line allowed us to screen for modifiers already in the first generation 
(F1 screen). This would not be possible if we wanted to misexpress the dominant negative forms 
of Drac1 and Dcdc42 in the embryo and to screen for modifiers of the resulting dorsal open (and 
lethal) phenotype.  
Furthermore, in contrast to the conventional loss-of-function screens, we chose to perform a 
gain-of-function screen. We adapted the enhancer-promoter (EP) screen developed by Rorth 
(Rorth, 1996; Rorth et al., 1998). Gain-of-function mutations are produced by UAS-containing P-
elements that are randomly inserted into the genome. Nearby genes become overexpressed 
when a Gal4 source is provided. Therefore we screened for genes that, upon overexpression, 
led to a modification of the rough eye phenotype. 
In the following chapter, I will explain in more detail the rationale of our screening strategy and 
describe the molecular nature of the P-element and the tester lines we used. 
 
2.2. Choosing the screening strategy: EP Screens 
 
In conventional genetic screens, mutations that reduce or eliminate a gene function are identified 
following random mutagenesis of the genome with chemicals, ionizing radiation or transposable 
elements. However, it has been estimated that only around 30% of all Drosophila genes can be 
mutated to an easily identifiable phenotype (Ashburner et al., 1999; Miklos and Rubin, 1996). 
This may be due to the fact that some genes have a pleiotropic phenotype. Another reason may 
be redundancy, i.e., a gene may be dispensable if the genome contains redundant, back-up 
copies of the gene or if the product of another, although not homologous, gene can exert and 
thereby replace the function of the mutated gene. For example, the two homologous genes 
scylla and charybde act as partially redundant genes in the regulation of growth in Drosophila 
(Reiling and Hafen, 2004). Furthermore, an early lethal phenotype hinders studies of later 
functions of the respective gene. 
 
Not only loss but also gain of function of a gene can result in specific phenotypes. Genes with 
missing, mild or pleiotropic loss-of-function phenotypes may therefore be identified based on 
their gain-of-function phenotypes. Rarely, gain-of-function mutants have been isolated from 
conventional mutagenesis screens. They could be identified based on their dominant 
phenotypes. Gain-of-function phenotypes, however, can also be generated by controlled 
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overexpression of a gene of interest. In addition, controlled overexpression allows to identify 
important genetic interactions. This is possible if increased expression of one gene enhances or 
suppresses the phenotype of a mutation in another gene, especially when their products are 
involved in the same process. For example, overexpression of the Drosophila JNK, bsk, rescues 
the dorsal open phenotype of a cno mutant embryo (Takahashi et al., 1998). Similarly, 
overexpression of dominant negative Drac1 leads to defective DC, which is rescued by 
expression of activated Djun (Hou et al., 1997). 
However, phenotypes caused by overexpression must be interpreted with caution. 
Overexpression of a gene may lead to non-physiological high levels of its product and may 
eventually produce a non-specific phenotype (see also discussion Chap. 2.8.).  
 
To allow systematic overexpression screens in Drosophila, Rørth (1996) developed a modular 
system combining P-element insertional mutagenesis with Gal4 regulated gene expression. The 
target P-element carries upstream activating sequences (UAS) that are recognized by the yeast 
transcription factor Gal4, and a basal promoter oriented to direct the expression of genomic 
sequences adjacent to the P-element insertion site (Fig. 4 and 6). Rorth named these P-element 
insertion lines ‘EP’ to indicate that both the enhancer (Gal4 binding sites) and the promoter are 
included in the P-element. When combined with a source of Gal4, the P-element will direct 
expression of any gene that lies next to its insertion site. The fact that P-elements insert 
preferentially into 5’ ends of genes (Spradling et al., 1995) greatly increases the number of 
essentially full-length transcripts (Rorth, 1996). The modular design makes the screen flexible 
and conditional, i.e. genes can be induced in any spatial or temporal pattern using different 
Gal4-lines. This misexpression approach has been successfully adopted in screens that aimed 
at identifying genes involved in specific developmental processes. In some reports, tissue 
specific Gal4 driver lines were crossed with EP element lines. The resulting overexpression of 
genes adjacent to the EP element were screened for specific phenotypes (Abdelilah-Seyfried et 
al., 2000; Kraut et al., 2001; Pena-Rangel et al., 2002; Rorth, 1996; Tseng and Hariharan, 2002). 
In other reports, the Gal4 driver lines carry in addition a mutation in a gene of interest causing a 
specific phenotype. These flies were crossed to the EP element lines and the F1 generation was 
screened for modifiers of this phenotype (Huang and Rubin, 2000; Raymond et al., 2004; Rorth 
et al., 1998). An example of the latter approach was recently published by Raymond et al. 
(2004). They screened EP element lines for modifiers of the rough eye phenotype caused by 
overexpression of RacGAP(84C). Proteins with established functions in small GTPase signaling 
were identified as well as novel potential partners of RacGAP(84C), none of which had been 
found in previous saturating loss-of-function screens (Raymond et al., 2004).  
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The aim of the present study was to identify novel genes implicated in the process of DC. Loss-
of-function mutageneses have already identified many DC genes. Due to the above mentioned 
limitations of loss-of-function screens we chose to perform a complementary gain-of-function 
modifier screen. Moreover, the modular design of the EP screen developed by P. Rorth makes it 
simple to use for the following reasons: many useful Gal4 pattern lines are already available; 
target lines are easy to generate and can be used repeatedly. As the mutagen is a P-element, 
the cloning of affected genes is greatly facilitated.  
 
We adapted the screening strategy introduced by Rorth to identify DC genes. To this end, we 
generated a large number of EP element insertion lines and  screened them for modifiers of a 
specific phenotype caused by mutant regulators of DC (see below). 
 
2.2.1. P-element with bidirectional upstream activator sequence (UAS) enhancers 
 
The EP element used in this study is slightly modified from that described by Rørth (Rorth, 1996; 
Rorth et al., 1998). The EP element used here (Fig. 4) contains Gal4 binding sites (UAS) and 
basal promoters (hsp70) at both ends of the P-element. Thus this double-headed element is 
able to drive the expression of endogenous genes on both sides of the insertion, thereby 
potentially doubling the number of genes that can be screened. A part of the EP element, 
including the UAS site at the 5' end, is flanked by Cre recombinase target (CRT, loxP) sites. This 
cassette is removed in flies expressing Cre recombinase, so that overexpression of an 
endogenous gene 5’ to the P element is lost. This allows to distinguish whether the gene 5’ or 3’ 
to the P element is responsible for the modified phenotype. In total we generated 10000 
independent EP element insertions (see Materials and Methods). 
 
Figure 4. Transcription from mobilized P elements was induced from bidirectional upstream 
activator sequence (UAS) enhancers using GMR-Gal4 
The “double-headed” EP element contains UAS sequences at both sides of the P-element. Cre 
recombinase excises the region between the Cre recombination target (CRT) sequences, including UAS 
sequences and the hsp70 promoter at the 5' end as well as the yellow reporter and the Ampicillin 
resistance gene (Figure modified from J. Reiling, see also Materials and Methods). 
 
 
CRT CRThsp70 hsp70yellow+ Amp®
5‘ 3‘
10xUAS 10xUASEcoRI Asp718
SacII
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2.2.2. The tester lines GMR>Drac1N17 and sev>Dcdc42N17 
 
A large number of independent EP element insertions were generated and tested in a Rac1 or 
Cdc42 sensitized genetic background. 
Drac1 and Dcdc42 are small GTPases that act as molecular switches that cycle between a 
GDP-bound ‘‘off’’ state and a GTP-bound ‘‘on’’ state. Active GTPases hydrolyze GTP to GDP 
and thereby get inactive. This GDP is removed by guanine nucleotide exchange factors (GEFs).  
We made use of dominant negative forms of Drac1 and Dcdc42 that carry both a T to N amino 
acid substitution at position 17. This mutation prevents the exchange of a bound GDP to a GTP. 
Thus, these dominant negative forms are thought to remain in an inactive GDP-bound state that 
binds to and sequesters endogenous GEFs. The consequent reduction of “free” GEFs results in 
decreased activation of Drac1, Dcdc42 and probably other RhoGTPases. Thus, it is also 
conceivable that the Drac1N17/Dcdc42N17 overexpression phenotype does not reflect a loss-of-
function phenotype of the endogenous proteins but might rather be compared to a composite 
phenotype of several GEF mutants. 
  
Both Drac1 and Dcdc42 are key regulators of DC. Embryos expressing dominant negative 
versions of either Drac1 (Drac1N17) or Dcdc42 (Dcdc42N17) die with defects in DC (Fig. 5 C and 
E). Lethality during embryogenesis prevents the use of these mutants for a screening of the F1 
generation, because the tester lines would not survive to adulthood. 
Theoretically the methodological difficulties caused by the lethality could be overcome by 
performing a screen in the F2 generation. To this end, the EP element insertion lines should first 
be crossed to flies carrying the Drac1N17 or Dcdc42N17 transgenes. The resulting flies of the F1 
generation should then be crossed to an embryonic Gal4 driver line to produce embryos in the 
F2 generation that carry the EP element, the Drac1N17/Dcdc42N17 and the Gal4 transgenes. Such 
a procedure is not suitable, however, for several reasons:  
First,  the EP insertion sites are not known and presumably 50% of the EP elements would 
segregate from Drac1N17/Dcdc42N17 transgenes in the second cross. These EP elements 
insertions could therefore not be investigated for interaction with Gal4-mediated 
Drac1N17/Dcdc42N17 overexpression phenotypes. 
Second, DC is a subtly balanced process that implies a summation of various, also antagonizing 
forces (see chapter 1.1.) (Kiehart et al., 2000). For example, mutations in both the Drosophila 
JNK, Basket, and its negative regulator, the phosphatase Puckered, lead to similar defects in 
dorsal closure (Martin-Blanco et al., 1998; Riesgo-Escovar et al., 1996). Furthermore, 
overexpression of Puckered also leads to a dorsal open phenotype (Martin-Blanco et al., 1998; 
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Rintelen et al., 2003). It might even be possible that a specific Rac or Cdc42 interactor could 
both suppress and enhance the dorsal closure phenotype depending on the level of expression. 
This is supported by the seemingly paradox fact that expression of either dominant negative or 
constitutive active Dcdc42 can partially rescue the dorsal open phenotype of Drac1N17 
expressing embryos (Harden et al., 1999). 
Therefore, and third, the analysis of these subtle changes of the embryonic phenotype is more 
time consuming than the analysis of adult phenotypes and hence limits the number of embryos 
that can be screened. A partial rescue to larval stages or a complete rescue to adulthood will 
probably occur very rarely. 
To overcome these difficulties we took advantage of two tester lines in which eye-specific Gal4 
drivers (sev-Gal4 and GMR-Gal4) activate expression of dominant negative versions of either 
Drac1 (Drac1N17) or Dcdc42 (Dcdc42N17) by using the Gal4/UAS system (Brand and Perrimon, 
1993). In the following paragraphs we will refer to the tester lines as GMR>Drac1N17 and 
sev>Dcdc42N17, respectively. The expression of these dominant negative proteins during eye 
development leads to a disruption of the normal eye structure (Fig. 5 D and F). 
The resulting rough eye phenotype, rather than the DC phenotype, was used as a starting point 
for our gain-of-function screen, assuming that Drac1 and Dcdc42 signaling is conserved in every 
cell type. Such assumptions are commonly made: Raymond et al., for example, recently showed 
that overexpressed RacGAP(84C) has the same in vivo substrate specificity during eye 
development and embryonic dorsal closure (Raymond et al., 2001). It has been shown earlier 
that Drac1N17 and Dcdc42N17 expression interferes with normal eye patterning (Fanto et al., 
2000; Raymond et al., 2004). Fanto et al. reported that the resulting defects of Drac1N17 
expression were similar to the loss-of-function phenotypes typical of tissue-polarity genes. 
Furthermore, Genova et al. showed that Dcdc42 mutant clones in the eye fail to produce adult 
ommatidia (Genova et al., 2000). 
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Figure 5. Expression of dominant negative Drac1 and Dcdc42 during embryonic and eye 
development.  (A) Cuticle preperation of a wildtype embryo. (B) Wildtype eye. Overexpression of DN 
Drac1 (C) and Dcdc42 (E) in the embryo leads to complete failure of dorsal closure. Expression of 
Drac1N17 and Dcdc42N17 in the eye using GMR-Gal4 or sev-Gal4, respectively, causes a rough 
appearance of the eyes due to disordered and partially fused ommatidia (D and F). The causes for this 
phenotype were not examined in detail but may involve aberrant cytoskeletal behaviours. As in DC, Rho, 
Rac and JNK signaling have been implicated in planar polarity in the eye (Fanto et al., 2000), thus the 
disorder of ommatidia could be due to defective planar polarity. This phenotype is dominantly suppressed 
by the herein identified suppressor EP elements that direct overexpression of a nearby gene (see Fig. 7 in 
chapter 2.4.).  
2.3. Screening for suppressors of a rough eye phenotype 
 
In total we crossed 4900 and 5500 independent EP insertion lines with the GMR>DRac1N17 and 
sev>Dcdc42N17 tester lines, respectively (Fig. 6, Tab. 2). A fraction of the EP lines were crossed 
with both tester lines.  
The F1 generation was then screened for modifiers of the rough eye phenotype. Modifiers either 
improved or worsened eye structure and were referred to as suppressors or enhancers, 
respectively. Modification of the rough eye phenotype is supposed to be caused by EP 
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dependent transcription of a nearby gene. These genes thus represent potential Drac or Dcdc42 
signaling components. 
 
 
 
Figure 6. Scheme of the EP suppressor screen 
Tester flies carrying the yeast Gal4 transgenes that are under the control of the sev- or GMR-enhancer, 
activate dominant negative UAS-Dcdc42N17 or UAS-Drac1N17 specifically in the eye. They have been 
crossed to a large number of flies with new EP element insertions. The combination of the eye-specific 
Gal4 with UAS-Dcdc42N17 or UAS-Drac1N17 gives rise to the rough eye phenotype. The overexpression of 
a gene X under the control of the UAS/Gal4 system may suppress or enhance the rough eye phenotype, 
especially when gene X is involved in the same pathway. 
 
2.4. Selection of 22 suppressors specific for either Drac1N17 or Dcdc42N17 
 
From the set of 4900 EP lines crossed with GMR>Drac1N17 83 (1.7%) lines behaved as 
suppressors and 1715 (35%) lines as enhancers of the rough eye phenotype. 173 (3.1%) out of 
5500 EP lines suppressed the rough eye phenotype of sev>Dcdc42N17 whereas 1069 (19%) 
were found to be enhancers (Tab. 2).  
The high percentage of enhancers suggested that the affected genes are not Drac1 or Dcdc42 
interactors but rather cause a disturbance of the eye structure by unrelated mechanisms. 
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Moreover, the high number of enhancer lines complicates the handling. Taking these 
considerations into account we decided not to characterize on these lines.  
Suppression, that manifests as improvement of the disrupted eye structure, can not be caused 
by additive effects. Suppression is rather caused by a specific restoration of the disturbed 
signaling pathways. The view that suppression is more specific is further supported by the low 
proportion (1.7 - 3.1%) of suppressors found for both tester lines. Thus we continued to analyze 
the suppressors. We retested the suppressors with the same tester lines as used in the first 
round. Upon retesting the percentage of confirmed suppressors was lower. This finding can be 
explained, first, by variability and unspecificity of the phenotypes of the suppressor lines and, 
second, by application of more stringent selection criteria. After this selection step, 28 
suppressors of GMR>Drac1N17 and 44 suppressors of sev>Dcdc42N17 remained (Tab. 2).  
 
 
tester line y,w; GMR-GAL4; UAS-
Drac1N17 
y,w; UAS-Dcdc42N17; sev-GAL4
# EP lines 4900 5500 
# enhancers  
(+lethals) 
1715 (35%) 1069 (19%) 
# suppressors 83 (1.7%) 173 (3.1%) 
# suppressors after 
retest 
28 (0.6%) 44 (0.8%) 
# specific/exclusive  
no additional interaction 
with other tester lines 
(Table 3) 
11 (0.2%) 12 (0.2%) 
Table 2. Numbers of screened EP lines and percentages of identified enhancers and suppressors 
4900 and 5500 EP lines were crossed with GMR>Drac1N17 and sev>Dcdc42N17, respectively. A high 
percentage of  EP lines enhanced the rough eye phenotype of the two tester lines, indicating unspecific 
effects. These enhancer lines were thus discarded. After retests of the rough eye suppressors 23 lines 
remained that exclusively interacted with one of the two tester lines. 
 
 
Next, we entered our results into a custom built database. We then compared the candidate 
lines with data obtained by other collaborators that participated in the screen with different tester 
lines. These other collaborators intended to find genes that potentially act in the insulin, TOR, 
myc, Wg or Hh signaling network (Tab. 3). The lines that did not exclusively suppress the 
GMR>Drac1N17 or sev>Dcdc42N17 phenotypes were considered to be less specific and were thus 
discarded. However, genes that participate in several pathways might be missed with this 
approach. For example, it is conceivable that components of the Wg signaling pathway modify 
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the phenotype of both tester lines sev-Wg and GMR>Drac1N17, since it has been shown that 
wingless signaling components and Drac1 work in a common pathway to affect planar polarity in 
the eye (Fanto et al., 2000; McEwen et al., 2000).  
After this selection step 23 suppressors fulfilled our strict criteria. Surprisingly, of these 23 
suppressors only one (EP43-018, specified as one of 11 GMR>Drac1N17 suppressors, not 
included in the 13 sev>Dcdc42N17 suppressors, see Tab.4) was shared by both tester lines, 
although it is conceivable that many signaling components are common to both RhoGTPases.  
The database also shows that an EP dependent enhancement phenotype is found many times 
in several apparently unrelated tester lines (data not shown). This is typical for unspecific 
interactions and further supports our previous suggestion that analysis of enhancers is 
inappropriate for our purpose .  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
overexpressed gene 
eye- or wing-
specific Gal4 
drivers
UAS-Dcdc42N17 sev-Gal4
UAS-Drac1N17 GMR-Gal4
UAS-InR GMR-Gal4
UAS-PKB, UAS-PDK1 GMR-Gal4
UAS-BaboonQD GMR-Gal4
UAS-myc(3) GMR-gal4
UAS-S6K ap-Gal4
sevE-hsp-sevS11 sEsP-Gal4
* sev-wg GMR-Gal4
UAS-lgs17E sal-Gal4
UAS-ptc sal-Gal4
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UAS-smo [I] sal-Gal4
* Gal4 independent wg-expression 
 
Table 3. Various additional tester lines of EP screen collaborators  
Several collaborators screened the EP lines with different tester lines that display either specific eye or 
wing phenotypes (not shown). Eye-specific overexpression of either sevS11 (activated form of the 
sevenless receptor tyrosine kinase), Dcdc42N17, Drac1N17, BaboonQD (activated form of Drosophila Activin 
receptor) or wg lead to a disruption of the normal eye structure. GMR-Gal4 dependent overexpression of 
either InR, combined PKB and PDK1, or dMyc (three copies) leads to overgrowth of the eyes. 
Overexpression of dS6K in the dorsal part of the developing wings using ap-Gal4 leads to overgrowth of 
this area and subsequently to a bending down of the wings. sal-Gal4 dependent overexpression of either 
lgs17E, ptc or smo[l] lead to patterning defects of the adult wing. 
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Figure 7. Overview of the rough eye suppressor phenotypes. 
On the left of (A) the rough eye phenotype of the GMR>DRac1N17 tester line is shown (see also Fig. 5D). A 
rough eye is characterized by an irregular array and disrupted structure of ommatidia. Improvement of eye 
structure (i.e. suppression of the GMR>DRac1N17 rough eye phenotype) is seen when the selected EP 
suppressors are co-overexpressed, (A) right side and (B-J). (A, right side) EP32-120 (responsible gene: 
MSP-300), (B) EP51-198 (MSP-300), (C) EP36-054 (SelD), (D) EP43-018 (CG30122), (E) EP34-026 (SA-
2), (F) EP39-161 (falafel), (G) EP47-082 (falafel), (H) EP55-127 (cpo), (I) EP58-173 (cpo), (J) EP53-065 
(HLHm7). 
Eye-directed overexpression of Dcdc42N17 also leads to a rough eye phenotype (K) left side (see also Fig. 
5F), which is suppressed by co-overexpression of suppressors specific to the sev>Dcdc42N17 tester line 
(K) right side and (L-V). (K, right side) EP31-149 (Rbf), (L) EP13-034 (Trf2), (M) EP29-104 (ATP7), (N) 
EP29-062 (e(y)3), (O) EP43-011 (CG6700), (P) EP33-095 (CG30188), (Q) EP14-215 (CG30421), (R) 
EP22-048 (CG30421), (S) EP33-059 (CG30421), (T) EP33-094 (RE29262 cDNA), (U) EP22-081 (Aats-
Glupro), (V) EP-28-221 (stg). 
 
 
2.5. Tissue-specific overexpression of putative genes affected by EP element 
insertion 
 
The rough eye modification of the suppressors already suggested a function of the 
corresponding proteins in Rho-GTPase signaling. We aimed at further investigating the function 
of the genes during development. To this end, we overexpressed the selected EP suppressors 
in different tissues and analyzed the resulting phenotypes. 
We crossed the EP lines to different Gal4 lines that drive expression either in the embryo, in the 
imaginal discs, during pupal thorax closure or ubiquitously during the entire development (Tab. 4 
and Fig. 8): 
The enhancer trap line 69B drives expression of UAS containing sequences in the embryonic 
ectoderm from stage 11 and in the eye-antennal, haltere, leg and wing imaginal discs. MD237 is 
a Gal4-containing P-element enhancer trap line in the pnr locus which is expressed in the 
dorsal-most regions of the embryo and the imaginal discs (Calleja et al., 2000). Gal4 fused to 
glass multiple reporter (GMR-Gal4) is expressed in post-mitotic cells of the developing eye, and 
actin(5C)Gal4 drives ubiquitous expression throughout development. 
We found that 10 lines produced a visible phenotype when driven by one of these Gal4 lines. 6 
out of 13 tested EP lines caused embryonic or pupal lethality in combination with Actin(5C)Gal4. 
When using 69B as source of Gal4, two EP elements produced penetrant dorsal closure and 
head involution defects (EP34-054, EP36-026, Fig. 8 A, B, respectively). Embryos with 69B and 
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EP28-221 displayed a defective germ band retraction. Two lines (EP39-161 and EP47-082) 
were semi-viable in combination with 69B and displayed a specific wing phenotype (Fig. 8 G). 
Furthermore, some dead embryos with dorsal open phenotypes were observed (Fig. 8 C). 
In four lines MD237 driven overexpression produced a cleft in the thorax of adult flies (two 
examples are shown, EP31-149 (Rbf) and EP47-082 (falafel), Fig. 8 E and F, respectively). This 
defect results from a failure in the fusion of the two imaginal wing discs during metamorphosis. 
The closure of the thorax during metamorphosis resembles the process of dorsal closure during 
late embryogenesis. In addition to morphological similarities, genetic evidence points to similar 
molecular mechanisms that direct embryonic dorsal and imaginal thorax closure, involving the 
JNK and Dpp signaling pathways (Agnes et al., 1999; Martin-Blanco et al., 2000; Zeitlinger and 
Bohmann, 1999).  
One EP line, EP53-065, led to missing bristles on the thorax and abdomen upon MD237 driven 
overexpression. Loss of bristles was also observed when this EP line was expressed in the eye. 
Nevertheless, the suppression of the rough eye phenotype was obtained by a clear improvement 
of the array and individual structure of ommatidia. The gene responsible for the suppression and 
overexpression phenotype  is HLHm7 (Tab. 4, Chap. 2.6. and 2.9.6.), which is known to play a 
role in neural development and the formation of mechanosensory bristles. 
Another line, EP29-104, displayed a pale cuticle of adult flies upon both MD237 and 
actin(5C)Gal4 driven overexpression (Tab. 4 and Fig. 8 H). In this case ATP7, a gene encoding 
a copper transporter, is responsible for the mutant phenotype. Consistently, misregulation of 
copper homeostasis has been shown to affect pigmentation in Drosophila (Zhou et al., 2003). 
This effect could be due to the requirement for copper of tyrosinase, a copper-dependent 
enzyme involved in melanogenesis and pigmentation. Petris et al. showed that human 
tyrosinase was inactive in ATP7A mutant fibroblast cells  (Petris et al., 2000). The role of ATP7 
in pigmentation is further described in Drosophila as well (Norgate et al., 2005). 
Thus, although the overexpression phenotypes do not necessarily define the normal function of 
these genes during development, our results indicate that meaningful dominant effects can be 
uncovered. Furthermore, overexpression of some of the EP lines interferes with developmental 
processes that are known to be dependent on functional Rho GTPase signaling, such as dorsal 
closure (reviewed by Harden 2002) and thorax closure (Ishimaru et al., 2004). The genes 
causing these phenotypes therefore represent putative new DC genes and Rho GTPase 
interactors, the identification of which was the initial purpose of the screen.  
The results of the overexpression experiments are summarized in Table 4, examples of the 
overexpression phenotypes are shown in Figure 8. 
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Figure 8. 69BGal4 and pnrGal4 mediated overexpression phenotypes of EP element lines. 
69BGal4 dependent overexpression phenotypes of EP element insertion lines affect embryogenesis. 
Defects in dorsal closure, head involution and germ band retraction in (A-D). (A) 69B>EP36-054 
(responsible gene: SelD), (B) 69B>EP36-026 (SA-2), (C) 69B>EP47-082 (falafel), (D) 69B>EP28-221 
(stg). (G) Wing defects in flies with 69B>EP47-082 (falafel). (E, F, H) pnrGal4 dependent overexpression 
phenotypes of EP element insertion lines affect thorax closure and adult cuticle pigmentation. (E) 
pnrGal4>EP31-149 (Rbf), (F) pnrGal4>EP47-082 (falafel), (H) pnrGal4>29-104 (ATP7), cuticle on thorax 
and abdomen is brighter in the pannier domain. 
 
 
2.6. Identification of the genes responsible for the suppression/ 
overexpression phenotypes 
 
2.6.1 Recovery of DNA sequences flanking the EP element insertions by plasmid 
rescue 
 
To characterize the genes responsible for the suppression and overexpression phenotypes, the 
DNA flanking the EP elements was isolated by plasmid rescue and the genomic region 
immediately downstream of the EP element promoter was sequenced.  
The obtained sequence was subjected to Blast searches against the fully sequenced genome of 
Drosophila using http://flybase.net/blast/. We then searched the region 5’ and 3’ of the insertion 
site for known or predicted genes. We found that 21 out of the 23 EP elements were inserted 5’ 
of the translational start site of at least one predicted or cloned gene suggesting that activation of 
gene transcription caused the suppression of the Drac1N17/Dcdc42N17 rough eye phenotype. The 
remaining two genes were located as follows: EP33-094 was inserted in a genomic region where 
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no obvious genes are located in the close vicinity. However, an expressed sequence tag (EST 
RE29262) of a cDNA aligns near the EP element insertion site. This locus was also identified in 
another misexpression screen which was designed to identify genes that, upon overexpression, 
cause defects in the male germ cells (Schulz et al., 2004). A second EP element (EP51-198) 
was inserted in the third exon of the gene encoding muscle specific protein 300 (MSP-300). This 
gene was hit by a second EP element (EP32-120). However, EP32-120 was located 5’ of the 
gene and is therefore likely to drive the expression of the full length transcript. All the 
suppressors with corresponding genes are listed in Table 4. 
 
2.6.2. From double- to single-headed EP elements to identify the responsible 
genes 
 
To distinguish whether the gene 5’ or 3’ of the EP element is responsible for the suppressive 
effect we crossed CRE recombinase expressing flies with those carrying the EP-elements. This 
led to the excision of the UAS sequences at the 5’ end of the EP element (see also Fig. 4). The 
resulting single headed EP element lines were then tested for suppression of the rough eye 
phenotype and their additional possible overexpression phenotypes. If the phenotype was lost 
after excision of the 5’ UAS sequences, we concluded that the responsible gene was located 5’ 
of the EP element. On the other hand, if the phenotype remained unchanged the gene was 
located 3’ of the EP element. However, the lines EP13-034 and 14-215 carried EP elements with 
defective CRT sites which prevented excision of the 5’ UAS sites. Another complication arose in 
4 lines, containing presumably functional CRT sites. No flies were obtained where the y+ marker 
gene was excised by the cre recombinase. In summary, for 16 of the 23 EP lines, we were able 
to identify single genes that are probably responsible for the suppression phenotypes and hence 
are potential DRac1 or Dcdc42 interactors (Tab. 4).  
In those lines where CRE-mediated excision of UAS sequences was not possible, we continued 
as follows: In the case of EP13-034, we made use of a previously published EP element 
EP(X)1310 (obtained from the Bloomington stock center). This single headed EP element is 
located at a similar position as EP13-034 but points to CG11190 only. This EP element, 
however, did not behave as a suppressor of the rough eye phenotype indicating that Trf2 rather 
than CG11190 is responsible for the suppression phenotype.  
In the case of EP22-081, we decided to overexpress one of the two candidate genes. We 
constructed an UAS-transgene containing the cDNA of AP-1 sigma. Co-overexpression of this 
transgene with sev>Dcdc42N17, however, did not result in suppression of the rough eye 
phenotype. This suggests that Aats-glupro rather than AP-1 sigma is responsible for 
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suppression of the rough eye phenotype. Since these two genes are positioned very close to 
each other (327bp) and the EP element inserted only 9bp upstream of the transcriptional start 
site of Aats-glupro we evaluated the possiblity that the EP element itself leads to a loss-of-
function situation. For that reason, we tested a deficiency strain in which the two genes were 
deleted and examined whether it also suppressed the rough eye phenotype of sev>Dcdc42N17. 
This was not the case. 
EP14-215 was inserted at exactly the same position as both EP22-048 and EP33-059. Cre/lox 
experiments for the latter two EP elements identified CG30421 as the gene responsible for the 
suppression phenotype. We therefore concluded that EP14-215 also drives CG30421 (see also 
Chap. 2.9.2.). 
The DNA sequence adjacent to EP33-095 aligns with the sequence of an expressed seqence 
tag (SD24970) which contains no open reading frame. Furthermore, there are no other ESTs in 
the same region. We therefore assume that SD24970 does not represent a real gene but an 
artefact. CG3162 is located 3' of the EP element, at a distance of 6kb. However, the orientation 
of the gene would lead to an antisense transcript if driven by the EP element. The best 
candidate gene is situated 5' of the EP element. The transcription start site of the cDNA 
RE72153 is 502 bp away from the EP element insertion. This cDNA is partially identical with the 
gene annotated as CG30188, thus RE72153 possibly represents an alternatively spliced 
transcript.  
EP55-127 and EP58-173 were inserted at exactly the same position in the couch potato (cpo) 
locus. The insertion site was 22kb upstream of the translation start site and 12kb downstream of 
the transcription start site, the third (untranslated) exon however starts only 29 bp downstream 
(3') of the EP element. Rim, encoding a Rab3A effector, is the next gene located 5' of the EP 
element, however at a huge distance of 35 kb. We therefore assume that cpo is the gene 
responsible for the suppression phenotype. 
 
In summary, after the plasmid rescue and CRE/lox experiments, we could determine  single 
genes probably responsible for the suppression phenotype in 17 of the 23 EP lines. No gene 
except for an EST could be assigned to one EP line (EP33-094). In the case of the five 
remaining EP lines one of the respective two candidate genes 5' and 3' of the EP element could 
be ruled out by several means: a) by testing a publically available single-headed EP element 
(CG11190), b) by testing a UAS construct (AP-1 sigma) and c) by sequence analysis. In 
consequence we had 23 EP suppressor lines corresponding to 17 genes (Tab. 4). 
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     overexpression phenotypes 
 
gene responsible 
for supression or 
candidate genes 
cytological 
position 
 
EP line 
insertion site  
relative to ATG 
 
69B-Gal4 
 
pnr-Gal4 
 
actin-Gal4 
Rbf 1C5 31-149 -565 bp lethal  thorax cleft  
(Fig. 8 E) 
ND 
Trf2, (CG11190) 7E7-9 13-034 -12602 bp 
(ATG of Trf2) 
WT WT lethal 
ATP7 10F1-2 29-104 -588 bp WT pigmentation defect 
in pnr domain  
(Fig. 8 H) 
pale cuticle,  
less bristles 
e(y)3  18D8-11 29-062 -742 bp WT WT ND 
CG6700 32B1 43-011 -376 bp WT WT WT 
CG30188, 
(SD24970) 
 
59D1 
33-095 -13234 bp 
(ATG of CG30188) 
 
WT 
 
WT 
 
ND 
 
CG30421 
 
60D16-E1 
14-215 
22-048 
33-059 
 
-7497 bp 
WT 
WT 
WT 
WT 
WT 
WT 
WT 
WT 
WT 
 
RE29262 
 
72D9 
 
33-094 
-34 bp (transcription 
start site) 
 
WT 
 
WT 
 
ND 
Aats-Glupro,  
(Ap-1 sigma) 
 
95D1 
 
22-081 
-91 bp 
(ATG of AatsGlupro)
 
WT 
variable slight thorax 
cleft 
 
WT 
 
stg 
 
99A5 
 
28-221 
 
-470 bp 
germ band 
retraction defects 
(Fig. 8 D)  
slight thorax cleft, 
less bristles 
 
ND 
D
cd
c4
2N
17
 s
up
pr
es
so
rs
 
       
       
pfrx 18C8 31-137 -467 bp ND ND ND 
32-120 +38644 bp (see text) WT WT lethal MSP-300 
 
 
25C7-10 51-198 -657 bp WT WT WT 
SelD 50E8 36-054 -246 bp anterior open 
(Fig. 8 A) 
WT lethal 
CG30122 
(also weak 
suppressor of 
Dcdc42N17) 
55E3 43-018 -243 bp WT WT WT 
SA-2  62A1 34-026 -8001 bp anterior open 
(Fig. 8 B) 
ND ND 
39-161  -3891 bp CG9351 (falafel) 
(Chap. 3) 
87F10-11 
47-082 -3901 bp 
semilethal – 
dorsal closure 
defects (Fig. 8 C, 
Fig. 11 F)), 
wings bent 
downwards (Fig. 
8 G, Fig. 11 E) 
thorax cleft 
(Fig. 8 F, Fig. 11 B) 
pupal lethal 
55-127 ND ND ND cpo, (Rim) 90D1-E1 
58-173 
-22486 bp  
(ATG of cpo) ND ND lethal 
D
ra
c1
N
17
su
pp
re
ss
or
s 
HLHm7 96F10 53-065 -247 bp WT less bristles in pnr 
domain 
less bristles 
        
Table 4. Identified genes and phenotypic effects of induced expression in different tissues 
List of all 23 EP insertions that were selected because they suppressed the rough eye phenotype of flies 
expressing either Dcdc42N17 or Drac1N17.  
To identify the loci of the EP insertions, the flanking DNA was isolated by plasmid rescue and the genomic 
region immediately downstream of the EP element promoter was sequenced. Since the EP-element used 
in this study has UAS sequences at both ends, CRT-sequences flanking the UAS sequences at the 5' end 
were excised by CRE-recombinase. The flies with these "halved" EP elements were then retested for 
suppression. The genes that were found to be responsible for the suppression are indicated. In the cases 
where the CRE/lox experiment did not yield a result, one of the respective two candidate genes 5' and 3' 
of the EP element, respectively, was ruled out (genes in brackets) by other means (see text).  
The distance between the EP element insertion site and the start of the open reading frame (as predicted 
by the Berkeley Drosophila Genome Project) is indicated. 
Overexpression: Gene expression driven by EP insertions was activated using the Gal4 driver lines 69B, 
pnr-Gal4 and actin-Gal4. 69B is expressed in the embryonic ectoderm from stage 11 and in the eye-
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antennal, haltere, leg and wing imaginal discs. pnr-Gal4 is expressed in the dorsal-most regions of the 
embryo and the imaginal discs. actin-Gal4 is ubiquitously expressed throughout development. 
 
 
2.7. Selection of two lines for further investigation 
 
The remaining 23 EP lines are specific suppressors for either GMR>DRac1N17 and 
sev>Dcdc42N17 and hence potentially play a role in RhoGTPase signaling. 
In the next step I evaluated and discussed each of the 17 genes corresponding to the 23 EP 
element insertions (see discussion). Based on these considerations I selected two genes that 
seemed particularly promising for further investigation: CG30421 and CG9351 (falafel). 
 
2.7.1. Overexpression of CG30421 leads to suppression phenotype 
 
The three EP element lines EP14-215, EP22-048 and EP33-059 were identified as suppressors 
of the sev>Dcdc42N17 rough eye phenotype. All three EP elements are inserted at exactly the 
same position on the right arm of the second chromosome at the cytological position 60D16-
60E1 (Fig. 9). EP14-215 had nonfunctional CRT sites, hence CG18510 which lies 5’ to the EP 
element could not be excluded to be responsible for suppression. The two other EP lines, 
however, had functional CRT sites. The orientation of the EP element with respect to the CRT-
flanked UAS seqences is different in these two lines. After excision of the UAS sequences the 
expression of CG30421 was maintained in EP22-048 (hereafter referred to as EP22-lox) but 
abolished in EP33-059. Only EP22-lox still suppressed the rough eye phenotype indicating that 
CG30421 was the responsible gene. To confirm this we cloned the open reading frame of 
CG30421 into the pUAST vector (Brand and Perrimon, 1993). As expected we found that co-
overexpression of UAS-CG30421 and sev>Dcdc42N17 suppressed the rough eye phenotype. 
 
 
 
Figure 9. Gene locus of CG30421 and P-element insertion sites  
 - 35 -  
The red triangle marks the insertion site of the 3 EP elements 14-215, 22-048 and 33-059, which is at a 
7kb distance from the transcription start site (left white box). The black boxes designate the ORF. Another 
insertion of a new P-element, KG04149, that could be used for a jump-out screen (see below), is 
represented by the black triangle. 
 
In the first release of the Drosophila genomic sequences, CG30421 was incorrectly annotated as 
two separate genes, CG9189 and CG3872. This was due to the finding that several cDNAs with 
expressed sequence tags (ESTs) spanned only parts of CG30421. I found that one cDNA, 
however, had a 5’ EST (GH27809.5prime) belonging to CG9189 and a 3’ EST 
(GH27809.3prime) belonging to CG3872. A later annotated full-length sequence of this cDNA 
confirmed that these two genes are in fact only one.  
CG30421 codes for a putative ubiquitin specific protease. Such enzymes cleave off ubiquitin 
residues of specific substrates and thereby prevent polyubiquitination and subsequent 
degradation of these substrates by the proteasome complex. Since CG30421 overexpression 
suppresses dominant negative Dcdc42, targets of CG30421 are likely to be positive regulators 
Dcdc42. A particularly interesting target would be Jun, which is known to be regulated by 
polyubiquitination in human cells (Wang et al., 2001) and has been shown to act downstream of 
Dcdc42 during the process of thorax closure in Drosophila (Agnes et al., 1999). 
 
2.7.2. Reversion of overexpression phenotypes of CG30421 by EMS mutagenesis  
 
CG30421 overexpression did not lead to any visible phenotypes when driven by either pnr-GAL4 
(MD237), actin(5C)Gal4 or 69B (see above). So far the only functional information of CG30421 
is the suppression of the rough eye phenotype in the sev>Dcdc42N17 tester line.  
In order to further address the function of CG30421 it is important to know the consequences of 
loss-of-function mutations. For this purpose I performed a mutagenesis screen by making use of 
the suppression phenotype caused by the EP-dependent overexpression of CG30421. 
Males containing EP22-lox were treated with ethyl methanesulfonate (EMS) and were 
subsequently crossed to females of the sev>Dcdc42N17 tester line. The F1 generation was then 
screened for flies that showed a reversion of the suppression phenotype, i.e., flies in which 
EP22-lox was no longer suppressing the Dcdc42N17 rough eye phenotype. These flies potentially 
carry mutations in CG30421. Unexpectedly I found a high proportion of revertants (10-20%). 
As I used a standard dosis of EMS, which is expected to induce one mutation every 100kb, the 
probability that specific mutations in CG30421 are responsible for all reversion events is close to 
zero. What could be the cause for the high proportion of revertants? Since EP22-lox does not 
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lead to a complete suppression of eye roughness back to wild type, this suppression phenotype 
may be too sensitive for second site modifiers. Such mutations do not necessarily affect genes 
involved in Dcdc42 signaling but may rather unspecifically interfere with eye development. Thus, 
reversion of suppression could be compared to the enhancement of the sev>Dcdc42N17 rough 
eye phenotype that was obtained in a similarly high proportion of EP lines (Tab. 2).  
Mutagenesis screens for reversion of an EP-dependent phenotype have been previously 
performed in our lab. For example, a very similar mutagenesis screen for revertants of a 
suppressor of the BaboonQD (Tab. 2) rough eye phenotype also failed because of improbably 
high numbers of revertants (S. Breuer, personal communication). However, a screen for 
reversion of suppression of an overgrowth phenotype (GMR>InR, Tab. 2) was performed 
successfully (Wittwer et al., 2005). The difference between the two screens may be that in one 
case the reversion event is overgrowth, which probably occurs less frequently than an 
enhancement of disruption of eye structure, i.e., reversion of the suppression phenotype.  
A characteristic and robust overexpression phenotype would be better suited for a reversion 
mutagenesis. In this case, the reversion would manifest as an improvement of a defective 
phenotype, which is in contrast to the reversion of a suppression phenotype, which manifests as 
an enhancement of a subtle phenotype. However, EP-dependent overexpression of CG30421 
does not lead to a visible phenotype (Tab. 4) that could be used for a mutagenesis screen. For 
example, EP-dependent overexpression of dMKP-3 in the eye led to a rough eye phenotype, 
and a mutagenesis screen for reversion to wild type eyes has been performed successfully 
(Rintelen et al., 2003). 
Thus, the function of CG30421 remains to be assessed. In summary, the gene was identified in 
an overexpression screen as a potential regulator of Dcdc42. However, overexpression 
phenotypes may result from unspecific effects rather than reflecting the physiological function of 
the gene. A better understanding of the precise function of CG30421 can be expected from the 
analysis of a loss-of-function mutation. However, a reversion mutagenesis screen to obtain 
mutants of CG30421 failed. Another possibility to generate mutations in CG30421 is a jump-out 
screen. This method requires the imprecise excision of a P-element that is inserted near the 
gene of interest. In the case of CG30421, the EP elements identified in our screen are located 
too far away (7kb) from the translational start site of the gene. A publically available P-element, 
KG04149 (Fig. 9), is located only 175 bp away from the ATG and could serve as a tool for doing 
a jump-out screen. 
 
2.7.3. CG9351/falafel 
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Mutagenesis of CG9351 was successfully perfomed. The results are presented in chapter 3. 
 
2.8. General discussion of the EP screen  
 
The aim of this study was to identify novel signaling components that contribute to dorsal closure 
of the Drosophila embryo. For this purpose I performed a gain-of-function screen for genes that 
interact with either Drac1 or Dcdc42, which are known key players in DC. A large number of flies 
with random and independent EP element insertions were crossed to flies that express dominant 
negative forms of either Drac1 or Dcdc42 specifically in the eye. The consequent rough eye 
phenotype of the Drac1/Dcdc42 tester flies was suppressed by a number of EP element 
insertions. After further strict selection steps 23 EP lines remained that exclusively suppressed 
the Drac1 or Dcdc42 phenotypes. These suppressor lines are therefore potential interactors of 
Drac1 or Dcdc42. The recovery of the DNA sequences near the EP element insertions allowed 
us to find the genes that are responsible for the suppression phenotype. This approach led to 
the identification of 17 genes, none of which has been previously reported to interact with Drac1 
or Dcdc42. The potential role of these genes in DC has not yet been investigated except for one 
gene, falafel (Chap. 3). 
In the following I discuss the characteristics of our approach and both its advantages and 
limitations. After this, each of the identified genes will be discussed (Chap. 2.9.) and evaluated 
for further use in investigation. 
 
2.8.1. Advantages and limitations of our screening strategy 
 
Genes involved in dorsal closure have been identified in conventional loss-of-function screens. 
However, this approach has limitations because mutations in a high proportion of Drosophila 
genes do cause pleiotropic phenotypes or do not result in phenotypic abnormalities (Ashburner 
et al., 1999; Miklos and Rubin, 1996).  
To complement the loss-of-function screens and to find novel genes involved in dorsal closure 
we decided to perform a gain-of-function screen. 
 
We misexpressed dominant negative versions of the two RhoGTPases Drac1 and Dcdc42 in the 
eye and used the resulting rough eye phenotype as a starting point for our genetic screen. The 
phenotype caused by overexpression results from the increased presence and function of a 
protein. The non-physiological high level of a protein, however, may perturb development also 
unspecifically: It may lead to non-specific protein-protein interaction, to non-physiological 
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distribution and formation of aggregates. All this may disturb the normal function and viability of 
a cell and thereby produce a non-specific phenotype. However, Fanto et al. observed that 
overexpression of a dominant negative form of Rac1 resulted in defects that were similar to the 
loss-of-function phenotypes typical of Drac1 interacting genes (Fanto et al., 2000). This finding 
makes us confident that the rough eye phenotype caused by Drac1N17/Dcdc42N17-
overexpression indeed reflects a specific phenotype of defective RhoGTPase signaling. 
Another general concern with respect to overexpression by the UAS/Gal4 system is that Gal4 on 
its own can cause developmental defects and apoptosis in the eye (Kramer and Staveley, 2003). 
This suggests that apoptosis inhibitors would also suppress Gal4 mediated phenotypes. I 
discarded EP lines that were found to suppress also other Gal4-dependent phenotypes of other 
tester lines suggesting that my selection does not include apoptosis inhibitors. 
 
Another concern is that Rac or Cdc42 signaling may not be common to all cell types. Based on 
the assumption that these signaling pathways are common to all cell types we performed the EP 
screen for eye rather than DC phenotype modifiers. This approach was useful because the 
viability of the corresponding tester lines allowed an F1 screen. Although this assumption is 
widely accepted in developmental biology, any conclusion must be interpreted with caution. The 
function of particular proteins in a signaling pathway may vary depending on cell type and 
circumstances, and thus it is not always straightforward to extrapolate from one system to 
another. Thus it is possible that eye specific components of Drac1/Dcdc42 signaling might have 
been selected in the EP screen that have no function in DC. However, it was shown for a 
regulator of Drac1, RacGAP(84C), that it has the same in vivo substrate specificity during eye 
development and embryonic dorsal closure (Raymond et al., 2001), suggesting that the use of 
an eye phenotype is appropriate for screening for DC genes. 
 
2.8.2. Expectations and findings of screening strategy 
 
Our screening strategy together with the above mentioned limitations allows to formulate a 
prediction of what can be identified: 
 
2.8.2.1. Suppressors, not enhancers 
 
I observed both suppression and enhancement of the rough eye phenotype mediated by 
overexpression of DN Drac1 and Dcdc42. Enhancement was produced by a large number of EP 
lines. However, many genes that are overexpressed in the eye lead themselves to a rough eye 
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phenotype and therefore are thought to enhance a rough eye phenotype in an additive rather 
than in a synergistic manner. For this reason we discarded the enhancers.  
However, when seeking the EP screen database I found plasmid rescue sequence data of other 
screen participants for a number of enhancers of Drac1N17 or Dcdc42N17. One of these 
enhancers turned out to be aop/yan which is a known negative regulator of both Ras/MAPK and 
Drac1/JNK signaling. Thus, it is possible that other "true" regulators of Drac1 and Dcdc42 
signaling have been missed by discarding the enhancer EP lines. 
Suppressors are much more specific because they improve a disturbed eye structure which is 
unlikely to be caused by additive effects. Suppression is rather achieved by a specific restoration 
of Drac1/Dcdc42 signaling. Accordingly we found a low number of suppressors. 
 
2.8.2.2. Positive regulators down- or upstream of Dcdc42/Drac1 
 
Suppressors of the Drac1N17/Dcdc42N17 phenotype are likely to be positive regulators of Drac1 or 
Dcdc42 signaling. This includes not only proteins that exclusively interact with Drac1 or Dcdc42 
but also those that interact with the GEFs, as discussed above. These regulators can act either 
upstream or downstream of Rac1 or Cdc42 signaling. In a complete loss-of-function situation of 
Dcdc42 or Drac1 only proteins downstream are able to restore signaling. But overexpression of 
Drac1N17/Dcdc42N17 probably leads to a hypomorphic situation: Endogenous Drac1/Dcdc42 is 
still active, but probably to a lesser extent because many GEFs are sequestered. Thus upstream 
regulators can act as suppressors by activating the endogenous proteins. 
 
2.8.2.3. The screen did not identify known components 
 
RhoGTPase signaling has been analyzed extensively and many regulators, such as the GEFs, 
and downstream effectors, such as members of the JNK pathway, have been shown to play a 
role in DC, eye development and/or various other processes. Our screen did not identify any of 
these known components of RhoGTPase signaling.  
Several factors may have hindered the isolation of these genes: 
1. Our screen did not reach saturation. The 4900 and 5500 EP insertions, that we screened, 
could have activated the expression of theoretically 25%-40% of all Drosophila genes (estimated 
gene number: 13400-21000 (Adams et al., 2000). However the number of targeted genes is 
certainly lower in our screen as not all EP elements will be inserted at positions that allow them 
to activate expression of full length transcripts. Moreover P-elements do not insert randomly in 
the genome (Spradling et al., 1995) but the genome contains regions where P elements 
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preferentially integrate ('hot spots'). Also in our study EP insertions driving the same gene were 
isolated repeatedly (see Tab. 4). 
2. Many proteins need to be activated to exert their function, for example by phosphorylation. In 
such a case, overexpression alone is not sufficient to cause a specific phenotype. This seemed 
to be the case for the members of the JNK pathway: When I tested UAS-transgenes of the 
Drosophila JNKK, JNK and Jun I observed only a very weak suppression of the GMR>Drac1N17 
or sev>Dcdc42N17 phenotypes (data not shown). Such a weak suppression phenotype would not 
have been selected in the EP screen. 
3. The fact that none of the GEFs have been identified may be explained by their significant 
redundancy; there are more than 20 members of this protein family apparent from the 
Drosophila genome (Adams et al., 2000). Possibly more than one GEF is required to restore the 
dominant negative Rac/cdc42 signaling. 
 
Recently a gain of function screen similar to ours was performed (Raymond et al., 2004). 
Raymond et al. also intended to find positive regulators of Rac signaling. They expressed a 
negative regulator of Drac1, RacGAP84C (instead of Drac1N17 in our case), in the eye and 
screened the flies with the resulting rough eye phenotype for suppressing EP element insertions. 
Despite the similarity between their and our tester lines very different sets of genes were 
recovered in the two cases. How can two similar misexpression screens generate such different 
outcomes?  
RacGap(84C) probably targets not only Drac1 but also other small GTPases. This is suggested 
by Raymond et al. since they found several genes as enhancers or suppressors of 
RacGAP(84C) that are known to interact with the small GPTases Ras or Rho. We did not 
characterize the enhancers. Furthermore, we also discarded suppressors that were not 
exclusively specific for either Drac1N17 or Dcdc42N17. Raymond et al. however described several 
enhancers (that we missed) and suppressors that also interacted with other tester lines. They 
described only 6 suppressing EP insertions corresponding to 4 genes and 24 enhancers 
corresponding to 20 genes 
The only gene that was identified in both screens is cpo. However, cpo overexpression leads to 
suppression of the Drac1N17 phenotype, whereas the RacGAP(84C) phenotype is enhanced. 
Since both Drac1N17 and RacGAP(84C) are expected to inhibit Drac1 signaling it is surprising 
that cpo was identified as both suppressor and enhancer. Moreover, the EP(3)3395 and 
EP(3)3608, which are responsible for this enhancement phenotype of RacGAP, and EP55-196 
and EP58-173 are inserted at the very same position 22 kb 5' of the translation start site of the 
cpo gene. 
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 Albeit all this, we certainly analyzed a significant part of the genes of Drosophila for interactions 
with RhoGTPase signaling. 
 
2.9. Discussion of individual EP lines 
 
In the following I discuss each of the identified genes and evaluate their use for further 
investigation.  
For most of the genes the connection to Rho GTPase signaling is not clearly evident. In addition, 
the identified genes represent a heterogenous group of genes with diverse functions. A 
classification into groups of genes with common functions was at first sight not compelling. 
However, after an extensive literature search I hypothesize a common function for six genes in 
mediating Rac/Cdc42 dependent regulation of homeostasis of reactive oxygen species (ROS). 
These six genes are Trf2, ATP7A, CG6700, CG30421, pfrx and SelD (found in either Cdc42 or 
Rac screen). Thus, a short introduction into the mechanisms and effects of ROS generation and 
their regulation by Rac and Cdc42 (Chap. 2.9.1.) precedes the discussion of the six genes 
(Chap. 2.9.2.). 
Furthermore, I put Rbf and stg into one chapter (Chap. 2.9.4.) based on their function in cell 
cycle control.  
Finally, the apparently unclassifiable genes are discussed (Chap. 2.9.5. and 2.9.6.). 
 
2.9.1. Rho GTPases and regulation of reactive oxygen species (ROS) 
 
Reactive oxygen species (ROS) are generated in living organisms when exposed to external 
factors like radiation, ultraviolet, metals and toxic substances. ROS are also produced in 
mitochondria as a by-product of aerobic respiration. So called "oxidative stress" occurs if ROS 
reach abnormally high levels. ROS react with various intracellular components such as DNA, 
proteins, and lipids to induce damage (oxidation of nucleic acid bases, DNA strand breakage, 
inactivation of proteins by oxidation, lipid peroxidation). The oxidative damage to DNA 
(especially mitochondrial DNA (Mandavilli et al., 2002)) is also implicated in various 
degenerative diseases, cancers, and aging. 
However, specific signaling mechanisms can also induce the production of ROS during the 
innate immune response to pathogens or during wound healing. Phagocytic leukocytes generate 
high concentrations of ROS to kill invading bacteria during inflammation. Thereby the cells 
produce ROS via a membrane-associated reduced nicotinamide adenine dinucleotide 
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phosphate (NADPH) oxidase. This multicomponent enzyme utilizes electrons derived from 
intracellular NADPH to generate superoxide anion (·O2-), which subsequently dismutes to 
hydrogen peroxide (H2O2) and further may be converted into the very toxic hydroxyl radicals 
(·OH-) by iron or copper ions. Hydroxyl radicals and other ROS can then be used for host 
defense.  
Remarkably, NADPH oxidase is one of the best-characterized Rac GTPase-regulated systems. 
Mammalian Rac1 and especially Rac2 have been shown to promote the assembly of the 
NADPH oxidase subunits (reviewed by (Diebold and Bokoch, 2005). Cdc42, on the other hand, 
seems to behave as an antagonistic competitor of Rac for binding to one of the subunits of 
NADPH oxidase (Diebold et al., 2004). These Rho GTPases are implied in the regulation of a 
large variety of important cellular processes (see Chap. 1.2.5.). In phagocytic leukocytes, Rho 
GTPases have evolved roles as crucial regulators of chemotaxis, polarized movement and 
phagocytosis during the innate immune response. Thus, the ability of Rac to stimulate 
superoxide production via the NADPH oxidase reflects just one mechanism how Rho GTPases 
regulate the innate immune response. Intriguingly, Rac dependent NADPH oxidase is localized 
at the leading edge of migrating cells. There the locally produced ROS is required for 
cytoskeletal reorganization and directed cell migration (reviewed by (Ushio-Fukai, 2006). 
Interestingly, dominant negative forms of both Rac and Cdc42 have been reported to inhibit the 
production of ROS (Diebold et al., 2004; Irani et al., 1997; Sundaresan et al., 1996). The 
inhibition appears to occur in both cases through direct binding to one subunit (cytochrome 
b558) of the NADPH oxidase (Diebold et al., 2004). Consistent with these findings, expression of 
constitutive active Rac increases ROS levels (Sulciner et al., 1996). 
Thus, although Rac and Cdc42 have antagonistic roles in NADPH oxidase regulation, the 
expression of dominant negative forms of both Rac and Cdc42 probably results in lower ROS 
levels. The tester fly lines we used in our EP screen also express dominant negative forms of 
either Drac1 (Drac1N17) or Dcdc42 (Dcdc42N17). Thus, the rough eye phenotype of these tester 
lines could be, at least partially, a cause of lowered ROS levels in the affected cells. Therefore, 
one possible mechanism for suppression of the Drac1N17 or Dcdc42N17 phenotypes is a direct 
regulation of ROS levels.  
How can low ROS levels lead to a rough eye phenotype? In addition to their role in bacterial 
killing by leukocytes, ROS generated by NADPH oxidase have been increasingly recognized as 
important components of signaling in other cell types. It has been shown that signal transduction 
from membrane receptors of various growth factors, cytokines, or other ligands is enhanced by 
ROS (Bae et al., 1997), reviewed by (Rhee, 2006). Furthermore, by triggering concomitantly the 
activation of NADPH oxidases these receptors can induce positive feedback effects on signal 
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transduction. ROS mediated signaling can have positive effects on cell proliferation (Boonstra 
and Post, 2004). Moreover, cancer cells often have high levels of ROS (Szatrowski and Nathan, 
1991). 
Consistently, overexpression of catalase (Brown et al., 1999) and MnSOD (Zhong et al., 1996) 
leads to inhibition of cell proliferation. These two enzymes catalyze a specific ROS, H2O2, into 
oxygen and water and hence lower the levels of ROS. Furthermore, eye-specific overexpression 
of the transcriptional activator of catalase, DREF (see also below Chap. dTrf2), leads to a rough 
eye phenotype which can be suppressed by an amorphic catalase allele. DREF is known to play 
an important role in regulating cell proliferation-related genes (Hyun et al., 2005; Yamaguchi et 
al., 1995). Thus, the rough eye phenotype could be a cause of disregulated cell proliferation. 
Therefore, the identified suppressor genes could interfere with cell proliferation. Interestingly, in 
addition to the six genes proposed to have a function in ROS regulation, two further genes 
identified in the EP screen possibly fit into this group of genes since they are known regulators of 
cell proliferation: Rbf and string (see below). Several reports have shown that ROS and NO (see 
below) affected Rbf and cdc25 function (Buhrman et al., 2005; Bulavin et al., 2001; Douglas et 
al., 2005; Douglas et al., 2001; Kuzin et al., 2000; Rudolph, 2005; Zhang et al., 2003b). 
On the other hand, high levels of ROS can induce cell death by activating apoptosis specific 
pathways (Boonstra and Post, 2004). This makes sense since thereby cells that potentially have 
accumulated DNA mutations induced by ROS can be eliminated.  
The expression of both dominant negative Drac1 and Dcdc42 GTPases is suggested to result in 
NADPH oxidase inhibtion and consequently in low ROS levels. Therefore, suppressor genes 
should somehow increase ROS levels or imitate the signaling effects of ROS. However, as 
discussed below, some of the identified genes with a suggested role in ROS signaling rather act 
negatively on ROS production. Furthermore, the fact that the suppressors interacted specifically 
with only either one of the two tester lines remains to be explained. 
 
2.9.2. Suppressors with possible role in ROS homeostasis/signaling 
 
Drosophila TBP related factor 2 (dTrf2) 
Drosophila TATA-box-binding protein (TBP)-related factor 2 (TRF2) is a member of a family of 
TBP-related factors present in metazoan organisms. However, unlike TBP, it fails to bind to DNA 
containing canonical TATA boxes. Since TRF2 is associated with chromosome loci distinct from 
TBP, it may have different promoter specificity and regulate a subset of genes (Rabenstein et 
al., 1999). 
A Drosophila complex containing Trf2 has been identified by antibody affinity purification. This 
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complex contains components of the nucleosome remodelling factor (NURF) complex as well as 
the DNA replication-related element (DRE)-binding factor DREF (Hochheimer et al., 2002). 
The Drosophila NURF complex is a chromatin remodeling complex that catalyzes nucleosome 
repositioning at promoter regions to regulate access by the transcription machinery. 
Interestingly, it has been reported that the direction of NURF-induced nucleosome movement 
can be significantly modulated by GAL4 sites (Kang et al., 2002). Therefore it seems possible 
that dTrf2 causes suppression by an interaction with the UAS/Gal4 system rather than by a 
specific interaction with Dcdc42. However, the fact that dTrf2 specifically suppressed the 
sev>cdc42N17 phenotype but not the phenotypes of other tester lines (Tab. 2) does not support 
the notion of a general inhibition of the UAS/Gal4 system by dTrf2. 
Interestingly, Trf2 bound as well to DREF. DREF is a transcription factor that specifically binds to 
the promoter-activating element DRE (DNA replication-related element) (Hirose et al., 1996). 
The DRE/DREF system plays an important role in transcription of genes related to cell 
proliferation, such as PCNA (proliferating cell nuclear antigen), DNA polymerase, CycA, D-raf, 
and E2F (Hirose et al., 2001; Ohno et al., 1996; Ryu et al., 1997; Yamaguchi et al., 1995). DREF 
also regulates the expression of catalase (Park et al., 2004) and sps2 (Jin et al., 2004). Both 
genes are involved in protection of the cell to harmful ROS concentrations (Burk, 1990; Morey et 
al., 2003b). The fact that a rough eye phenotype caused by ectopic DREF expression can be 
suppressed by a catalase mutation (Park et al., 2004) further indicates that these two genes 
interact with each other. This suggests that DREF and Trf2 not only regulate general cell 
proliferation genes but also DNA damage protection genes. This is consistent with PCNA being 
also an essential protein for repair of DNA damage (Essers et al., 2005). 
DREF/Trf2 activate the expression of catalase and sps2. The products of these two genes lower 
the levels of ROS. As mentioned above, Dcdc42N17 was reported to inhibit NADPH oxidase and 
its expression should therefore also lead to lower ROS levels. The suppression by dTrf2 
overexpression rather suggests the contrary. 
Since DREF and Trf2 were found in a complex together with the chromatin remodeling NURF 
components it is interesting to note that several trithorax group genes with a role in chromatin 
remodeling interacted as well with the DREF rough eye phenotype (Hirose et al., 2001). One of 
these interacting genes, moira, was also identified in the EP screen. However, moira 
overexpression (in the EP line EP09-012) not only suppressed the sev>Dcdc42N17 phenotype 
but also the phenotypes of other tester lines (see Chap. 2.4., Tab. 2 and 3, and data not shown). 
Therefore we discarded this EP line.  
A further role for Trf2 in cell cycle and G2-M checkpoint regulation was suggested (Shimada et 
al., 2003). Thus, Trf2 could act as a checkpoint regulator to assure that damaged DNA gets 
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repaired before progression of the cell cycle. 
In summary, DREF and its co-factor Trf2 regulate transcription of genes that are involved in cell 
proliferation and DNA replication. This regulation possibly happens in a bigger complex that 
contains the chromatin remodeling NURF components as well as gene products of the trithorax 
group. Furthermore, the fact that catalase, sps2 and PCNA are target genes of DREF and Trf2 
indicates that they also regulate at least some aspects of the antioxidant defense system and 
the repair of DNA damage (possibly caused by excessive ROS).  
However, it remains unclear how exactly Trf2 and Dcdc42 genetically interact. A possible 
involvement of Dcdc42 in G2-M checkpoint regulation has already been suggested (Muris et al., 
2002; Richman et al., 1999) and is discussed further below in chapter 2.9.4. (string and Rbf). 
Thus, it is possible that Dcdc42 and Trf2 act in the same pathway to control progression of the 
cell cycle. 
 
SelD 
selD is the Drosophila ortholog of the human selenophosphate synthetase 1 (sps1) gene. Like 
the Trf2-DREF target gene sps2 (see above), sps1 is involved in the biosynthesis of 
selenoproteins. Since selenoproteins often have important antioxidant functions by neutralizing 
ROS they affect as well the intracellular ROS levels (Alsina et al., 1999; Burk, 1990; Morey et al., 
2001). Accordingly, a null mutation in selD causes an impairment of selenoprotein synthesis and 
a strong increase in intracellular ROS (Morey et al., 2003a). Consistently, selD mutant flies are 
hypersensitive to oxidative stress (Morey et al., 2003b).  
Furthermore, selD mutant flies have a higher proportion of cells that are arrested at the G2 
phase of the cell cycle (Alsina et al., 1999) and cell proliferation and differentiation are abnormal 
(Alsina et al., 1998; Serras et al., 2001).  
This suggests that the Drac1N17-mediated rough eye phenotype is at least partly caused by 
impaired ROS signaling and possibly an altered cell cycle checkpoint regulation. 
However, although selD overexpression in EP36-054 led to suppression of the GMR>Drac1N17 
phenotype, no interaction with the sev>Dcdc42N17 phenotype was observed. On the other hand, 
the transcriptional activator of sps2, Trf2 (EP13-034, see above), was identified exclusively in 
the screen for suppressors of the sev>Dcdc42N17 phenotype. Therefore, it is difficult to imagine 
how both Trf2 and SelD control similar aspects of ROS signaling since they interact exclusively 
with one and not both of the small GTPases. 
 
ATP7 
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ATP7 encodes a P-type transmembrane ATPase. It is the single ortholog of the mammalian 
Menkes (ATP7A; MNK) and Wilson (ATP7B; WND) disease proteins (reviewed by (Voskoboinik 
and Camakaris, 2002; Voskoboinik et al., 2002). These proteins serve a dual function. They 
deliver copper ions to cuproenzymes in the Golgi compartment and translocate excess copper 
outside the cell (Pase et al., 2004). Indeed, accumulation of copper in Drosophila S2 cells was 
significantly increased when ATP7 was suppressed using double-stranded RNA interference, 
demonstrating that ATP7 is essential for efflux of excess copper (Southon et al., 2004).  
Menkes disease in humans is a rare neurological disease that manifests in progressive neuronal 
degeneration and death in early childhood. The defects arise from impaired cellular efflux and 
thus excessive copper accumulation in the cells. Besides being an essential metal ion for the 
function of key metabolic enzymes, copper has a pro-oxidant activity and can therefore be a 
source of ROS. Since the central nervous system has a high oxygen consumption and relative 
poor antioxidant defense, it is highly susceptible to ROS-mediated toxicity. Thus, it has been 
proposed that oxidative damage would be the main cause for the degeneration of neuronal cells 
in Menkes disease patients (reviewed by (Llanos and Mercer, 2002; Rossi et al., 2004). 
Interestingly, a recent report implicated the Rho GTPase Dcdc42 in regulating the trafficking of 
Menkes disease protein between different membrane compartments (Cobbold et al., 2002). 
Thus, it is tempting to speculate that expression of Dcdc42N17 leads to mislocalization of ATP7, 
which in turn results in unsufficient efflux of intracellular copper. The excess copper then causes 
oxidative damage through production of ROS. This would be rescued by overexpression of 
ATP7, which is obtained with the identified EP element insertion. Indeed, it has been shown in 
mammalian cell culture studies that enhanced expression of ATP7A was sufficient to correct the 
copper accumulation and copper retention phenotype of ATP7 mutant cells (Camakaris et al., 
1995; La Fontaine et al., 1998).  
However, as mentioned above, Dcdc42N17 was reported to inhibit NADPH oxidase and its 
expression should therefore lead to lower ROS levels. The suppression by ATP7 overexpression 
rather suggests the contrary. 
 
CG6700 
The protein encoded by CG6700 contains at its C-terminus a SAC3/GANP domain. Proteins 
sharing this motif are involved in nuclear export and mitotic progression (Bauer and Kolling, 
1996; Jones et al., 2000; Khuda et al., 2004; Lei et al., 2003). Interestingly, the human homolog 
LENG8 was suggested to be involved in host defense response to pathogens by leukocytes 
since the gene lies in the leukocyte receptor cluster (LRC) located in the 19q13.4 region that 
contains mainly genes encoding killer cell inhibitory receptors (KIR) and immunoglobulin-like 
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transcripts (ILT) (Wende et al., 1999). Such genes do not lie in the vicinity of CG6700. However, 
located next to CG6700 is another gene for which a role in the defense response has been 
reported: NOS, the gene that encodes the nitric oxide (NO) synthase. An attractive, but 
nevertheless very speculative model would consider CG6700 and NOS as two clustered genes 
that become activated upon attack of pathogens. Alternatively, NOS itself could be the gene 
responsible for the suppression phenotype since the last exon of CG6700 overlaps with the first 
exon of NOS. Thus, the EP element EP43-011 could drive both CG6700 and NOS upon Gal4-
activation.  
NO, the product of NOS, is a free radical that is very reactive and unstable, like ROS. For 
example, it reacts with superoxide to form peroxynitrite (ONOO-), a reactive nitrogen species 
(RNS) that can oxidize and thereby damage DNA, proteins and lipids. On the other hand, again 
like ROS, in moderate levels NO can act as a signaling molecule to induce gene expression, cell 
differentiation and immune activation (Foley and O'Farrell, 2003; Kuzin et al., 2000; Kuzin et al., 
1996). 
Interestingly, yeast two-hybrid and GST pull-down assays revealed both Rac1 and Rac2 small 
GTPases as NOS interacting proteins (Kuncewicz et al., 2001). Furthermore, the dominant 
negative Rac1N17 was shown to suppress expression of NOS in rat livers (Harada et al., 2003). 
Also, NO was shown to have an important role in wound healing (reviewed by (Luo and Chen, 
2005; Rizk et al., 2004). A recent study could show that increased ROS levels caused nitric 
oxide deficiency and delayed wound healing. This effect could be suppressed by expression of 
Rac1N17 (Luo et al., 2004). Thus, NO signaling seems to interact with ROS signaling. 
In Drosophila, NO has been reported to regulate cell proliferation in imaginal discs (Kuzin et al., 
1996). Interestingly, ectopic expression of NOS in the Drosophila eye suppressed the rough eye 
overexpression phenotype of dE2F, and Rbf interacted synergistically with NOS (Kuzin et al., 
2000). In the course of the EP screen, overexpression of Rbf was also found to suppress the 
Dcdc42N17 rough eye penotype (see below). This is important since the EP line 43-011 that 
drives CG6700 and possibly NOS was also identified as suppressor of the Dcdc42N17 but not of 
the Drac1N17 phenotype. Thus, despite the well documented interactions between NOS and Rac, 
especially in the context of wound healing, here NOS would probably interfere with cell 
proliferation. The role of CG6700 itself remains to be analyzed. 
 
6-phosphofructo-2-kinase (pfrx) 
pfrx encodes the glycolytic enzyme that catalyzes the irreversible transfer of a phosphate from 
ATP to fructose-6-phosphate. Since this step is irreversible, pfrx (PFK in mammals) gets a key 
role in the control of glycolysis. 
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In Drosophila, pfrx shows strong expression in crystal cells. These cells are part of the 
Drosophila hematopoietic system. Together with plasmatocytes and lamellocytes, they provide 
the organism with the capacity for wound healing, immune response, and removal of apoptotic 
cells. 
There is some evidence from mammalian cell culture studies that the Rac/Cdc42 effector Pak 
regulates the glycolytic pathway in a related cell type, phagocytes, during host defense response 
(Shalom-Barak and Knaus, 2002). Thus, the Rac1N17 phenotype could be a result of disregulated 
glycolysis that would be suppressed by enhanced pfrx expression. 
Interestingly, most of the glycolytic enzymes, including phosphofructokinase, have been reported 
to bind to the actin and tubulin cytoskeleton (Knull and Walsh, 1992). This interaction has been 
identified as an important mechanism to generate ATP in the vicinity of the cytoskeleton and 
thereby modulating cell morphology. However, it remains difficult to imagine how the mere 
overexpression of pfrx can rescue the Drac1N17 phenotype. 
Another possible mechanism for the suppression of Rac1N17 by pfrx expression could involve 
again ROS since high levels of glycolytic products can induce ROS (at the mitochondria). High 
extracellular glucose levels (hyperglycemia) also have been reported to augment intracellular 
ROS levels through several ways ((Nishikawa et al., 2000), reviewed by (Brownlee, 2001)). 
Interestingly, ROS formation induced by this extracellular high glucose could be inhibited by 
expression of dominant negative Rac1 (Rac1N17) (Luo et al., 2004). The authors also showed 
that the augmented ROS levels led to NO deficiency and consequently to impairment of wound 
healing. NO in turn has been shown in another study to suppress PFK activity (Tsuura et al., 
1998) and furthermore, PFK has been found to be associated with NOS in an affinity 
chromatography assay (Firestein and Bredt, 1999).  
The clear link between pfrx and Drac1 still remains to be established. It might be interesting to 
further evaluate the role of pfrx in wound healing and its connection to ROS, NO and especially 
Rac signaling.  
 
CG30421 
The protein encoded by CG30421 contains a ubiquitin carboxyl-terminal hydrolase family 2 
(UCH2) domain. This domain is shared by enzymes that cleave off ubiquitin residues from 
proteins and thereby are likely to inhibit ubiquitin dependent degradation by the proteasome 
complex (Amerik and Hochstrasser, 2004).  
The increasing number of deubiquitinating enzymes raises the possibility that specific protein 
turnover rates can be differentially regulated by these enzymes. Such regulation would imply 
that deubiquitinating enzymes possess a considerable degree of substrate specificity. 
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Interestingely a Y2H screen database (http://pim.hybrigenics.com) recently reported an 
interaction of CG30421p with the small GTPase Rap1 (also known as Roughened and Dras3). 
This raises the possibility that CG30421 acts as a specific deubiquitinating enzyme of small 
GTPases. Thus the prevention of degradation of the endogenous GTPase Dcdc42 may be 
responsible for the suppression phenotype. Rap1 has been previously reported to interact with 
another deubiquitinating enzyme (fat facets) in eye development (Li et al., 1997).  
Moreover Rap1 has been shown to have a function in DC (Boettner et al., 2003) which 
additionally supports a function of CG30421 in DC. Rap1 is involved in the regulation of both 
integrin- and cadherin-mediated cell adhesion in several cases (Caron et al., 2000; Fujita et al., 
2005; Hogan et al., 2004; Huelsmann et al., 2006; Reedquist et al., 2000). Interestingly, Cdc42 
has been suggested to function downstream of Rap1 in mammalian epithelial cell cultures and in 
yeast cells (Chant and Stowers, 1995; Hogan et al., 2004). Rap1 is also a highly abundant 
protein in phagocyte membranes and Huelsmann et al. (2006) showed that it regulates integrin-
dependent adhesion and migration (Huelsmann et al., 2006). Additionally, Rap1 has been 
reported to be a subunit of NADPH oxidase (Vignais, 2002), and expression of wild type or 
dominant negative as well active forms of Rap1 affects ROS production (Gabig et al., 1995). 
This suggests the further possibility that the gene product of CG30421 affects ROS signaling via 
Rap1 or even Dcdc42. 
 
 
2.9.3. Summary of suppressor genes with a proposed function in ROS signaling 
 
Cdc42 and especially Rac have well documented roles in the regulation of NADPH oxidase. The 
analysis of the genes that were identified in the EP screen suggests that the Rho GTPases 
regulate ROS homeostasis not only through NADPH oxidase but also through other 
mechanisms. The proposed inhibition of NADPH oxidase and therefore downregulation of ROS 
by the Dcdc42N17/Drac1N17-expression in the tester lines should lead to lowered ROS levels. 
However, EP dependent overexpression of three suppressor genes (dTrf2, dATP7A and SelD) 
probably leads itself to lowered ROS levels. This rather suggests that expression of DN 
Drac/Dcdc42 in fact leads to elevated levels of ROS. On the other hand, EP dependent 
overexpression of the suppressor gene pfrx (and possibly also CG6700 or NOS) probably leads 
to elevated ROS. In the case of CG30421 it is not apparent how ROS levels would be affected. 
Thus, although these six genes potentially are involved in ROS signaling, their exact roles 
remain to be assessed.  
The effects of Dcdc42N17 or Drac1N17-expression on ROS levels and the role of the six genes in 
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this context could be tested by several means: First, as in SelD mutant clones of Drosophila eye 
imaginal discs (Morey et al., 2003a), ROS could be detected in vivo in the Dcdc42N17/Drac1N17-
tester lines. The ROS levels could then be compared to those in flies carrying additionally a 
suppressing EP element. Second, Dcdc42N17/Drac1N17 and EP-dependent expression could be 
tested whether it may confer to sensitivity to oxidative stress (e.g. paraquat or hydrogen 
peroxide) (Morey et al., 2003b). Third, antioxidants or specific inhibitors of the NADPH oxidase 
(Diebold et al., 2004) could be tested whether they modify the overexpression phenotypes. To 
further support the relevance of the potential connection between ROS, Rho GTPase signaling 
and the identified six genes, such experiments should be performed also with loss-of-function 
mutants. 
A schematic representation of the six genes in the context of ROS signaling is shown in Figure 
16 (Chap. 4.2.). Rbf and string and a further identified suppressor, Falafel (see below), are as 
well represented in Figure 16 because of their roles in cell cycle checkpoint regulation and DNA 
damage repair in response to various stresses, including ROS. 
 
2.9.4. string and Rbf, two suppressors with a role in cell cycle regulation, possibly 
dependent on ROS levels? 
 
As discussed above, ROS can damage several cell components but can also act as a signaling 
molecule. ROS mediated DNA damage leads to cell cycle arrest, thus it makes sense that cell 
cycle regulators are influenced by ROS. Two suppressors that have been identified in the 
Dcdc42-screen correspond to well known cell cycle regulators: string (cdc25) and Rbf (see 
below). This finding further supports the role of Cdc42 in cell cycle checkpoint regulation in 
response to ROS. 
string is a Cdc25-type phosphatase that promotes cell cycle progression. In a wild-type 
background, string is required for progression from G2 to mitosis; when overexpressed it causes 
premature initiation of mitosis (Edgar and O'Farrell, 1989). 
string has been targeted by another independent EP insertion and was also identified to 
suppress the phenotype of the tester line sal-Gal4>UAS-lgs17E that was designed to identify 
wingless signaling components. Thus, string is not a specific suppressor of Dcdc42N17. 
Interestingly, twist and zerknüllt are two transcription factors shown to alter string expression and 
they are regulated by dpp signaling in early embryogenesis. One might speculate that Dcdc42 
signaling downstream of dpp induces twist and zen expression and these in turn activate string 
expression. Thus, downregulated cdc42 signaling could be restored by string expression. 
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Surprisingly, Rbf was also identified in the sev>Dcdc42N17 screen. Whereas string promotes cell 
cycle progression from G2 to M phase, Rbf is known to block transition from G1 to S phase. 
Recently, the human ortholog of Rbf (Rb) was also shown to be involved in the G2/M transition. 
Disruption of RB accelerated G2/M progression in the presence of DNA damage by elevating the 
expression of a set of mitotic regulatory genes (Eguchi et al., 2006). Thus, the simplest 
explanation for the interaction of cdc42 with both string and Rbf could be that Dcdc42N17 
expression leads to an abnormally high level of G2 arrested cells which would be suppressed by 
string or Rbf overexpression. In yeast there is evidence that Cdc42 is indeed essential for G2/M 
transition (Richman et al., 1999). On the other hand, it has been shown in mammalian cells that 
Cdc42 can inhibit cell cycle progression at G1/S through a mechanism requiring activation of 
p38 (Molnar et al., 1997). Thus, the inhibition of G1/S progression by Dcdc42 could be 
prevented by expression of Dcdc42N17, eventually leading to more cells arrested in G2. 
I observed a clear reduction of bristles on the thorax upon stg or Rbf overexpression (Fig. 8 E 
(Rbf) and data not shown). Pena-Rangel et al. (2002) reported the same phenotype when stg 
was overexpressed in the thorax (Pena-Rangel et al., 2002). This phenotype might be explained 
by the fact that exit from the cell cycle into G2 is required for proper neural cell fate 
determination (Negre et al., 2003). This exit would be perturbed by both stg or Rbf 
overexpression.  
The G2 checkpoint prevents cells from entering mitosis when DNA is damaged, providing an 
opportunity for repair and stopping the proliferation of damaged cells. ROS are known to 
damage DNA. Interestingly, the mammalian homolog of string, cdc25, has been shown to be 
regulated by ROS (Savitsky and Finkel, 2002). The mechanism for this regulation is explained 
by the fact that cdc25 has at its active site a highly reactive cystein-disulfid-bond that can react 
directly with ROS, leading to enzyme inactivation (reviewed by(Rudolph, 2005). A role for cdc25 
in DNA damage response is further supported by several evidences that place cdc25 
downstream of ATM and Chk2 (reviewed by (Busino et al., 2004).  
Considering the herein proposed new function/regulation of cdc42 and Rac by ROS signaling, it 
is worthwhile to speculate that cdc42 function in cell cycle regulation is also sensitive to ROS. 
 
 
 
 
 
2.9.5. Remaining unclassifiable suppressors of the Dcdc42N17-phenotype 
 
glutamyl-prolyl-tRNA synthetase (Aats-Glupro) 
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Aats-Glupro catalyses the aminoacylation of glutamic acid and proline tRNA, respectively (Cerini 
et al., 1997). It is difficult to imagine how a component of the tRNA synthetase machinery can 
specifically regulate Dcdc42 signaling.  
 
enhancer of yellow 3 (e(y)3) 
The protein encoded by enhancer of yellow 3, e(y)3, contains an AT-hook, two PHD fingers, and 
a novel evolutionarily conserved domain with a transcriptional coactivator function. The function 
of the PHD finger motif is not yet known but it has been suggested to be involved in the 
regulation of transcription by direct binding of the DNA as well as in protein-protein interaction. 
BLAST homology searches for e(y)3 reveal only proteins of unknown function except for a short 
stretch of homology to the vertebrate transcription factor Requiem which is required for 
apoptosis. To further investigate the function of e(y)3 loss-of-function analysis should be 
performed. Several recessive lethal P-element insertions in e(y)3 are available at the 
Bloomington stock center. The mutant flies die in the late pupal stage as pharate adults. Two 
reports corroborate an essential function for e(y)3 during embryonic development (Nikolenko Iu 
et al., 2005; Shidlovskii et al., 2005). They also show that e(y)3 acts indeed as a transcriptional 
coactivator. The possible specific function of e(y)3 in the context of Dcdc42 signaling has to be 
further investigated. 
 
CG30188 
CG30188 encodes a protein that contains two immunoglobulin-like domains. BLAST searches 
do not reveal homologous proteins with an already known function. CG30188 showed no 
overexpression phenotypes with the tested driver lines. No mutant lines are available at the 
public stock centers. The long distance (13234 bp) between the insertion site of the EP element 
and the translation start site of CG30188 would make it difficult to generate deletion mutations. 
Therefore I decided not to work further on this line. 
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2.9.6. Remaining unclassifiable suppressors of the Drac1N17-phenotype 
 
HLHm7 
HLHm7 encodes a small basic helix-loop-helix (bHLH) protein that belongs to eight partially 
redundant genes of the Enhancer of split complex, E(spl)-C. Notch activates the E(spl)-C genes 
which, in a negative feedback loop, negatively regulate expression of the Notch ligand Delta 
through the achaete-scute complex genes (Heitzler et al., 1996).  
These genes act downstream of Notch to repress the adoption of neural and other differentiated 
cell fates. This happens through a process known as lateral inhibition whereby a single cell in a 
cluster of neurocompetent cells becomes neural while the other cells remain undifferentiated.  
The overexpression phenotypes of HLHm7 are consistent with the fact that HLHm7 represses 
neural cell fate since sensory organs like interommatidial and thorax bristles are markedly 
reduced (data not shown). 
When overexpressed in the corresponding EP lines, HLHm7 suppresses the Drac1N17 tester line 
phenotype. Drac1 and JNK signaling have been proposed to have a role in planar polarity in the 
Drosphila eye by affecting Notch signaling. However, this notion is solely based on 
overexpression data using dominant negative and active forms of Drac1. Strutt et al. (2002) 
provided evidence that Drac1 and JNK are not major effectors of planar polarity (Strutt et al., 
2002). However, it is conceivable that the suppression of the dominant negative Drac1 
(Drac1N17) mediated rough eye phenotype by HLHm7 expression is comparable to the results 
reported earlier concerning planar polarity and Drac1/JNK signaling (Fanto et al., 2000). 
 
couch potato (cpo) 
couch potato (cpo) encodes a Drosophila RNA-binding protein that has been implicated in the 
regulation of several aspects of proneuronal cell development (Glasscock and Tanouye, 2005). 
achaete, scute and daughterless gene functions are required for proper expression of cpo in the 
PNS (Bellen et al., 1992). cpo was identified as suppressor of the Drac1N17 phenotype. It 
remains to be explained how cpo interacts with Drac1 signaling.  
 
CG30122  
The protein encoded by CG30122 contains a SAP (after SAF-A/B, Acinus and PIAS) domain, a 
alpha/beta-hydrolase domain (Ollis et al., 1992), and a SPRY domain (named from SPla and the 
RYanodine Receptor). Furthermore there is a predicted domain COG4639 that is obtained by 
clustering of orthologous groups of proteins. The SAP motif is a putative DNA binding domain 
found in diverse nuclear proteins involved in chromosomal organization (Aravind and Koonin, 
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2000). The alpha/beta hydrolase fold is common to a large group of hydrolytic enzymes of widely 
differing phylogenetic origin and catalytic function. The function of the SPRY domain is not 
known. The COG4639 sequence has a predicted function of a kinase. 
CG30122 is very homologous to the vertebrate hnRNP U-like 1 (Hnrpul1), a protein that belongs 
to the subfamily of heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA 
binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins 
are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing 
and other aspects of mRNA metabolism and transport (reviewed by (Krecic and Swanson, 
1999). A function for CG30122 in mRNA metabolism is supported by yeast-two-hybrid protein 
interactions of CG30122p with several RNA binding proteins of the spliceosome, the small 
nuclear ribonucleoprotein and the ribosome complexes (Fly GRID database, (Giot et al., 2003)). 
What could be the connection to Rac signaling? Romero et al. detected in a yeast two-hybrid 
screen and with GST fusion proteins a specific interaction of the (human) Rac GDP exchange 
factor Vav with a heterogeneous nuclear ribonucleoprotein, hnRNP C (Romero et al., 1998). The 
clear role and the consequences of this interaction have not been described yet. However, the 
genetic data obtained with CG30122 and the physical binding between Vav and hnRNP C could 
reveal a new function for Rac in the regulation of at least some aspects of mRNA metabolism. 
Furthermore, Hnrpul1 was identified in a complex with histones H2A, H2B, H3 and H4 
(Kzhyshkowska et al., 2003). H2A is involved in the DNA damage response, it is therefore 
interesting to note that Hnrpul1 gets activated by p53 upon stress (Krieg et al., 2006). A role for 
Drac1 and one of the suppressors (Falafel) in DNA damage response and H2A regulation is 
discussed in chapter 3. 
 
MSP-300/Nesprin 
Only one of the two EP-elements that are inserted at the Muscle-specific protein 300 (MSP-300) 
gene locus is supposed to drive a full-length transcript (EP51-198) whereas EP32-120 is 
inserted in an intron near the putative 3' end of the gene. When the UAS sites at the 3' of EP51-
198 were excised by the Cre/lox system, the suppression phenotype was lost, indicating that 
expression of MSP-300 is required for suppression. On the other hand however, EP32-120 still 
showed the suppression phenotype when the UAS sites pointing to further 3' of MSP-300 were 
excised by the Cre/lox system. This suggested that either the EP-element insertion EP32-120 on 
its own or antisense-expression of MSP-300 is responsible for the suppression phenotype. The 
situation is further complicated since MSP-300, an already huge protein of 7000 amino acids, 
has been reported to correspond to the N-terminal two-thirds of the Drosophila nesprin ortholog 
which lies further 3' (Zhang et al., 2002). The gap of 29-kb between the MSP-300 gene and the 
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putative nesprin gene is occupied by an intronless, sense-strand, 26-kb ORF ("repetitive ORF", 
CG31916) capable of encoding an 8722-amino-acid protein. Zhang et al. found that MSP-
300/nesprin represents a single gene from which N- and C-terminally truncated proteins are 
generated, in addition to a low-abundance, full-length product of 11720 amino acids.  
MSP-300 contains an amino-terminal calponin homology (CH) domain. This motif is predicted to 
bind actin (Gimona et al., 2002). This prediction is supported by studies that showed co-
localization of MSP-300/nesprin with F-actin (Volk, 1992; Zhang et al., 2002). The central part of 
MSP-300/nesprin is occupied by multiple spectrin repeats. These repeats are usually found in 
proteins that assemble multiprotein structures involved both in cytoskeletal architecture as well 
as in forming large signal transduction complexes (reviewed by (Djinovic-Carugo et al., 2002). 
The carboxy-terminal part of MSP-300/nesprin contains a nuclear envelope localization domain 
called the KASH domain (for Klarsicht/ ANC-1/Syne-1 homology) (Starr and Han, 2002). 
MSP-300/nesprin and homologous vertebrate proteins such as Syne-1, Syne-2 and Dystrophin, 
the product of the Duchenne Muscular Dystrophy gene, have assigned functions in muscle cells. 
MSP-300/nesprin is expressed by muscle precursors at muscle-ectoderm and muscle-muscle 
attachment sites (Rosenberg-Hasson et al., 1996; Volk, 1992). Syne-1 is similarly clustered at 
the neuromuscular junction and is enriched at the nuclear envelope of myonuclei. The 
localization to the nuclear envelope by the KASH domain and the existence of the CH actin 
binding domain suggest a role for these proteins in anchoring the nucleus to the cortical actin 
cytoskeleton. The huge size of these proteins would allow to stretch between the nucleus and 
the actin cytoskeleton as it was proposed for ANC-1, another KASH domain containing protein 
(Starr and Han, 2002). Thus, Drac1N17 expression could possibly disrupt the anchoring of the 
nucleus to the actin cytoskeleton which could somehow be restored by increased MSP-
300/nesprin levels (with EP51-198). More generally, the actin binding protein MSP-300/nesprin 
is a good candidate of a Rac effector that is involved directly in the rearrangements of the 
cytoskeleton. It would also be important to investigate the role of Rac1 in muscle development. 
  
Stromalin 2 (SA-2 = SNM) 
Stromalin in Meiosis (SNM) was identified as a suppressor of the Drac1N17 tester line. It belongs 
to the SCC3/SA/STAG family of cohesin proteins that are required for conjunction and regular 
segregation of homologous chromosomes in Drosophila male meiosis (Thomas et al., 2005). 
Interestingly, the suppression phenotype was observed only in male eyes whereas the female 
eyes displayed an even more disrupted (enhanced) phenotype. This finding supports a sex-
specific function for SNM. So far there is no evidence for Drac1 having a role in male meiosis. 
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CG9351/falafel (flfl) 
Two EP elements (EP39-161 and EP47-082) inserted at the falafel locus. falafel encodes a 
novel RanBP domain containing protein that is evolutionarily conserved. Analysis of further 
overexpression phenotypes, subcellular localization, the generation of mutations, the analysis of 
the mutant phenotype (dorsal open and reduced body size) are presented in the next chapter 
(Chap. 3). Furthermore, an RNAi experiment against the Caenorhabditis elegans falafel 
ortholog, SMK-1, was performed. SMK-1 was shown to possess a stress responsive function by 
interacting with the insulin receptor (DAF-2), possibly as a co-regulator of the FOXO 
transcription factor DAF-16 (Wolff et al., 2006). Moreover, it was shown that the yeast and 
human Falafel orthologs function in a cisplatin sensitive protein phosphatase 4 (PPP4) complex 
(Gingras et al., 2005; Hastie et al., 2006; Wu et al., 2004)(see Chap. 3.7.2. and 3.7.3.). In 
collaboration with Gingras et al. (2005), we provided evidence that Drosophila falafel mutants 
also display cisplatin sensitivity (supplementary paper). These findings support a role for falafel 
in the response to DNA damage caused by various stresses. 
 
Table 5 summarizes the molecular and functional data about all the identified suppressor genes. 
 
 
 
 
 
 
 
 
 
 
 
 
RESPONSIBLE 
GENE 
MOLECULAR AND FUNCTIONAL INFORMATION SUPPRESSOR 
OF 
VERTEBRATE HOMOLOG 
dTrf2 TATA-box-binding protein (TBP)-related factor 2 
co-regulator of DREF, involved in cell proliferation 
Dcdc42N17 TBP-like 1 
ATP7 Copper-transporting P-type ATPase, required for 
efflux of excess cellular copper ions 
Dcdc42N17 ATP7A/B, 
Menkes/Wilson disease 
genes 
CG6700 SAC3/GANP protein domain, possibly involved in 
nuclear export and mitotic progression 
Dcdc42N17 LENG8 
pfrx 6-phosphofructo-2-kinase 
key enzyme in glycolysis 
Drac1N17 PFK-1 
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CG30421 Ubiquitin carboxyl-terminal hydrolase family 2 
(UCH2) 
de-ubiquinating enzyme 
Dcdc42N17 Ubiquitin carboxyl-
terminal hydrolase 43 
SelD involved in selenium-protein synthesis 
redox regulation, cell proliferation, imaginal disc 
development 
Drac1N17 selenophosphate 
synthetase 2 (sps2) 
stg protein tyrosine phosphatase  
regulation of G2/M transition of mitotic cell cycle  
Dcdc42N17 cdc25 
Rbf repressor of gene transcription 
tumor suppressor, pivotal role in the negative 
control of the cell cycle  
Dcdc42N17 Rb 
falafel RanBP domain, structure similar to EVH1/PH 
domains  
regulatory subunit of protein phosphatase 4 (PP4)
cisplatin sensitivity 
see chapter 3 
Drac1N17 PP4R3 
Aats-Glupro glutamyl-/prolyl- tRNA synthetase Dcdc42N17 glutamyl-prolyl tRNA 
synthetase 
e(y)3 Zn-finger-like, PHD finger 
transcriptional coactivator 
Dcdc42N17 PHD finger protein 10  
CG30188 
 
Immunoglobulin-like domains 
cell adhesion, signal transduction? 
Dcdc42N17 hemicentin? 
HLHm7 Basic helix-loop-helix dimerization region bHLH 
Enhancer of split complex, E(spl)-C 
Notch signaling, neuronal cell development 
Drac1N17 HES (Hairy and 
enhancer of split) 
cpo RNA-binding 
proneuronal cell development 
Drac1N17 spinocerebellar ataxia 
type 1 gene (SCA1) ? 
CG30122 SAP domain (DNA-binding)  
SPRY domain  
COG4639 predicted kinase  
pre-mRNA processing? 
Drac1N17 Hnrpul1  
(heterogeneous 
nuclear 
ribonucleoprotein U-like 
1) 
MSP-
300/Nesprin 
actin binding, nuclear envelope binding 
muscle development 
Drac1N17 Dystrophin, Nesprin, 
Syne 
SA-2 SCC3/SA/STAG family of cohesin proteins  
required for meiosis 
Drac1N17 stromal antigen 2 
(STAG2) 
 
Table 5. Suppressor genes identified in the EP screen. 
The genes with a proposed function in ROS homeostasis are yellow shaded. The two cell cycle regulators 
stg and Rbf are marked with red shading, and the putative DNA damage responsive gene falafel is orange 
shaded. 
3. CG9351/Falafel: A novel regulator of dorsal closure 
 
3.1. Identification of the gene responsible for suppression 
 
Two independent EP element insertions (EP39-161 and EP47-082) were located at almost the 
same site, at a distance of 10 bp to each other, in the 5' UTR of CG9351 (Fig. 10). In the 
following I will refer to this gene as falafel, based on the mutant phenotype (see Chap. 3.6.). 
Both EP lines displayed a very similar suppression phenotype when crossed to the Drac1N17 
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tester line (Fig. 7, Chap. 2.4.). CG9591, a gene with unknown function so far, lies 5' to the two 
EP elements. A further single-headed EP element line driving Gal4-mediated expression of 
CG9591 (EP(3)0929, (Rorth, 1996)) was available from public stock centers and tested for 
suppression of the Drac1N17 phenotype. No suppression was observed indicating that CG9591 
was not the responsible gene.  
Cre-mediated excision (see Chap. 2.6.2) of the UAS-containing sequences on the 5' part of the 
EP element EP47-082 led to a single-headed EP element with UAS directed only to falafel 
(EP47-082(loxed)). This EP element still showed suppression of the Drac1N17 tester line 
phenotype indicating that falafel was the responsible gene. Moreover, a UAS-falafel construct 
was generated and transgenic flies were obtained that showed the same suppression 
phenotype. These findings clearly show that falafel is the gene responsible for suppression of 
the rough eye phenotype of the Drac1N17 tester flies. 
 
 
 
 
 
 
 
 
 
 
Figure 10. Gene locus of falafel and P-element insertion sites. 
The red triangle marks the insertion site of the two EP elements EP39-161 and EP47-082, which is in the 
5'UTR (left white box). The black boxes designate the translated transcript. Another P-element, l(3)L4179, 
is inserted at the very same position as EP47-082. Red asterisks mark the positions of mutations in falafel 
that were obtained following mutagenesis (see Chap. 3.5.). The EP element EP(3)0929 with UAS 
sequences directed to CG9591 is located 800 bp further upstream in the 5'UTR of CG9591.  
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 3.2. Further overexpression phenotypes of falafel 
 
The rough eye phenotype of GMR-Gal4>UAS-Drac1N17 flies was suppressed by co-
overexpression of falafel (Fig. 11 A). 
When crossed to different Gal4-drivers alone, EP39-161 and EP47-082 produced several 
misexpression phenotypes, including wing defects, a strong thorax cleft and pupal lethality (Fig. 
11), depending on the Gal4 driver line used. 
 
 
 
 
 
 
Figure 11. Overexpression phenotypes of falafel 
(A, left side) Rough eye phenotype of the GMR>DRac1N17 tester line, (A, right side) suppression by co-
overexpression of falafel in the EP47-082 line. (B) Thorax cleft phenotype in pnrMD237>UAS-falafel flies. (C) 
Wing (but no thorax) defect in apGal4>UAS-falafel flies. (D) Defective posterior wing parts in 
enGal4>UAS-falafel flies. (E) Wing defects  in 69B>EP47-082(loxed) flies. (F) Dorsal closure defects in 
69B>EP47-082 embryos. 
 
The MD237 Gal4 enhancer trap insertion insertion in the pannier locus (pnrMD237) drives 
expression in the mediodorsal parts of thoracic and abdominal segments of embryos, larvae and 
adult flies (Calleja et al., 2000). Together with one of the two EP elements, EP39-161 or 47-082, 
MD237 gives rise to a penetrant thorax cleft phenotype (Fig.11 B).  
Thorax closure during pupariation resembles the process of dorsal closure during late 
embryogenesis. In addition to morphological similarities, genetic evidence points to similar 
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molecular mechanisms, led by the JNK and Dpp signaling pathways, directing embryonic dorsal 
and imaginal thorax closure (Agnes et al., 1999; Martin-Blanco et al., 2000; Zeitlinger and 
Bohmann, 1999). 
However, crossing the EP elements with apGal4 (Calleja et al., 2000), which drives expression 
in a similar domain as pnrMD237, does not result in a thorax cleft but in wing defects (Fig. 11 C). 
This suggests that the thorax cleft may be caused by genetic interaction of falafel 
overexpression with pnrMD237, which is itself also a hypomorphic pnr allele (Calleja et al., 2000; 
Pena-Rangel et al., 2002). 
Overexpression of falafel  by using an engrailed–Gal4 enhancer trap line led to another specific 
wing phenotype. In these wings the posterior engrailed-Gal4 expressing part was markedly 
reduced (Fig 11 D). 
Wing defects are also obtained with the P{GawB}69B enhancer trap line (see Fig. 8, Chap. 2.5.). 
When using the single-headed EP47-082(loxed) the wing defect is more subtle. The distal 
portion of the wing blade of 69B>EP47-082(loxed) flies is folded back (Fig. 11 E). This Gal4 line 
drives expression of UAS in the embryonic ectoderm from stage 11 and in the eye-antennal, 
haltere, leg and wing imaginal discs. Apart from the specific wing phenotype, no other adult 
tissues appear to be affected in 69B>EP47-082 flies. Nevertheless, embryogenesis also seems 
to be impaired to some extent since several dead embryos were observed and examined. These 
embryos displayed variable phenotypes including anterior open, dorsal open and germ band 
retraction defective phenotypes (Fig. 11 F).  
armadillo-Gal4 (arm-Gal4, P{GAL4-arm.S}) (Rorth et al., 1998) is a weak Gal4 line that drives 
ubiquitous expression throughout development. falafel overexpression by arm-Gal4 gave rise to 
healthy flies with slightly corrugated wings (not shown).  
The strong ubiquitously expressed Gal4 driver line Act5CGal4 (Ito et al., 1997) gave rise to early 
pupal lethality when crossed to either EP39-161 and 47-082 (not shown). 
JNK signaling target gene expression upon overexpression of falafel was examined. For this 
purpose, pucLacZ reporter gene expression was followed in embryos that overexpress CG9351 
(in EP47-082) under the control of the pnrMD237 Gal4 driver. pucLacZ expression was not altered 
in pnrMD237>EP47-082 embryos indicating that JNK target gene expression may not be affected 
by falafel overexpression (data not shown). 
 
3.3. Falafel is a novel well conserved RanBP domain containing protein 
 
falafel encodes a novel evolutionarily conserved protein. Figure 12 A shows an CLUSTAL W 
alignment (Thompson et al., 1994) of the protein sequences of Falafel, one of the human 
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orthologs, PP4R3α, the C.elegans ortholog SMK-1, and the budding yeast ortholog PSY2. 
Falafel shares significant identity and similarity at the amino acid level in the aligned region with 
PP4R3α (62% identity and 83% similarity), SMK-1 (40%/64%) and Psy2 (27%/46%). The 
RanBP domain is the most conserved portion of the protein across species. For example, the 
RanBP domains of Falafel and PP4R3α share 87% identity and 95% similarity.  
Figure 12 B shows a schematic representation of the Falafel protein domains. The predicted 
two- and three-dimensional structures for a fragment of 120 amino acids at the N-terminus show 
an extensive structural homology to the Ran binding domain found in RanBP2 (Gingras et al., 
2005). Interestingly, many of the amino acid residues establishing contact with Ran are 
conserved. This raises the intriguing possibility that this portion of Falafel could serve as a small 
GTPase-binding domain. The human ortholog of Falafel, PPP4R3, was tested for interaction 
with Ran by co-immunoprecipitation assays, but no binding could be detected  (Gingras et al., 
2005).  
The predicted structure of this N-terminal fragment also shows homology to pleckstrin homology 
(PH) and enabled/VASP (vasodilator-stimulated protein) homology 1 (EVH1) domains.  
The PH domain occurs in a large variety of signaling proteins. It has been demonstrated to 
recognize phosphoinositide headgroups (Lemmon, 2003) and can thereby localize to the plasma 
and internal membranes (Cozier et al., 2004).  
The EVH1 domain is found in multi-domain proteins implicated in a diverse range of signaling 
and nuclear transport events. Many EVH1-containing proteins also associate with actin-based 
structures and play a role in cytoskeletal organisation (Ball et al., 2002; Callebaut, 2002; 
Fedorov et al., 1999; Renfranz and Beckerle, 2002; Zettl and Way, 2002).  
The amino acids 160-360 of Falafel constitute a domain of unknown function, DUF625. The 
domain architecture with an N-terminal RanBP domain followed by DUF625 is conserved in all 
proteins homologous to Falafel except the C.elegans protein, which has a predicted non-
homologous sequence N-terminal to the EVH1 domain. Threading algorithms (Kelley et al., 
2000) indicated that the middle part of Falafel (aa 120- 600, including the DUF625) as well as of 
the orthologous human proteins possesses a number of HEAT or armadillo repeats ((Gingras et 
al., 2005) and personal communication). The evolutionarily related ARM and HEAT motifs are 
tandemly repeated sequences of approximately 50 amino acid residues that form a conserved 
three-dimensional structure (Andrade et al., 2001). ARM/HEAT containing proteins function in 
various processes, including intracellular signaling and cytoskeletal regulation. 
Additionally, two putative nuclear localization signals lie also at conserved positions (aa 158-164 
and 236-241) 
The Falafel C-terminal region of 300 amino acids rich in serines and glutamines is not conserved 
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except for a small box of 12 amino acids with a consensus LVDY at the extreme C-terminus (not 
aligned with the C.elegans LVDY motif, see turquoise box in Fig.12 A, not conserved in yeast 
Psy2). Interestingly, overexpression of a Falafel protein lacking this C-terminal part did not 
reproduce the full-length Falafel overexpression phenotypes, neither was it capable to rescue 
falafel mutants to adulthood (not shown). Therefore, despite its low conservation, this C-terminal 
part seems to be required for Falafel function. 
 
 
 
 
A 
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Figure 12. Falafel-like proteins are conserved throughout eukaryotae and share a similar domain 
architecture. 
(A) Alignment of Drosophila Falafel with the orthologous proteins in human, Caenorhabditis elegans and 
budding yeast. Identities between any two proteins are in black and similarities are in grey. The green line 
marks the RanBP domain, dark blue lines indicate potential nuclear localization signals (NLS), and a 
putative conserved LVDY motif is colored in turquoise. The identified mutations (see Chap. 3.5.) are 
indicated with red color or, in (B), with numbered red asterisks, corresponding to the flfl1, flfl2, flfl3 and flfl4 
alleles.  
(B) Schematic view of Falafel. The green box indicates a domain with homology to the Ran binding 
domain of RanBP2 as well as moderate homology with pleckstrin homology (PH) and EVH1 domains. The 
orange box denotes a domain of unknown function, DUF625, present in all orthologs. The red box 
represents a number of armadillo (ARM)/HEAT repeats. A not conserved part that consists of many 
serines and glutamins is colored in yellow. The turquoise box at the extreme C-terminus indicates a novel 
conserved LVDY motif. 
 
 
3.4. Falafel is a nuclear protein that is ubiquitously expressed  
 
The expression of falafel was examined using RNA in situ hybridization. During embryogenesis 
falafel is expressed ubiquitously, possibly with a slight upregulation in the CNS (data not shown, 
comparable to the published expression patterns of the Berkeley Drosophila Genome Project). 
falafel is also ubiquitously expressed in larval tissues, e.g. in all imaginal discs, in the salivary 
gland, but not in the larval brain (data not shown). 
The N-terminal RanBP domain in Falafel suggests a nuclear as well as a cytoplasmic 
localization of the protein. However, the predicted structural similarity of this N-terminal fragment 
of Falafel to the PH as well to the EVH1 domains would suggest further potential localizations to 
the membrane or cytoskeleton. Moreover, Falafel has two predicted nuclear localization signals 
(Fig. 12 A).  
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Falafel protein localization was followed by overexpressing an HA-tagged UAS-falafel construct. 
HA-antibody staining revealed an exclusive nuclear localization of Falafel (Fig.13). 
 
 
 
Figure 13. HA-tagged Falafel is located to the nucleus 
Falafel protein localization was examined by using a transgene expressing hemagglutinin (HA) epitope-
tagged Falafel (Falafel::HA) under the control of the UAS/Gal4 system. HA-Flfl complemented a lethal 
heteroallelic flfl combination, demonstrating that it was fully functional. Nuclear HA antibody fluorescence 
(shown in red in (A) and (B), and in green in (C) and (D)) is apparent in all cells throughout development. 
(A) Falafel::HA antibody staining in the nucleus and cytoskeletal GFP::actin fluorescence (shown in green) 
in leg imaginal disc cells (A) and gut cells (B) of wandering third instar larvae. UAS-falafel::HA and UAS-
GFP::actin were expressed by using engrailed-Gal4. 
(C) Falafel::HA antibody staining in a stage 13 embryo, at the onset of dorsal closure (lateral view), and 
(D) just before ultimate closure (dorsal view, detail). UAS-falafel::HA was expressed by using act5C-Gal4. 
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3.5. Generation of mutations in falafel 
 
falafel was identified because of its overexpression phenotypes. In a rather artificial 
overexpression system the gene interacts with Drac1.  
Double and triple mutants of the three known Racs in Drosophila display dorsal closure defects. 
Such defects are also caused by overexpression of either constitutive active or dominant 
negative Rac1 in the embryo. Overexpression of falafel does not seem to lead to severe 
embryonic phenotypes although some dead embryos with variable (also dorsal open) 
phenotypes have been observed (Fig. 11 F). In order to identify the potential role of Falafel 
during dorsal closure and related processes it is important to know the mutant phenotype. To 
generate mutations in falafel we made use of the phenotypes caused by the EP-dependent 
overexpression of the endogenous gene. EP47-082 produces a 100% penetrant wing phenotype 
with 69B-Gal4. In an EMS mutagenesis of EP carrying flies we screened 4000 flies for reversion 
of this overexpression phenotype to wild-type wings. In a second EMS mutagenesis we 
screened for reversion of pupal lethality caused by EP overexpression with actinGal4. In both 
screens revertants were recovered, five of them transmitted the mutation to the germ line (see 
materials and methods). Sequencing of four alleles identified mutations in falafel (Fig. 10 and 
12). Two alleles, flfl1 and flfl2, code for proteins with substitutions of well conserved amino acids 
in the RanBP1 domain. Interestingly, the flfl1 D22N mutation lies on a very conserved beta 
strand. The equivalent portion on RanBP is known to be involved in contacting the effector loop 
of Ran-GDP. The flfl2 mutation leads to a substitution of an isoleucine to a threonine at position 
57 of the protein. The two other mutations in the flfl3 and flfl4 alleles give rise to truncated 
proteins. The flfl3 and flfl4 mutations are both substitutions of a glutamine to a stop codon at 
positions 347 and 493, respectively. Sequencing of the fifth revertant and thus potential falafel 
mutant (flfl5) did not identify a mutation so far. Only the translated region of the gene was 
sequenced. 
 
3.6. Mutant phenotype 
 
flfl1 is homozygous viable, flfl2, flfl3 and flfl4 are homozygous lethal. The deficiency Df(3)urd, 
which entirely deletes flfl, does not complement flfl3, flfl4 and, at 29°C, flfl2. However, Df(3)urd is 
viable in combination with flfl1 and flfl2 (at 25°C), indicating the presence of second hits on the flfl1 
and flfl2 chromosomes reducing the viability. To confirm that loss of flfl is responsible for the 
lethal phenotype, we expressed a rescue construct containing UAS sequences driving a flfl 
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cDNA. Using the ubiquitous Gal4 driver line arm-Gal4, a few heteroallelic animals (flfl3/flfl4) are 
rescued to adulthood.  
flfl3/flfl4 and flfl3or4/Df(3)urd heteroallelic mutant embryos display a variable and not fully penetrant 
dorsal closure and head involution defect (Fig. 14 A and B).   
The phenotype reminded a hungry scientist of a (“dorsally”) opened-up bread that is filled with 
salad and small so-called falafel balls composed of chick-peas, hence the name. Only 20% of 
the presumptive flfl3/flfl4 and flfl3or4/Df(3)urd heteroallelic mutant embryos display dorsal closure 
and/or head involution defects. The remaining mutant embryos develop further and die during 
larval stages (until late 3rd instar).  
The low penetrance of the dorsal open phenotype could be due to the endurance of maternal 
gene product. Maternal Falafel activity was eliminated by generating falafel homozygous germ 
line clones (GLCs, Chou and Perrimon 1996). flfl2, flfl3 and flfl4 GLCs produced very few 
embryos, some of which displayed dorsal closure or germ band retraction defects (Fig. 14 C and 
D). This variable phenotype of homoallelic flfl mutants could possibly be due to second hit 
mutations. No embryonic defective phenotypes have been observed for flfl1 GLCs.  
Animals possessing the heteroallelic combinations of flfl1 or flfl2 with flfl3, flfl4 or Df(3)urd reached 
adulthood and displayed a statistically significant reduction of body size and weight (Fig. 14 E 
and F). The measured weight reduction lied between 10 and 30% as compared with their wild-
type counterparts, depending on the allelic combination used. The size of single ommatidia 
seemed to be normal. This suggests that the reduction of overall body size is due to decreased 
cell number. 
The fact that body size in hemizygous hypomorphic falafel flies (e.g., flfl1/ Df(3)urd) is not more 
reduced as compared to flies with heteroallelic falafel combinations (e.g., flfl1/flfl3) suggests that 
flfl3 (and flfl4) are strong – possibly null – alleles, at least with respect to growth. Furthermore, the 
flfl3 and flfl4 alleles potentially give rise to truncated proteins in which the last 633 (flfl3) or 487 
(flfl4) amino acids are missing. Overexpression of a flfl transgene in which 300 amino acids of 
the C-terminus were truncated did not reproduce the full-length Falafel overexpression 
phenotypes (not shown). This finding additionally supports the notion that flfl3 and flfl4 are strong 
alleles. 
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Figure 14. falafel mutant phentoytpe  
(A-D) Cuticle preparations of stage 13 embryos, lateral views, with anterior at left. flfl3/ Df(3)urd (A) and 
flfl4/ Df(3)urd (B) embryos display dorsal closure and head involution defects.  
(C, D) germ line clones. (C) flfl5 germ line clone embryo with slight puckering of dorsal midline due to 
imperfect dorsal closure. (D) flfl2 germ line clone embryo with large dorsal/anterior hole. flfl3, flfl4 germ line 
clones produced very few embryos, some of which displayed dorsal closure or germ band retraction 
defects. 
(E, F) Body size and weight reduction of falafel mutant flies with viable heteroallelic combinations. (E) 
flfl2/flfl3 mutant fly (right) is reduced in size compared to the control (y, w; TM3 balancer, y+ marked, left). 
(F) flfl2/flfl3 mutant flies display a statistically significant reduction of weight of 12% (males) and 23% 
(females) as compared to controls (y, w; TM3 balancer). 
 
 
3.7. falafel orthologs in other organisms 
 
3.7.1. RNAi against the C. elegans falafel orthologue SMK-1 
 
The C. elegans genome encodes a single ortholog of falafel (smk-1). We addressed the 
question whether this gene would have similar functions in cell migration processes. For 
example, it would be interesting to know whether smk-1 loss-of-function affects ventral enclosure 
in C.elegans, a process similar to dorsal closure in Drosophila. Interestingly, smk-1 RNA 
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interference resulted in embryonic lethality with a high penetrance. Most of the embryos started 
to develop normally, but displayed several general defects in morphogenesis late in 
embryogenesis (Fig. 8). However, ventral enclosure did not seem to be exclusively affected. 
 
 
 
Figure 14. RNAi phenotype of the Caenorhabditis elegans falafel ortholog 
(A, upper panel) Wildtype worm embryo expressing the adherens junction marker JAM::GFP, below the 
corresponding DIC image. (B,C) F1 embryos after RNAi treatment. SMK-1 RNAi leads to lethality during 
embryonic development with a high penetrance. Dead embryos display various morphogenesis defects. 
 
Interestingly, a recent report revealed SMK-1 as a stress responsive protein that regulates the 
FOXO transcription factor DAF-16 (Wolff et al., 2006). Furthermore, the authors showed that a 
daf-2 (Insulin receptor) mutant mediated longevity phenotype was completely suppressed by 
smk-1 RNAi. Like Falafel, SMK-1 also localized predominantly to the nucleus.  
Thus, the interaction of smk-1 with components of the insulin pathway possibly provides an 
explanation for the reduced body size phenotype observed in falafel mutants. Moreover, the fact 
that SMK-1 is required for DAF-16 mediated transcription of oxidative stress responsive genes 
(Wolff et al., 2006) fits well with the herein proposed function of Drac1 and some of the identified 
suppressors in oxidative stress response. 
 
 
 
3.7.2. The yeast and human orthologues of Falafel function in a protein 
phosphatase 4 (PPP4) complex 
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There is one yeast ortholog of falafel, PSY2 (Fig. 12 A). Two independent studies analyzed 
protein complexes in large scales and identified PSY2 in a phosphatase complex, composed of 
Pph3 and YBL046w, the putative orthologs of the PP2A-like PPP4 catalytic and regulatory 
subunit 2, respectively (Gavin et al., 2002; Gavin and Superti-Furga, 2003; Ho et al., 2002). A 
recent report (Keogh et al., 2006) identified the same complex by tandem-affinity-purification 
(TAP) tag purification (Rigaut et al., 1999). In addition, a two-hybrid interaction was reported for 
PSY2 and YBL046w, which indicates a probable direct interaction (Gingras et al., 2005; Ito et al., 
2001). 
There are two highly related human Falafel orthologs PPP4R3α and β (KIAA2010 and 
KIAA1387, respectively). Using TAP tags, it has been shown that PPP4R3α and β co-purified 
specifically with the catalytic subunit of the serine/threonine phosphatase PPP4 (PPP4c) and the 
regulatory subunit, PPP4R2 (Gingras et al., 2005) (see supplementary paper). 
Preliminary results of pull-down experiments indicate that the portion of Falafel able to assemble 
with PPP4R2/PPP4C is located between aa 213-719, corresponding to the DUF-625 domain 
and the predicted ARM/HEAT repeats (A.C. Gingras, personal communication). Thus the 
mutations that were obtained in the N-terminal RanBP domain of falafel (flfl1 and flfl2) are 
probably not affecting the binding to PPP4C/PPP4R2. The two stop mutations (flfl3 and flfl4) at 
aa positions 347 and 497, however, give rise to truncated proteins that probably display an 
impaired or abolished binding to the phosphatase complex components. 
 
3.7.3. Cisplatin sensitivity of Falafel and the yeast and human PPP4 complex 
components: Function in DNA damage response? 
 
It was shown that deletion of the three components of the yeast PPP4 complex, PPH3, 
YBL046w and PSY2 rendered cells hypersensitive to cisplatin treatment (Gingras et al., 2005; 
Hastie et al., 2006; Wu et al., 2004). Importantly, the hypersensitivity of psy2 deletion could be 
reverted by expression of the human ortholog PP4R3, indicating that PSY2 and PPP4R3 are 
functionally equivalent in mediating resistance to cisplatin (Gingras et al., 2005). Furthermore, 
we showed that loss of falafel function also leads to hypersensitivity to cisplatin in flies (Gingras 
et al., 2005) (see supplemented paper). 
Cisplatin is a DNA-damaging agent that is used as a chemotherapy drug to treat various types of 
cancers. It acts by crosslinking DNA in several different ways. Normally, damaged DNA sets off 
DNA repair mechanisms, which can also activate apoptosis when repair proves impossible. 
Conversely, defective repair mechanisms can lead to accumulations of mutations and eventually 
to cancer. Therefore, the hypersensitivity to cisplatin suggests for the PPP4 complex a function 
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in the regulation of DNA repair. 
Through progression of the cell cycle, several factors at specific checkpoints control if extensive 
DNA damage has occurred or if a key event, such as the attachment of a chromosome to the 
mitotic spindle, has not occurred properly. These checkpoints help to ensure that a cell divides 
only when it has completed all of the molecular prerequisites for producing healthy daughter 
cells. 
Intriguingly, an important regulator of DNA damage checkpoint response, RAD53 (Chk2, loki in 
flies) was also reported to interact with PSY2 in yeast two-hybrid assays (Gingras et al., 2005; 
Uetz et al., 2000). Chk2 is a cyclin-dependent kinase that drives cells into mitosis. When DNA is 
damaged in response to genotoxic insults, Chk2 plays an essential role in inducing a cell cycle 
arrest through the ATM/Chk2 pathway in Drosophila (Masrouha et al., 2003). In the absence of 
Drosophila Chk2/loki function, there is failure of chromosome segregation probably due to 
damaged or incomplete replicated DNA. Interestingly, this phenotype was partially suppressed 
by reducing the gene dosage of cdc25/string (Xu and Du, 2003). Human Cdc25A is a known 
target of Chk2, which itself gets activated by ATM in response to DNA damage (reviewed by 
(Busino et al., 2004). Drosophila cdc25, string, was also identified in this work as a suppressor 
(see Chap. 2.4. and discussion Chap. 2.9.4.). string also dephosphorylates Cdc2 and Cdk2, 
positive regulators of cell division. The cyclin-dependent kinase Cdc2 normally drives cells into 
mitosis, and it is the ultimate target of pathways that mediate rapid arrest in G2 in response to 
DNA damage (reviewed by (Stark and Taylor, 2006). We tested Drosophila cdc2 for genetic 
interaction with falafel. Preliminary results indicated indeed a dominant enhancement of body 
size reduction of viable flfl allelic combinations when cdc2 function is impaired (in cdc2E1-23 
heterozygous mutants, data not shown). 
Another connection between the PP4 complex and DNA damage is demonstrated by the fact 
that the yeast PP4 complex dephosphorylates the histone H2 variant H2A (Keogh et al., 2006). 
H2A (H2AX variant in higher eukaryotes) is phosphorylated by ATM, ATR and DNA-PK in 
response to DNA double-strand-breaks (DSB) (Rogakou et al., 1998; Stiff et al., 2004) (reviewed 
by (Fernandez-Capetillo et al., 2004). This modification is important for recruiting numerous 
DSB-recognition and repair factors to the break site, including DNA damage checkpoint proteins. 
Keogh et al. showed that the yeast H2AX dephosphorylation by PPP4 is necessary for efficient 
recovery from the DNA damage checkpoint, thereby allowing cells to enter the cell cycle again. 
All three components of the yeast PPP4 complex, Pph3, Ybl046w and Psy2, were also isolated 
in TAP tag affinity purifications with the H2A and H2B subtypes, HTA1, HTA2, HTB1 and HTB2 
(Krogan et al., 2006). All these histones have been shown to have a role in the DNA damage 
response or in DSB formation during meiosis. 
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Interestingly, one of the human PPP4 complex components, PPP4R2, physically interacts with 
histone H1 (A.C. Gingras, personal communication). It can be speculated that through this 
interaction the phosphatase complex is brought in proximity to the histone H2 substrate. 
Several reports suggest that ATM activation and H2AX phosphorylation are also induced by 
ROS-mediated DNA damage (reviewed by (Tanaka et al., 2006). Thus it is conceivable that the 
PPP4 complex and the herein identified subunit Falafel/PPP4R3 are involved in ROS induced 
DNA damage response. As proposed in Chapter 2.9.2., four Dcdc42N17 and two Drac1N17 
suppressors are possibly also involved in some aspects of ROS induced signaling. 
Additionally, the catalytic and the regulatory subunit R1 of PPP4 were co-purified with the 
histone deacetylase HDAC3 and PPP4 was shown to negatively regulate HDAC3 (Zhang et al., 
2005), demonstrating a further link between PPP4 and histone regulation. In this context it is 
interesting to note that HDAC3 has been shown to suppress the transcriptional activity of c-Jun 
(Weiss et al., 2003). This HDAC3-dependent suppression was relieved by phosphorylation by 
JNK. 
 
Further links between the PPP4 complex and DNA damage were described and are discussed 
in the supplementary paper (Gingras et al., 2005). 
 
3.7.4. PPP4, JNK signaling and stress 
 
JNK was recently also shown to phosphorylate H2AX in response to UV stress (Lu et al., 2006). 
The Drosphila PPP4 subunit Falafel was originally identified as a Drac1 interactor, thus the 
finding that JNK as well as the yeast PPP4 complex regulate H2AX phosphorylation state is 
particularly interesting since Drac1 has been shown to activate JNK in several systems. 
Furthermore, human PPP4R3 (Falafel ortholog) was reported to be phosphorylated in response 
to stress (referred to as unpublished data in (Wolff et al., 2006)). Moreover, PPP4 was shown to 
positively regulate JNK in response to TNF-α signaling (Zhou et al., 2002). The requirement of 
PPP4 for JNK and AP-1 activity was also shown by Inostroza et al. (2005) (Inostroza et al., 
2005). In addition, PPP4 acts as a positive regulator of hematopoietic progenitor kinase 1 
(HPK1), a Ste20-like protein kinase acting upstream of JNK (Zhou et al., 2004). Interestingly, the 
Dictyostelium discoideum Falafel ortholog SMEK was identified as a suppressor of MEK1, a 
member of the MAPKK family of kinases (Mendoza et al., 2005). SMEK suppresses MEK1 null 
cell polarity, chemotaxis, and gene expression defects. In addition, SMEK was shown to be 
required for proper cytokinesis and myosin II assembly. 
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In C.elegans, JNK also directly interacts with and phosphorylates the FOXO transcription factor 
DAF-16 (Oh et al., 2005), which is interesting since the Falafel ortholog SMK-1 was shown to be 
required for several (including oxidative) stress responsive functions of DAF-16, and genetic 
analysis revealed an interaction with the insulin/IGF-1 receptor DAF-2 (Wolff et al., 2006).  
A role of PPP4 in insulin signaling is further supported by the fact that degradation of the insulin 
receptor substrate 4 protein (IRS-4) stimulated by TNF-α is dependent on PPP4 
(Mihindukulasuriya et al., 2004). Moreover, okadaic acid, a potent PPP4 inhibitor, was shown to 
increase IRS-4 phosphorylation induced by Insulin (Villarreal et al., 2006). 
 
3.8. PPP4 and the centrosome 
 
In Drosophila, orthologous proteins for the catalytic subunit and the second regulatory subunit of 
the PPP4 complex exist, Pp4-19C and PPP4R2, respectively. The two proteins have been 
isolated in one complex (Hastie et al., 2000), and recently Falafel has also been shown to be 
part of this complex (Hastie et al., 2006). As PPP4c in human cells (Brewis et al., 1993), Pp4-
19C localizes to centrosomes and seems to be an essential protein for nucleation, growth, and 
stabilization of microtubules at centrosomes during cell division (Helps et al., 1998). There are 
two PPP4c orthologous proteins in C.elegans, PPH-4.1 and PPH-4.2. As PP4-19C in 
Drosophila, PPH-4.1 also localizes to centrosomes and is required for the maturation and 
microtubule nucleation of the centrosome (Sumiyoshi et al., 2002). Furthermore, PPH-4.1 
appears to play a role in either the establishment or the maintenance of chiasmata between 
homologous chromosomes during meiosis. 
Interestingly, in mitotic cells, activated ATM was also shown to be localized at centrosomes 
(Oricchio et al., 2006). The authors suggested that ATM could thereby monitor spindle integrity 
during mitosis. Thus, it seems that both PP4 and ATM are not only involved in a DNA damage 
response but also in further cell cycle defect responses, perhaps in the same pathway? 
 
3.9. PPP4 and Rac? 
 
falafel was identified as a suppressor of a Drac1N17-mediated rough eye phenotype. What could 
be the physiological relevance of this interaction? So far, no interaction between Rac and the 
PPP4 complex has been reported. PP2Ac, a phosphatase similar to PPP4, seems to negatively 
regulate the actin cytoskeleton via a TAP42 and Rho GTPase-dependent mechanism (Wang 
and Jiang, 2003). TAP42 was shown to interact with all PP2a-like phosphatases, including PPP4 
(Chen et al., 1998; Gingras et al., 2005). One might speculate that TAP42 and PPP4 could be 
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involved in a similar Rho or Rac GTPase signaling pathway. It will be interesting to know 
whether the small GTPase Ran binding protein domain (RanBP) in Falafel could bind the small 
GTPase Drac1. So far, no interaction could be detected between Falafel with either Ran or Rac 
by co-immunoprecipitation assays ((Gingras et al., 2005) and personal communication)). 
Intriguingly, Drosophila RhoGAP68F has been shown to interact with PP4-19C (PPP4c) in a 
yeast two-hybrid assay (Stanyon et al., 2004). Thus, Falafel and the PPP4 complex might 
regulate Drac1 through RhoGAP68F. Using affinity purification and mass spectrometry, the 
yeast Falafel orthologous protein Psy2 was also found in complex with two RhoGAPs, BEM2 
and RGA2 (Gavin et al., 2006; Gavin et al., 2002), further indicating a link between the PPP4 
complex and Rho GTPases. We have identified two mutations that lead to substitutions of 
conserved amino acids in the RanBP domain of Falafel (flfl1 and flfl2). These mutant alleles could 
be used to investigate possible genetic interactions with RhoGAP68F or other RhoGAPs. 
 
3.10. Open questions 
 
There are now some good clues about the function of Falafel. In summary, they suggest that 
Falafel functions as a regulatory subunit of the PPP4 complex that is involved in DNA damage 
repair in response to a number of stresses. However, several questions remain to be addressed, 
especially concerning the body size and dorsal closure phenotypes of falafel mutants and the 
connection to Drac1 signaling. 
With respect to the reduced body size of viable falafel allelic combinations it will be worthwhile to 
examine possible genetic interactions with components of the insulin pathway, which has a 
leading role in growth control. As mentioned above, the Falafel C.elegans ortholog SMK-1 
genetically interacts with DAF-2, the C.elegans Insulin receptor. Since smk-1 RNAi completely 
suppresses the daf-2 mutant longevity phenotype it will be interesting to see whether falafel 
mutants display a longevity phenotype. The fact that the daf-2/InR mutant phenotype is 
suppressed by smk-1 RNAi suggests that SMK-1 and PPP4 act as a negative regulator of 
Insulin signaling. On the other hand however, the falafel hypomorphic mutant phenotype – 
reduced body size – would be contradictory to a negative role in Insulin signaling.  
Interestingly, small interfering RNAs directed against the human falafel ortholog PPP4R3β 
shorten mitotic transit time (Kittler et al., 2004). A shortened cell division cycle eventually leads 
to smaller cells since they have less time to grow. Additionally, RNA interference against 
Drosophila PPP4c (PP4-19C) caused a 20% reduction in growth of Drosophila Schneider cells 
(Silverstein et al., 2002). I did not observe a clear reduction of cell size at the level of ommatidial 
size. Since the overall body size reduction was about 10-30% it is possible that an ommatidial 
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size reduction in a similar range was overseen. The cell number was not examined. 
flfl3 and flfl4 heteroallelic embryos display a dorsal closure defective phenotype. This is 
consistent with the role of Drac1 in dorsal closure. The reported interactions of the PPP4 
complex with the JNK pathway (see above) further indicate that Falafel could act in a Drac1/JNK 
signaling pathway. A hypomorphic PP4-19C mutant does not show dorsal closure defects (Helps 
et al., 1998). Additional loss-of-function alleles of PP4-19C and the second regulatory PPP4 
subunit (R2) will possibly elucidate the potential role of PPP4 in dorsal closure. Interestingly, all 
eight subunits of the TRiC/CCT complex were co-purified with PPP4c (Gingras et al., 2005) as 
well as with TAP42 (Ho et al., 2002). The TRiC/CCT complex is an ATP-dependent chaperonin 
that mediates protein folding in the eukaryotic cytosol. Genetic and biochemical data initially 
showed that it is required for the folding of the cytoskeletal proteins actin and tubulin, but a 
number of recent reports described other proteins that require TRiC/CCT for proper folding 
(Dunn et al., 2001). The involvement of PPP4 interactor TAP42 in actin regulation was already 
mentioned (see above). Therefore, one might speculate that the interactions between 
actin/tubulin, TAP42, TRiC/CCT and PPP4 could contribute to either remodeling of the 
cytoskeleton that occurs during dorsal closure as well to microtubule nucleation at centrosomes. 
A further indication for the relevance of the dorsal closure defective phenotype of falafel mutants 
and of a putative role of PPP4 in the regulation of the cytoskeleton stems from studies with the 
Dictyostelium discoideum Falafel ortholog SMEK. SMEK is required for cell polarity, proper 
cytokinesis and myosin II assembly (Mendoza et al., 2005). 
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4. Conclusion 
 
The initial aim of this study was to identify novel signaling components that act during dorsal 
closure. Therefore known key players in dorsal closure, Drac1 and Dcdc42, were used as  
starting points for a genetic screen. Dominant negative Drac1 or Dcdc42 (N17) were mis-
expressed in the eye, the resulting rough eye phenotype was suppressed by co-overexpression 
of several EP-lines as described. This screening system is rather artificial but it is validated by 
the fact that the mutations generated in one of these suppressor lines (falafel) cause dorsal open 
phenotypes. In addition, new functions for Rac and Cdc42 signaling in body size control, ROS 
homeostasis, and DNA damage repair could possibly have been revealed. Another argument for 
this kind of gain-of-function screen is that genes can be identified that possibly do not have any 
loss-of-function phenotype, or that have, like falafel, no clear phenotype that would be identified 
in loss-of-function screens. 
 
4.1. Falafel 
 
falafel overexpression in two EP lines was identified to suppress the Drac1N17-mediated rough 
eye phenotype. falafel overexpression leads to further phenotypes including a thorax closure 
defect in adult flies. Thorax closure resembles dorsal closure in both mechanistic and molecular 
ways. HA-tagged Falafel was shown to localize predominantly to the nucleus and RNA in situ 
hybridization revealed a ubiquitous expression of falafel transcripts. EMS-generated mutations in 
falafel were easily identified as reversions of two specific overexpression phenotypes. The 
mutant phenotype included a not fully penetrant dorsal closure defect and a reduced body size 
of the viable allelic combinations.  
Furthermore, the RNA interference phenotype of the C.elegans falafel ortholog smk-1 was 
investigated. The animals displayed several morphogenesis defects late in embryogenesis. 
Ventral enclosure, a process similar to dorsal closure, did not seem to be exclusively affected.  
Several reports in yeast, human cells and recently also in Drosophila eventually showed Falafel 
and the orthologous proteins to be part of the tripartite protein phosphatase 4 (PPP4) complex. 
Furthermore, components of this complex were shown in all three systems to be sensitive to 
cisplatin indicating that Falafel and PPP4 could be involved in DNA damage repair. This is 
further supported by the reported interactions of yeast Falafel (Psy2) with the cell cycle 
checkpoint protein Rad53 (Chk2) as well as of yeast and mammalian PPP4c with H2AX (see 
above).  
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Cisplatin is commonly used as an anti-cancer agent. Resistance of cancer cells to cisplatin is a 
major impediment to the clinical success of this drug. The cisplatin sensitivity of falafel mutant 
flies offers therefore a good oppurtunity to get a better understanding of the signaling pathways 
involved, potentially leading to the design of new anti-cancer drugs. It will be interesting to know 
whether mutations in one of the three Drosophila Rac genes possibly give rise to cisplatin 
sensitive flies as well. 
A further function of the PPP4 complex in stress response mediated by the JNK and the 
insulin/FOXO pathways is suggested by a number of reports. This is intriguing, since Falafel, as 
a part of the PPP4 complex, was identified as a suppressor of a Drac1 dominant negative 
(Drac1N17) phenotype. Falafel is therefore a putative positive regulator of Drac1 signaling, which 
itself has also been shown to activate the JNK pathway, possibly through Falafel and PPP4. This 
is additionally supported by the reported interactions of RhoGAPs with components of the PPP4 
complex (see above). 
In Drosophila, as well as in human and C.elegans, components of the PPP4 complex localize to 
mitotic centrosomes. Interestingly, ATM, a candidate upstream regulator of PPP4 (see above), 
also localizes to centrosomes, possibly as a checkpoint regulator to control the integrity of the 
spindle apparatus before allowing cells to progress further through the cell cycle. This suggests 
that both PPP4 and ATM are not only involved in a DNA damage response but also in 
responses to other defects that can occur during cell division. 
 
 
4.2. EP screen suppressors: Potential role in the regulation of ROS, DNA damage 
response and cell cycle 
 
The rough eye phenotype of the Drac1/Dcdc42 tester flies was specifically suppressed by 23 EP 
element insertions that correpond to 17 genes, none of which has been previously reported to 
interact with Drac1 or Dcdc42. The identified genes represent a rather heterogeneous group 
whose products are involved in a variety of cell signaling, transcriptional regulation, cytoskeletal 
and other events. The function, if known, of each of these genes and their potential role in Rho 
GTPase signaling and dorsal closure are discussed in chapter 2.9.  
Initially, for three of these genes (SelD, dTrf2 and dATP7A) it was apparent that they probably 
interfere with cellular ROS (reactive oxygen species) levels. After a further evaluation of all 
identified suppressor genes I hypothesized a potential role in ROS regulation for three additional 
genes (CG30421, CG6700/NOS and pfrx, see chapter 2.9.2.). 
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ROS have been traditionally regarded as toxic by-products of metabolism. Furthermore, ROS 
have been implicated in several human processes and diseases, including cancer, heart 
disease, and neurodegenerative diseases. Because of their high reactivity, ROS bring about 
damages to various cellular macromolecules, including DNA. The identification of falafel, which 
is possibly involved in a DNA damage response, as a suppressor of Drac1N17 could therefore be 
in line with the other genes proposed to have a function in ROS signaling. In order to counteract 
oxidative DNA damage, cells have evolved a wide variety of adaptive cellular responses ranging 
from transient growth arrest to permanent growth arrest, apoptosis or necrosis. Importantly, the 
JNK pathway has been demonstrated to play essential roles in the cellular protective response 
against ROS and other forms of stress. This is of particular interest since JNK has been shown 
to be regulated by small Rho GTPases.  
Accumulating evidence implicates ROS also in normal physiological signaling by growth factors 
and cytokines. The primary sources of ROS that are involved in such signaling pathways are 
plasma membrane oxidases, preferentially NADPH oxidases. Cdc42 and especially Rac1 and 
Rac2 have well-documented roles in the regulation of NADPH oxidases. This suggests that the 
rough eye phenotype of the Drac1N17 and Dcdc42N17 tester flies could be due to oxidative 
damage or misregulation of cellular redox states in the affected cells. Therefore, one possible 
mechanism for the suppression phenotype is a direct regulation of ROS levels by the 
responsible genes. Interestingly, endogenously produced ROS (via Rac stimulated NADPH 
oxidases) have been demonstrated to be important mediators of actin cytoskeleton remodeling 
(Irani and Goldschmidt-Clermont, 1998 and Moldovan et al., 1999). Thus, the rough eye 
phenotype could be due to a misregulation of the cytoskeleton. Further experiments with Drac 
and Dcdc42 mutants and with mutants of the identified suppressor genes to test the potential 
hypersensitivity to oxidants remain to be performed. 
Furthermore, several studies have demonstrated that ROS may also play an important role in 
cell cycle progression. Interestingly, ROS have been shown to cause a cell cycle arrest at the 
G2/M transition (Thorn et al., 2001; Chung et al., 2002; Zhang et al., 2001; Zhang et al., 2003 
and Bijur et al., 1999). It is thus conceivable that the identified suppressor genes could interfere 
with cell proliferation, possibly via regulation of ROS. Importantly, two known regulators of cell 
proliferation, Rbf and string (Drosophila cdc25), were identified as suppressors of Dcdc42N17, as 
well as the gene encoding the transcription factor dTrf2. Together with DREF, dTrf2 has been 
demonstrated to regulate transcription of genes that are involved in cell proliferation, DNA 
replication and DNA damage protection. DREF binds to the promoter-activating element DRE 
(DNA replication-related element). Interestingly, two such DRE sequences lie in the 5' region of 
the gene encoding the catalytic subunit of the PPP4 complex in Drosophila, PP4-19C. Moreover, 
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the yeast Falafel ortholog Psy2 has been shown to interact with the important cell cycle 
checkpoint regulator Rad53/Chk2, and preliminary results in Drosophila indicate that falafel and 
cdc2 interact genetically. In addition, the Drac1N17 suppressor SelD, which is implicated in the 
response to oxidative stress, may also be involved in cell cycle regulation (Alsina et al., 1999; 
Alsina et al., 1998; Serras et al., 2001). 
 
In summary, of the 17 genes that have been identified in the EP screen nine are possibly 
involved in ROS signaling, DNA damage response or cell cycle regulation. These three 
processes are surely linked together: ROS can be expected to trigger cell cycle checkpoint 
responses directly via the induced damage to DNA or indirectly via various signaling pathways. 
Thus, these nine genes possibly represent a group of genes whose products take part in a 
Dcdc42 or Drac1 mediated response to stress and subsequent regulations of the cell cycle 
(schematically summarized in Fig.16). The nine genes are: dTrf2, dATP7A, CG6700 (NOS?), 
CG30421, Rbf and stg (Dcdc42N17 suppressors), pfrx, SelD and flfl (Drac1N17 suppressors). 
Except for dATP7A and stg, none of them was implicated in Dcdc42/Drac1 signaling before. On 
the other hand, the role of Cdc42 in cell cycle regulation and of Rac1/2 (and to a lesser extent of 
Cdc42) in the regulation of NADPH oxidase and thereby of ROS has already been appreciated. 
The identification of the nine genes as suppressors of Dcdc42N17 or Drac1N17 additionally 
supports a role of the small Rho GTPases in the regulation of ROS and of the cell cycle. Further 
analysis of these nine genes could also shed light on new modes of ROS and cell cycle 
regulation. 
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Figure 16. Model of ROS signaling, DNA damage response and cell cycle progression in the 
context of some of the herein identified Drac1/Dcdc42 suppressor genes 
Oxidative stress by reactive oxygen species (ROS) induces both damage to DNA as well as signaling 
pathways leading to cell cycle arrest and DNA damage repair. Rac1/2 (and possibly Cdc42) regulate ROS 
levels through the NADPH-oxidase enzyme complex. Cdc42 positively regulates cell cycle progression 
(G2/M transition). The identified suppressors with a proposed function in ROS signaling, DNA damage 
response and cell cycle progression are shown in red. 
 
Eight further genes were identified as Dcdc42N17 or Drac1N17 suppressors. These genes encode 
transcription factors, RNA and DNA binding proteins and cytoskeleton proteins. Their exact roles 
in Drac1 or Dcdc42 signaling remain to be assessed. 
 
To conclude, our genetic approach of systematic gene overexpression successfully identified 
novel interactors of Drac1 and Dcdc42. Several novel interactions suggest additional functions 
for Drac1 and Dcdc42 in ROS signaling, DNA damage response and cell cycle progression. 
Furthermore, in the case of one interactor, falafel, we could show that a screen in the fly eye can 
be used as a valid assay for targeting genes that function during dorsal closure.  
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5. Material and Methods 
 
Fly stocks 
Flies were grown at 25°C on standard food. It contains the following ingredients per 1 liter: 75g 
glucose/dextrose, 55g maize, 10g flour, 8g agar, 15ml nipagin (33g/l EtOH)/nipasol (66g/l EtOH), 
and 100g live yeast. Crosses were performed at 25°C except for crosses with 
GMRGal4>Drac1N17 and Sev>Dcdc42N17, which were performed at 18°C.  Most fly stocks have 
been described previously:  
GMR-Gal4  (Freeman, 1996) 
sev-Gal4 (sevE-hsP-Gal4 K25, generated in our lab) 
UAS-Drac1N17 (Luo et al., 1994)) 
UAS-Dcdc42N17 (Luo et al., 1994) 
The stock y, w; Sp/CyO; hsp-Cre (666-10) Sb/TM6B has not been published yet (K. Basler). 
en-Gal4 and arm-Gal4 flies were kindly provided by K. Basler.  
y, w; ap-Gal4 (Bloomington stock center) 
y, w; act-Gal4/TM6By+ (Bloomington stock center) 
pnr-Gal4 (pnrMD237) (Bloomington Stock Center) 
69B-Gal4 (Bloomington stock center) 
puclacZ (Bloomington Stock Center) 
Df(3)urd (Bloomington stock center) 
EP(3)0929 (Bloomington stock center) 
EP(X)1310 (Bloomington stock center) 
cdc2E1-23 (Bloomington stock center) 
UAS-AP-1sigma (this study) 
UAS-CG30421 (this study) 
UAS-falafel (this study) 
UAS-falafel-HA (this study) 
flfl1-flfl5 alleles (this study) 
 
EP screen   
We made use of two new versions of an EP element called pDA530 and pDA543 (D. Nellen and 
K. Basler, personal communication). pDA530 and pDA543 drive expression of neighboring 
genes on both sides of their insertion site because of two sets of UAS (each set contains 10 
copies of the UAS) pointing into opposite directions (Fig. 4). One of the two UAS sites is flanked 
by Cre recombinase target (loxP) sites to allow removal of this UAS site in flies expressing Cre 
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recombinase (Siegal and Hartl, 1996). The loxP sites are defective in pDA530, which was used 
during the first part of the screen (EP insertion numbers until EP12-118). pDA543, which was 
used in the second part of the screen, is identical to pDA530 except for the functional loxP sites.  
Transgenic flies containing an insertion of pDA530 or pDA543 were used as "starter lines", in 
which the EP insertion was mobilized in the presence of P(∆2-3)99B transposase (Rorth, 1996). 
Males carrying novel EP insertions were subsequently crossed to y, w; GMR-Gal4; Drac1N17 or 
y, w; sev-Gal4; Dcdc42N17 virgin female flies exhibiting a rough eye phenotype. F1 progeny were 
scored under a dissecting microscope for modification of the rough eye phenotype. Lines that 
suppressed the original phenotype were retested at least once.  
 
Identification of genes responsible for suppression phenotype  
Plasmid rescue was done as described (Pirrotta, 1986) using EcoRI. For sequencing the 
isolated plasmids, we used primer P3' (5'-CGACGGGACCACCTTATGT TATTTCATCATG-3').  
Flanking sequence was analyzed at the National Center for Biotechnology Information (NCBI) 
database (http://www.ncbi.nlm.nih.gov/blast) or the Berkeley Drosophila Genome Project 
(BDGP) database (http://www. fruitfly.org/blast/) using the Basic Local Alignment Search Tool 
(BLAST). Identification of the genes surrounding the P-element insertion was performed with the 
GeneSeen (Gadfly) (http://www.fruitfly.org/cgi-bin/annot/query) and Flybase 
(http://flybase.bio.indiana.edu/) databases. 
A subset of the EP insertions was analyzed by Cre recombinase mediated excision of the UAS 
site, which is flanked by loxP (CRT) sites (Fig. 4). Briefly, flies containing the EP insertion and 
hsp-Cre were generated. These flies express Cre recombinase sufficiently in the absence of a 
heat-shock. Subsequently, these flies were crossed to balancer flies. F1 flies that carried EP-
containing chromosomes and were phenotypically yellow were selected. These "single-headed" 
EP insertions, which lack the loxP-UAS-GAGA-yellow-ampR-loxP cassette (Fig. 4), were now 
assessed for their ability to suppress the GMR-Gal4>UAS-Drac1N17 or sevGal4>UAS-Dcdc42N17 
phenotypes. This approach allowed us to identify the gene which is responsible for the 
suppression phenotype for the following EP insertions: EP22-048, EP29-104, EP31-149, EP32-
120, EP33-059, EP36-054, EP39-161, EP47-082, EP53-065 (see Chap. 2.6.2., Tab. 4). 
 
 
Isolation of falafel alleles 
We performed two mutagenesis screens in which we selected mutated chromosomes carrying 
EP47-082 that either no longer showed the specific wing phenotype when crossed to 69B-Gal4 
or were viable in combination with act-Gal4. For this purpose, EP47-082 males were fed 25 mM 
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EMS (ethylmethane-sulfonate) (Lewis, 1968) and subsequently crossed to 69B-Gal4 or act-Gal4 
virgins. 4000 F1 flies were screened for a reversion of the wing phenotype of 69B>EP47-082 
flies. 32 selected flies were subsequently backcrossed to 69B, and three (flfl1, flfl3 and flfl4)  
showed germline transmission of the mutation. Seven revertants of the act-Gal4>EP47-082 
lethality phenotype were backcrossed to act-Gal4, and two (flfl2 and flfl5) showed germline 
transmission of the mutation. The molecular nature of the mutations was determined by 
amplifying genomic DNA of mutant flies by PCR and sequencing the PCR products. Promising 
mutations were verified by double peak analysis of the sequences using the Sequencher 
program (Gene Codes Corporation ). We could identify mutations leading to amino acid 
substitutions (flfl1 and flfl2) and premature stop codons (flfl3 and flfl4). For the fifth EMS allele, the 
molecular nature is unknown. 
  
Production of Germline Clones with the Autosomal FLP-DFS Technique 
flfl alleles were recombined onto the FRT82B chromosome. Virgin females of the genotype y, w; 
FRTflfl / TM3, Ser, y+ were crossed to males of genotype hs70-FLP / Y; FRT P[ovoD1] / TM3, 
Sb. After a prelay at 25°C for one day, laid eggs were collected over a period of 24 h and 
incubated for another 36 h at 25°C. First instar larvae were then heat shocked for 1 hr at 37°C 
and put back to 25°C to complete development. 15-20 eclosed females of genotype y w / y w 
FLP; FRT flfl / FRT P [ovoD1] were mated with y, w / Y; FRT flfl / TM3, Ser, y+ males. Due to 
presence of the dominant female sterile mutation ovoD1 in the female germline, only germline 
clones homozygous for the flfl mutations can form eggs.  
 
Cuticle preparations 
Cuticle preparations of embryos were performed as described in Protocol 36.1 (Sullivan, 2000). 
Aged embryos were dechorinated in 50% bleach, rinsed and mounted in Hoyer’s Mounting 
Medium. The medium was cured overnight at 60°C. These preparations were examined by dark-
field microscopy.  
 
 
Establishment of transgenic flies 
To generate UAS-falafel, UAS-ap-1sigma, and UAS-CG30421, the ORFs coding for these genes 
were amplified by PCR from the full-length cDNA clones LD13350, GH27809, LD14109, 
respectively (obtained from Research Genetics, Huntsville, AL). The PCR products were ligated 
into the pUAST Drosophila transformation vector (Brand and Perrimon, 1993). Additionally, a 
haemoglutinin (HA) tag was added to Falafel to follow ist subcellular localization. To this end, the 
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PCR product of flfl cDNA was cloned into the pCRII-TOPO cloning vector (Invitrogen) and 
sequenced. Subsequently, the flfl cDNA was cloned upstream of the haemoglutinin (HA) tag into 
the NotI site of the Drosophila transformation vector pUAST-4HA to generate UAS-falafel-HA, 
which has a C-terminal HA-tag. The plasmid pUAST-4HA was provided by Isabel Hanson (MRC 
Human Genetics Unit, Edinbrgh, UK). It is a modified version of plasmid pUAST (Brand and 
Perrimon, 1993), which was generated by cloning four HA repeats into the XhoI site of pUAST 
(Isabel Hanson, personal communication). The resulting plasmids UAS-falafel, UAS-falafel-HA, 
UAS-ap-1sigma, and UAS-CG30421 were subsequently used to generate transgenic flies by 
means of P element-mediated germline transformation as described (Basler et al., 1991). The 
constructs were injected into y, w embryos. 
 
Immunohistochemistry and histology  
Antibody staining was done using mouse anti-HA primary (1:1500, Boehringer Mannheim) and 
anti-mouse FITC secondary antibodies (1:500). Pictures were taken using a Leica SP2 confocal 
laser scanning microscope.  
To detect β-galactosidase activity, embryos and third instar imaginal discs were fixed and 
subjected to a standard X-gal color reaction at 37°C. 
 
RNAi interference in Caenorhabditis elegans 
C. elegans strains were cultured at 20°C as described (Brenner, 1974). RNAi was performed by 
feeding worms with dsRNA-producing E. coli as described (Kamath et al., 2001) with the 
following modifications:  
Five to ten L1 larvae were placed on the RNAi plates, and the P0 and F1 generations were 
inspected for embryonic phenotypes. Three millimolar IPTG was added to the agar to induce the 
expression of dsRNA. 
Using the oligos oMZ51 (5'-TGTCTTGTCTGCACTGAAGC-3') and oMZ52 (5'-CGCCTTAAAACA 
CGTCTAGG-3'), or oMZ53 (5'-AAAAGGATCCAAACTCTAATTGTTTGGTCC-3') and oMZ54 (5'-
AAAAAAGCTTGAAGTAGCGTTACAATGTCG-3'), two fragments of the C.elegans falafel 
ortholog (F41E6.4/SMK-1) were PCR amplified. The PCR products were cloned into a feeding 
vector (L4440) between two T7 promoters in inverted orientation and then transformed into a 
bacterial strain carrying IPTG-inducible expression of T7 polymerase (Timmons and Fire, 1998). 
The bacterial E. coli strain (HT115(DE3)) was used, which lacks double-strand-specific RNase 
III, improving the ability to produce RNAi phenotypes (Kamath et al., 2001).  
The dsRNA-producing E. coli were fed to wildtype worms expressing the adherens junction 
marker JAM-1::GFP (Mohler et al., 1998). This allowed to follow embryogenesis under 
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fluorescent light microscope. To this end, animals were mounted on 3% agarose pads in M9 
solution containing 15 mM NaN3. GFP expression was observed under fluorescent light 
illumination with a Leica DMRA microscope equipped with a cooled CCD camera (Hamamatsu 
ORCA-ER) controlled by the Openlab 3.0 software package (Improvision).  
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A Novel, Evolutionarily Conserved Protein
Phosphatase Complex Involved in Cisplatin
Sensitivity*□S
Anne-Claude Gingras‡§, Michael Caballero¶, Marcel Zarske¶, Amy Sanchez‡,
Tony R. Hazbun, Stanley Fields**, Nahum Sonenberg‡‡, Ernst Hafen¶, Brian Raught‡,
and Ruedi Aebersold‡§§¶¶
Using a combination of tandem affinity purification tag-
ging and mass spectrometry, we characterized a novel,
evolutionarily conserved protein phosphatase 4 (PP4)-
containing complex (PP4cs, protein phosphatase 4, cis-
platin-sensitive complex) that plays a critical role in the
eukaryotic DNA damage response. PP4cs is comprised of
the catalytic subunit PP4C; a known regulatory subunit,
PP4R2; and a novel protein that we termed PP4R3. The
Saccharomyces cerevisiae PP4R3 ortholog Psy2 was
identified previously in a screen for sensitivity to the DNA-
damaging agent and anticancer drug cisplatin. We dem-
onstrated that deletion of any of the PP4cs complex or-
thologs in S. cerevisiae elicited cisplatin hypersensitivity.
Furthermore human PP4R3 complemented the yeast psy2
deletion, and Drosophila melanogaster lacking functional
PP4R3 (flfl) exhibited cisplatin hypersensitivity, suggest-
ing a highly conserved role for PP4cs in DNA damage
repair. Finally we found that PP4R3 may target PP4cs to
the DNA damage repair machinery at least in part via an
interaction with Rad53 (CHK2). Molecular & Cellular
Proteomics 4:1725–1740, 2005.
Reversible protein phosphorylation is a highly conserved,
essential regulatory mechanism involved in a host of cellular
processes. Yet, while the phosphorylation of regulatory mol-
ecules by kinases has been studied intensively, their subse-
quent dephosphorylation is much less well understood. In
eukaryotes, dephosphorylation on serine/threonine residues
is effected by two distinct groups of functionally diverse phos-
phatases, the phosphoprotein M (represented by a sole mem-
ber in higher eukaryotes, PP2C) and PPP1 families (1). Within
the much larger PPP class, a common catalytic domain (of
280 aa) is highly conserved, whereas the N and C termini are
more divergent and further separate the PPP proteins into
subfamilies. A number of distinct PPP subfamilies have thus
been characterized (PP1, PP2A, PP2B, PP5, and PP7; Ref. 2)
based on sequence homology, associated regulatory sub-
units, sensitivity to different types of chemical inhibitors, and
metal ion requirements. A major PPP subfamily that plays a
variety of critical roles in a multitude of physiological pro-
cesses is the PP2A-type phosphatases, PP2AC (the catalytic
subunit of PP2A; human gene names PPP2CA and PPP2CB),
PP4C (gene name PPP4C, formerly known as PPX), and
PP6C (PPP6C; Ref. 3).
PP2A often functions as a standard trimeric complex with a
catalytic (C) subunit (encoded by two genes in mammals)
associated with one of many regulatory (or B) subunits via one
of two adaptor (A) molecules (4, 5). The regulatory and adap-
tor subunits are thought to confer substrate specificity to the
complex (5).
In contrast to PP2A, the supramolecular architecture and
subunit composition of PP4 multiprotein complexes remains
largely unknown. Two mammalian PP4 regulatory subunits
were previously identified (here termed PP4R1 and PP4R2,
gene names PPP4R1 and PPP4R2; Refs. 6 and 7). Although
PP4R1 shares some sequence homology with the PP2A
adaptor proteins (PPP2R1A and PPP2R1B), it does not bridge
PP4C and PP4R2; PP4R1 and PP4R2 display mutually exclu-
sive PP4C interactions (Refs. 6 and 7; and see below). Other
PP4C-interacting partners have also been reported (e.g. Refs.
8 and 9), but whether these proteins represent bona fide
regulatory subunits or phosphatase substrates and how these
binding proteins may affect PP4 activity are unclear.
To gain a better understanding of the composition, func-
tion, and regulation of PP4, we systematically analyzed mam-
malian and yeast PP4C-interacting proteins. In doing so, we
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were able to characterize several different mutually exclusive
PP4C-containing complexes and identified a novel, evolution-
arily conserved PP4C binding partner (which we termed
PP4R3) that assembles into a complex with PP4C and
PP4R2. Interestingly deletion of the yeast PP4R3 ortholog
PSY2 was demonstrated previously to elicit hypersensitivity
to the DNA damage-inducing drug cisplatin (10). We found
that deletion of the other components of the yeast
PP4CPP4R2PP4R3 complex also yielded cisplatin hyper-
sensitivity; therefore we termed this complex PP4cs (protein
phosphatase 4, cisplatin-sensitive; see below).
Platinum-based anticancer agents such as cisplatin and
carboplatin display a broad range of activities against solid
tumors (11, 12). However, the response to platinum-induced
DNA damage is not well understood; multiple intracellular
signaling pathways are clearly involved in DNA repair (12). A
common problem with cisplatin-based cancer therapies is
resistance to cisplatin. A better understanding of the cellular
processes and effectors involved in the response to cisplatin
treatment may thus improve our ability to treat cancer.
EXPERIMENTAL PROCEDURES
Plasmids and Yeast Strains—pcDNA3-flagA was a kind gift from
Dr. S. Morino, and pcDNA3-GST and the original pcDNA3–3HA were
generous gifts from Dr. H. Imataka. pESC-URA was purchased from
Stratagene, and the yeast two-hybrid vectors were described previ-
ously (13, 14). The yeast tandem affinity purification (TAP) tag strains
as well as diploid deletion strains in the BY4743 background and
haploid MAT strains in the BY4742 background were from Open
Biosystems. The yeast two-hybrid strains pJ69-4A and pJ69-4 as
well as the vectors pOAD and pOBD-2 were described previously
(13, 14).
To generate mammalian TAP tag vectors for the production of
N-terminal (NTAP) and C-terminal (CTAP) fusion proteins, the TAP
sequences (from the versions with two immunoglobulin binding do-
mains, a TEV site, and a calmodulin binding domain) from the Schiz-
osaccharomyces pombe vectors pREP-NTAP or pFA6a-2xPA-CTAP
(Ref. 15; kind gifts from Dr. K. Gould, Vanderbilt University) were
amplified by PCR. For NTAP, the 5 primer introduced a KpnI site,
whereas the 3 primer introduced sites for PmeI, AscI, PacI, and
BamHI. The PCR product was digested with KpnI and BamHI and
inserted into the KpnI and BamHI sites of pcDNA3 (Invitrogen). For
CTAP, the 5 primer added an XhoI site followed by sites for PmeI,
AscI, and PacI, whereas the 3 primer introduced an ApaI site. The
PCR product was digested with XhoI and ApaI and inserted into the
XhoI and ApaI sites of pcDNA3. Inserts were completely sequenced.
Unique sites and polylinker sequence for pcDNA3-NTAP and
pcDNA3-CTAP are shown in Supplemental Fig. 1 and at www.
proteomecenter.org.
To generate pcDNA3-flagnew and pcDNA3-EE (Glu-Glu), adapters
encoding the sequences MDYKDDDDKAAS and MEYMPMEAAS,
respectively, were cloned into the KpnI and PmeI sites of
pcDNA3-NTAP (thereby replacing the NTAP cassette with the appro-
priate epitope tag). pcDNA3–3HAnew was generated by amplifying
the triple HA tag from the original pcDNA3-3HA (a kind gift from
Dr. H. Imataka) and inserting this tag into the KpnI/PmeI sites of
pcDNA3-NTAP. All epitopes and multiple cloning site were
sequenced.
Coding sequences for proteins of interest were amplified by PCR
using Pfu Ultra from yeast genomic DNA (all yeast ORFs), a cDNA
library from HeLa cells (Stratagene; hTIP41, NM_152902; PP2AC,
NM_002715; PP2AC, NM_004156; PP4C, NM_002720; PP6C,
NM_002721), a cDNA library from human placenta (Ambion; PP4R2,
NM_174907), a pcDNA3-alpha4 (alpha4) construct kindly provided by
Dr. K. Arndt (NM_001551), or clones from the mammalian gene col-
lection (MGC) or IMAGE clones (KIAA2010, NM_032560; KIAA1387,
NM_020463; TCP1, NM_030752; PP1C, NM_002708). All accession
numbers in parentheses are from GenBankTM. Inserts were cloned
in-frame into appropriate vectors. 3 and 5 junctions of all inserts or
entire inserts obtained through library amplification were sequenced.
Preparation of Extracts and Detection of Expression Levels—For
stable cell pools, low passage number HEK293 cells (ATCC; CRL-
1573) were transfected with Lipofectamine PLUS (Invitrogen) accord-
ing to the manufacturer’s instructions and selected with 750 g/ml
active G418 (Mediatech cellgro). Selection medium was changed
every 2–3 days for 14 days when a stable cell population was
obtained. Expression was monitored, and cells were amplified further
to generate 10–20 150-mm plates per experiment.
Cells were washed three times in ice-cold PBS, harvested by
scraping, and then centrifuged to remove excess PBS. TAP lysis
buffer (10% glycerol, 50 mM Hepes-KOH, pH 8.0, 100 mM KCl, 2 mM
EDTA, 0.1% Nonidet P-40, 2 mM DTT, 10 mM NaF, 0.25 mM NaOVO3,
and 50 mM -glycerophosphate supplemented with 1 protease
inhibitor mixture (Sigma catalog number P8340), 5 nM okadaic acid,
and 5 nM calyculin A) was added (0.5–1 ml of lysis buffer/150-mm
plate), and the mixture was incubated on ice for 30 min. Lysis was
further enhanced by performing two freeze-thaw cycles. In prelimi-
nary experiments, varying concentrations of the specific serine/thre-
onine phosphatase inhibitors were used; the interactions reported
here were observed under all conditions.
Saccharomyces cerevisiae TAP tag strains (Open Biosystems) were
grown to OD 0.8–1.0 and harvested by centrifugation. After one
rinsing step in 20 mM Hepes, pH 7.5, 10 mM EDTA, cells were pelleted
and flash frozen. Pellets were thawed in TAP lysis buffer using 1 ml of
lysis buffer/g. Yeast were lysed by glass bead beating.
For the preparation of cleared extract from mammalian cells or
yeast, debris were pelleted via centrifugation (15,000 rpm for 30 min
at 4 °C), and protein concentration was determined by a Bradford-
type assay (Bio-Rad). Expression levels of recombinant proteins in
transfected mammalian cells or yeast strains were analyzed by sep-
arating 10–25 g of total cell extract by SDS-PAGE followed by
immunoblotting with normal rabbit serum (ICN Biomedicals Inc.;
1:2000) as the primary antibody and donkey anti-rabbit-horseradish
peroxidase (HRP) (Amersham Biosciences; 1:5000) as a secondary
antibody.
TAP Tag Purification—The purification strategy used here was
largely the same as that described by Rigaut et al. (16) with minor
modifications (see below) and adaptation for direct LC-MS analysis.
More details may be found at www.proteomecenter.org.
Mammalian cells or yeast were lysed in TAP lysis buffer, and
extracts were centrifuged to remove debris as described above.
Mammalian TAP tag purifications were performed with extract from
5–20 15-cm plates of stably transfected HEK293 cells (roughly 40–
150 mg of protein extract). Alternatively TAP purification was per-
formed with extract from 1–2 liters of yeast grown to OD 0.8–1.0.
Extracts were incubated with 100 l of packed, prewashed IgG-
Sepharose beads (Amersham Biosciences) for 4–6 h at 4 °C with
gentle agitation. Beads were pelleted and washed three times with
TAP lysis buffer and three times with TEV cleavage buffer (10 mM
Hepes-KOH, pH 8.0, 150 mM NaCl, 0.1% Nonidet P-40, 0.5 mM
EDTA, and 1 mM DTT). Beads were then resuspended in 300 l of TEV
lysis buffer containing 100–200 units of recombinant AcTEV (Invitro-
gen) and returned to incubation with gentle agitation at 4 °C for 10–16
h. After TEV cleavage, the IgG beads were pelleted, and the super-
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natant was transferred to a fresh tube. IgG beads were rinsed three
times with calmodulin binding buffer (10 mM Hepes-KOH, pH 8.0, 150
mM NaCl, 10 mM -mercaptoethanol, 1 mM MgOAc, 1 mM imidazole,
0.1% Nonidet P-40, and 2 mM CaCl2), and all washes were combined
with the supernatant. CaCl2 (5 l of a 1 M stock) was added to the
mixture, which was centrifuged once more and then transferred to a
fresh tube containing 75 l of packed calmodulin-Sepharose beads
(Amersham Biosciences). Incubation was performed for 2–3 h at 4 °C
with agitation. The slurry was transferred into empty Bio-spin columns
(Bio-Rad), and the flow-through was removed through gentle air
pressure. Two washes in calmodulin binding buffer (750 l each) were
performed followed by three washes in calmodulin rinsing buffer (50
mM ammonium bicarbonate, pH 8.3, 75 mM NaCl, 1 mM MgOAc, 1 mM
imidazole, and 2 mM CaCl2). The last drops of rinsing buffer were
drained with gentle pressure, and Bio-spin columns were transferred
to fresh tubes. Two elutions with 100 l each of calmodulin elution
buffer (50 mM ammonium bicarbonate, pH 8.3, and 25 mM EGTA, pH
8.0) were performed, and the Bio-spin column was transferred into
another tube for two additional elutions.
Trypsin Digest and Preparation for Mass Spectrometry—Sequenc-
ing grade modified trypsin (Promega; 0.5–1 g) was added directly to
the eluate. Digestion was performed overnight at 37 °C. Following
digestion, the sample was lyophilized and then resuspended in re-
versed-phase HPLC buffer A (20 l; 0.4% AcOH, 0.005% heptaflu-
orobutyric anhydride in H2O). Prior to loading onto the reversed-
phase column, the sample was centrifuged at 13,000 rpm for 10 min,
and the supernatant was transferred to a fresh tube.
LC-MS/MS—Microcapillary reversed-phase columns (75-m inner
diameter, 363-m outer diameter; Polymicro Technology) were cut to
a final length of 15–20 cm, and spray tips were pulled in-house by
hand. Columns were packed in-house (12 cm) with Magic C18 100-Å,
5-m silica particles (Michrom, catalog number PM5/61100/00) using
a pressure bomb. Prior to loading the sample, columns were equili-
brated in HPLC buffer A. Half of the sample was applied to the column
using a pressure bomb and then washed off line in buffer A  5%
acetonitrile for 30–60 min. The LC column was then placed in front of
a Finnigan LCQmass spectrometer, programmed for data-dependent
MS/MS acquisition (one survey scan, three MS/MS of the most abun-
dant ions). After sequencing the same species three times, the
mass 3 Da was placed on an exclusion list for 3 min. Peptides were
eluted from the reversed-phase column using a multiphasic elution
gradient (5–14% acetonitrile over 5 min, 14–40% over 60 min, and
40–80% over 10 min). The remaining half of the sample was then
processed in the same manner. To prevent cross-contamination,
each sample was processed on a freshly prepared reversed-phase
column.
Data Analysis—Raw files generated by Xcalibur (Finnigan) were
converted to the mzXML format (17), and combined runs (from the
same sample) were searched using SEQUEST against the human
International Protein Index (IPI) database, version 3.01, or against the
Saccharomyces Genome Database (SGD) yeast ORF database (April
22, 2004 version). SEQUEST searches were performed without con-
straining for the number of tryptic termini, with a mass tolerance on
the precursor ion of 2, and methionine oxidation (16) as a variable
modification. SEQUEST html output was analyzed with INTERACT
(18), PeptideProphet (19), and ProteinProphet (20) using the default
parameters of each program. With the exception of Xcalibur and
SEQUEST, all other software tools are open source and available from
the Institute for Systems Biology (www.proteomecenter.org/software.
php).
Non-radioactive Transcription/Translation Assays—Mixtures of
plasmid DNA containing a T7 promoter (100–500 ng) were used to
program 25 l of a reticulocyte transcription/translation system con-
taining Transcend tRNA (Promega) essentially according to the man-
ufacturer’s instructions. Translated proteins were subjected to SDS-
PAGE and transferred to a nitrocellulose membrane. The membrane
was blocked for 1 h in PBS  0.5% Tween 20. Streptavidin-HRP
(Amersham Biosciences; 1:10,000) was used to detect the newly
synthesized proteins incorporating biotinylated lysine. After washing
the membrane (3 5 min with PBS 0.5% Tween 20; 3 5 min with
water), chemiluminescence was performed. Immunoprecipitations
were performed by diluting the TNT reaction with TAP lysis buffer and
incubating with 5–10 l of packed anti-HA beads (Roche Applied
Science) or anti-FLAG resin (Sigma). After three washes with TAP lysis
buffer, the sample was eluted directly in protein sample buffer lacking
reducing agent by incubation for 30 min at 37 °C. Reducing agent was
added, and the sample was boiled and loaded onto SDS-PAGE gels.
Cisplatin Sensitivity Assay in Drosophila—flfl2 (I57T) and flfl3 (pre-
mature stop codon at position 347) are ethyl methanesulfonate-in-
duced alleles. Healthy heterozygous flies carrying either flfl2 or flfl3
over a marker chromosome (MKRS) were maintained on apple agar
plates at 25 °C and allowed to lay eggs for 24 h. Agar plates were then
changed and incubated for another 24 h at 25 °C. First instar larvae
were collected and distributed to vials containing standard fly food
into which the cisplatin solution was allowed to diffuse. Cisplatin
powder (Alexis Biochemicals, Lausanne, Switzerland) was dissolved
in 0.9% NaCl to obtain 0.4, 0.8, and 1.2 mM stock solutions. To test
for putative undesirable effects of the MKRS marker chromosome,
MKRS/ flies were also tested for cisplatin sensitivity. The MKRS/
as well as the control flfl2/ or flfl3/ flies showed no change in
cisplatin sensitivity as compared with wild type flies.
RESULTS
Identification of Human PP4C-binding Proteins—TAP tag-
ging and mass spectrometry, in which a protein complex of
interest is purified in a two-step affinity enrichment process
and its components are identified by the fragment ion spectra
of selected tryptic peptides, have proven to be invaluable
tools in the characterization of protein complexes (16, 21–23).
As compared with single tag purification strategies, samples
isolated by TAP tagging are significantly cleaner, thereby
reducing the likelihood of false-positive identifications. Harsh
washing conditions are also not necessary, allowing for re-
covery of native complexes. Another advantage of such ap-
proaches is that they are generic, making them particularly
suited to the study of interaction networks in which binding
partners for multiple proteins can be analyzed in parallel.
To gain insight into the supramolecular architecture of PP4-
containing complexes, we tagged the catalytic subunit at its N
terminus with a TAP tag, expressed this protein stably in
HEK293 cells, and then processed the tagged protein along
with its binding partners for purification (see “Experimental
Procedures” and Fig. 1A). Eluted proteins were subjected to
LC-MS/MS and identified via database searching followed by
statistical analysis of the search results using a suite of soft-
ware tools, including PeptideProphet and ProteinProphet
(Refs. 19 and 20; see “Experimental Procedures”). To estab-
lish a list of background contaminant proteins, we analyzed
cells stably expressing the TAP tag alone. In addition, proteins
detected in numerous unrelated samples were flagged as
dubious interactors and added to the contaminant list (see
Supplemental Table I). For a list of PP4C-interacting pro-
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teins see Table I. The data are also represented pictorially in
Fig. 1B.
In addition to the recovery of the TAP-tagged “bait” protein
itself (PP4C), we observed a number of peptides derived from
the known PP4C regulatory subunits PP4R1 and PP4R2 (Ta-
ble I). We also observed many peptides derived from alpha4
(IGBP1) previously demonstrated to interact directly with all of
the PP2A-like phosphatase catalytic subunits (24, 25). Alpha4
is the ortholog of the yeast Tap42 protein, which links the target
of rapamycin signaling pathway to PP2A-type phosphatases
(26–28). However, the role of the PP2A-type phosphatases
in rapamycin-sensitive signaling in mammals is not well
understood.
Interestingly our analysis also identified all eight subunits of
FIG. 1. Protein-protein interactions surrounding the mammalian PP4 catalytic subunit and identification of novel PP4C-interacting
partners. A, iterative TAP tag strategy to detect interacting proteins. B, proteins present in the TAP tag purification of the PP4 catalytic subunit.
Only interactions detected in our TAP tag experiments are represented. Green arrows represent interactions that were also previously reported,
whereas red arrows indicate novel interactions. C, PP4R3 is conserved throughout eukaryotic evolution. Shown is the alignment between
KIAA2010, KIAA1387, Falafel, and Psy2p. Green boxes represent armadillo (ARM)/HEAT repeats, and the yellow box indicates a domain with
homology to the Ran binding domain of RanBP1 as well as moderate homology with pleckstrin homology (PH) and EVH1 domains. D, PP4C
interaction network. Arrows indicate directionality; bait 3 prey. hTIP41 and alpha4 were also found to be associated with the PP2A and PP6
phosphatases. E, PP4C appears to be a component of several different types of mutually exclusive complexes.
TABLE I
Human protein interactions detected by mass spectrometry
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an ATP-dependent chaperonin, the TRiC/CCT complex. The
TRiC/CCT complex was initially thought to be highly special-
ized for the folding and assembly of actin and tubulin, but
recent work suggests that it participates in the folding and
assembly of a broader range of substrates (23). The interac-
tion with TRiC/CCT appears to be evolutionarily conserved as
both Pph3 (the ortholog of PP4C) and Tap42 also co-precip-
itated with this complex in a large scale study (29). The
functional significance of the TRiC/CCT complex interaction
with PP4cat is unknown at this time.
A Novel Evolutionarily Conserved Protein Interacts with
PP4C—Other than the known PP4C-interacting partners and
the TRiC/CCT complex, only two additional (non-contami-
nant) proteins were detected in the TAP-PP4C purification:
KIAA2010 and KIAA1387. The human KIAA2010 is 820 aa in
length, and KIAA1387 is 764 aa. The two proteins share 67%
sequence identity and 77% homology at the amino acid level
(Fig. 1C). To be consistent with the nomenclature of the
PP2A-type phosphatases, here we refer to KIAA2010 as
PP4R3 and to KIAA1387 as PP4R3 (see below for further
justification). PP4R3-like proteins are conserved throughout
Eukaryotae: the Drosophila falafel (flfl) protein shares 58%
identity with KIAA2010 at the amino acid level, and the S.
cerevisiae Psy2 protein exhibits 27% identity with KIAA2010
over 699 amino acids (Fig. 1C).
The predicted two- and three-dimensional structure of the
PP4R3 protein family indicates that a 115-aa fragment at the
extreme N terminus shares extensive structural homology
with a Ran binding domain found in RanBP1 (Fig. 1C). The
predicted structure of this fragment is also reminiscent of
pleckstrin homology domains. The Ran binding-like region is
the most conserved portion of the protein across species,
sharing 46% identity (60% similarity) at the amino acid level
with yeast Psy2p and 87% identity (95% similarity) with flfl.
Threading algorithms (30) indicate that the KIAA2010 and
KIAA1387 proteins also possess a number of HEAT or arma-
dillo repeats. Whether PP4R3 can interact with Ran is un-
known at this time; we were unable to detect this interaction
by co-immunoprecipitation following in vitro translation or
co-transfection in 293 cells (data not shown).
Interestingly small interfering RNAs directed against
KIAA1387 shorten mitotic transit time (31). Falafel (flfl) was
first identified in a modular misexpression screen designed to
identify novel dRac-specific signaling components; loss of flfl
resulted in defects in dorsal closure, a phenomenon also
associated with dRac deletion (Ref. 32; see below). Finally the
yeast PP4R3 homolog was dubbed Psy2p based on hyper-
sensitivity of deletants to the anticancer drug cisplatin (Ref.
10; see below).
Mammalian PP4 Module Interaction Network—To confirm
the observed novel interactions and to better understand the
supramolecular architecture of PP4C-containing complexes
in mammals, we cloned the human alpha4, PP4R1 (PPP4R1),
PP4R2 (PPP4R2), and PP4R3 (KIAA2010) ORFs into TAP tag
vectors, established HEK293 cell lines stably expressing
these tagged proteins, and repeated the purification and
mass spectrometric identification process for each of these
proteins and their interacting partners (Fig. 1, A and D, and
Table I).
The PP4R1 pull-down yielded only the bait itself and PP4C.
No peptides derived from alpha4, the TRiC/CCT complex,
PP4reg2, or PP4reg3 were detected in these experiments
(Table I). Alpha4 pull-downs yielded primarily TRiC/CCT com-
plex proteins in addition to a single PP4C peptide and a few
peptides from the other known alpha4 binding partners
(PP6C, one peptide; and PP2AC, three peptides). In a PP4R2
pull-down, the TAP-tagged protein itself and PP4C were iden-
tified as well as many peptides from PP4R3 and PP4R3.
Thus, as with PP4C, PP4R2 appeared to be present in a
complex with PP4R3 and/or PP4R3. In addition to these
proteins, the PP4R2 pull-down also yielded MGC3794, the
human homolog of S. cerevisiae Tip41 (Tap42-interacting pro-
tein, molecular mass of 42 kDa), a protein involved in rapa-
mycin signaling through phosphatase regulation (33, 34). We
cloned the MGC3794 ORF (hereafter referred to as hTIP41)
into the TAP tag vectors and repeated the pull-down/identifi-
cation process with this fusion protein. PP4C and PP4R2
peptides (in addition to other phosphatase subunits, which
will be reported elsewhere) were identified. This observation is
intriguing because the yeast Tip41 protein was reported to
interact with the yeast alpha4 homolog Tap42 and to prevent
Tap42 from forming complexes with phosphatases (Ref. 33;
see “Discussion”). Finally a pull-down of PP4R3 (KIAA2010)
confirmed the interaction with PP4C and PP4R2. No addi-
tional proteins were identified in the PP4R3 pull-down.
Taken together, these data suggest that PP4C is present in
several distinct complexes: 1) a binary complex with PP4R1,
2) a complex involving alpha4 and the chaperonin TRiC/CCT,
FIG. 2. Assembly and specificity of the PP4CPP4R2PP4R3 complex. A and B, epitope-tagged versions of PP4R3 (EE tag), PP4R2 (3HA
tag), and PP4C (FLAG tag) were co-translated in a reticulocyte lysate containing biotinylated lysine ( denotes addition of the corresponding
cDNA to the reaction). Following co-translation, reactions were either analyzed directly by SDS-PAGE (bottom panels) or incubated with an
anti-FLAG Sepharose resin (A) or anti-HA Sepharose resin (B) prior to gel analysis. Proteins were transferred to nitrocellulose and visualized
by incubation with streptavidin-HRP followed by chemiluminescence. Black dots denote the location of the weaker PP4C band. C, model
depicting the preassembly of a binary complex between PP4C and PP4R2 prior to the stable association of PP4R3 into PP4cs. D and E,
specific interactions of PP4R2 and PP4R3 (but not hTIP41) with PP4C. PP4R2 (3HA-tagged; D), PP4R2  PP4R3 (EE-tagged; D), or hTIP41
(GST-tagged; E) were co-translated in a reticulocyte lysate with the indicated FLAG-tagged catalytic subunit. Following translation, samples
were analyzed directly via SDS-PAGE (bottom panels) or immunoprecipitated as above using an anti-FLAG Sepharose resin (top panels). IP,
immunoprecipitation.
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and 3) a complex containing PP4R2 and PP4R3, which may
also include hTIP41 (Fig. 1E). The PP4CPP4R2PP4R3 complex
will be referred to throughout this study as PP4cs (see below).
These results also demonstrate how an iterative TAP tagging/
mass spectrometry approach may be used to characterize the
components of individual multiprotein complexes.
Interaction of PP4R3 with PP4C Requires Preassembly of
PP4C and PP4R2—We next confirmed that PP4C, PP4R2,
and PP4R3 (KIAA2010) form a multimeric complex. Each
protein was tagged at its N terminus with a different epitope
tag to allow for detection and immunoprecipitation. Plasmid
DNA coding for each of the tagged proteins was used to
program a coupled transcription/translation (TNT) reticulocyte
lysate containing biotinylated lysine (see “Experimental Pro-
cedures”). Following separation by SDS-PAGE and transfer to
a nitrocellulose membrane, translation products were de-
tected using streptavidin conjugated to HRP. When all three
proteins were co-translated, both 3HA-tagged PP4R2 and
Glu-Glu (EE)-tagged PP4R3 were co-immunoprecipitated
with FLAG-tagged PP4C (Fig. 2A, lane 6). (The 3HA-PP4R2
constructs often yielded two products with slightly different
electrophoretic mobilities. This is most likely because of al-
ternative translation initiation start site usage, since the
smaller product does not react with the anti-HA antibody.)
Similarly a 3HA-PP4R2 protein pull-down (Fig. 2B, lane 5)
co-precipitated both FLAG-PP4C and EE-PP4R3. Exclusion
of PP4R3 from the TNT reaction had no apparent effect on the
interaction between FLAG-PP4C and 3HA-PP4R2 (Fig. 2A,
lane 5). Thus, binary complex formation between FLAG-PP4C
and 3HA-PP4R2 is not dependent on PP4R3. Importantly,
however, omission of 3HA-PP4R2 from the TNT mixture pre-
cluded co-immunoprecipitation of EE-PP4R3 with FLAG-
PP4C (Fig. 2A, lane 4), suggesting that PP4R2 is necessary to
mediate the interaction between PP4C and PP4R3. Consist-
ent with this observation, a two-hybrid association between
the putative yeast orthologs of PP4R2 (Ybl046w) and PP4R3
(Psy2p; Ynl201c) was reported previously in a large scale
study (Ref. 35; also see below). However, a putative direct
interaction between PP4R2 and PP4R3 in the TNT system is
apparently not sufficient for the formation of a stable complex
as omission of FLAG-PP4C from the TNT mixture prevented
efficient co-precipitation of EE-PP4R3 with 3HA-PP4R2 (Fig.
2B, compare lanes 4 and 5). It thus appears that a binary
complex between PP4C and PP4R2 must be assembled be-
fore PP4R3 can stably interact as illustrated in Fig. 2C. This
situation differs from the assembly of PP2AC-containing tri-
meric complexes in that the adapter (A subunit, or PPP2R1)
can efficiently co-precipitate either the catalytic or the regu-
latory B subunits (e.g. Ref. 36).
PP4R2 and PP4R3 Interact with PP4C but Not with the
Related Phosphatases PP2AC or PP6C—Our TAP tagging
data strongly suggested that the binding of PP4R3 and
PP4R2 is specific to PP4C: no peptides derived from other
phosphatases were recovered following TAP-mediated puri-
fication of PP4R2 or PP4R3. Similarly no PP4R2 or PP4R3
(KIAA2010 or KIAA1387) peptides were observed following
TAP-mediated purification of PP2AC, PP6C, or PP1C (data
not shown). To confirm these observations, we tested
whether the two regulatory proteins can co-precipitate with
the other mammalian PP2A-type phosphatases. The coding
sequences for PP2AC (PPP2CA), PP2AC (PPP2CB), and
PP6C (PPP6C) were cloned into the pcDNA3-flag vector and
co-translated in a TNT lysate with 3HA-PP4R2 alone (Fig. 2D,
lanes 1–4) or 3HA-PP4R2 and EE-PP4R3 (lanes 5–8). All cata-
lytic subunits were expressed (bottom panel), yet PP4R2 and
PP4R3 were only co-precipitated on an anti-FLAG Sepharose
resin when co-expressed with FLAG-PP4C (lanes 3 and 7). The
interaction with PP4C is thus specific, and PP4R3 (KIAA2010)
appears to be a bona fide PP4 regulatory subunit.
The specificity of the PP4cs intracomplex interactions con-
trasts with that of hTIP41, which interacted with all of the
PP2A-like phosphatase catalytic subunits in our study. Con-
sistent with this, GST-hTIP41 co-translated with the FLAG-
tagged phosphatases in the TNT system was efficiently co-
immunoprecipitated with FLAG-PP2AC, FLAG-PP4C, and
FLAG-PP6C (Fig. 2E, lanes 2–4). However, the serine/threo-
nine phosphatase PP1C (the PPP phosphatase most closely
related to PP2A with 41% identity to PP2AC) was unable to
precipitate hTIP41 (lane 1). In this respect, hTIP41 resembles
the human alpha4 protein, which can establish interactions
with all PP2A-type phosphatases (24). In contrast to a previ-
ous report documenting an interaction between the S. cerevi-
siae Tip41 and Tap42 proteins (33), hTIP41 was unable to
co-precipitate FLAG-alpha4 (Fig. 2E, lane 5). Taken together,
these results indicate that hTIP41 can interact with all of the
PP2A-type phosphatase catalytic subunits and is therefore
not a specific interacting partner for the PP4 complex.
Interaction among Yeast Orthologs of the PP4 Complex—
The S. cerevisiae genome contains orthologs of the mamma-
lian PP4C, PP4R2, and PP4R3 proteins. The protein sharing
the most homology to PP4R3 in S. cerevisiae is Psy2
(Ynl201c; Fig. 1C). The yeast Pph3 protein (Ydr075w) is most
closely related to PP4C, although the sequences of the other
S. cerevisiae PP2A-type phosphatases (Sit4, Pph21, Pph22,
and Ppg1) are also closely related. Although no yeast protein
exhibits sequence homology to PP4R2 throughout its entire
sequence, the Ybl046w ORF possesses a small stretch of
homology in its N terminus. Large scale experiments have
provided evidence for interactions between these yeast or-
thologs; a two-hybrid interaction was reported between Psy2
and Ybl046w (35), and complexes containing Pph3, Ybl046w,
and Psy2 (along with other proteins) have been detected
using pull-down/mass spectrometry approaches (29, 37). We
thus set out to determine whether yeast Pph3-containing
complexes were organized in a manner similar to mammalian
PP4C-containing complexes and whether a PP4cs-like com-
plex has been conserved throughout evolution. To this end,
we obtained yeast strains expressing C-terminally TAP-
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tagged Pph3, Ybl046w, Psy2, and Tip41 proteins and used
the same purification and mass spectrometry approach to
identify interacting partners for these polypeptides. As shown
in Table II and Fig. 3, interactions among the yeast proteins
were extremely similar to those we observed for the human
PP4cs proteins: Pph3, Ybl046w, and Psy2 all established
reciprocal interactions. As in the mammalian system, Tip41p
was also associated with this complex, although the coverage
ratio suggests that it was present in lower amounts than the
other components. We did not detect the TRiC/CCT complex
or alpha4 in the Pph3-TAP pull-down; however, this may be
due to the presence of the relatively large TAP tag at the C
terminus of the protein (the mammalian PP4C was tagged at
its N terminus) as both Pph3-FLAG and Tap42-FLAG were
previously shown to co-precipitate with the TRiC/CCT com-
plex (29).
Interestingly, we also detected the transcription elongation
factor complex components Spt4 and Spt5 in TAP tag puri-
fications of both Psy2 and Ybl046w (Spt5 was also detected
previously as a Psy2 and Ybl046w interactor in a large scale
experiment; Ref. 37). Conversely purification of TAP-tagged
Spt5 yielded Spt4 and RNA Pol II subunits, as expected, in
addition to several peptides for Psy2, Ybl046w, and Pph3. A
putative role for PP4cs may thus be to target the Pph3 phos-
phatase to the transcription elongation machinery.
The Yeast PP4cs Complex Is Involved in the Response to
Cisplatin-induced DNA Damage—A genome-wide scan for
hypersensitivity to the DNA-damaging agents cisplatin and
oxaliplatin (10) yielded three novel uncharacterized genes,
including platinum sensitivity 2 (PSY2; YNL201c; Ref. 10).
Interestingly PPH3 deletion was also found to render cells
hypersensitive to cisplatin treatment (10). Deletion of PPH3 or
PSY2 was also reported to moderately increase the sensitivity
of S. cerevisiae to methyl methanesulfonate (38). Because in
mammalian cells PP4R2 is an obligatory partner for the asso-
ciation of PP4C and PP4R3, and Tip41 associates with PP4cs
in yeast and mammals, we characterized the sensitivity of
yeast lacking the YBL046W or TIP41 (YPR040W) genes to
cisplatin treatment. Diploid yeast strains were treated with
cisplatin or vehicle alone, and the growth of yeast was mon-
itored 36 h after plating onto fresh YPD agar plates. As ex-
pected from the large scale studies, deletion of PPH3, PSY2,
or the polymerase -associated protein REV1, rendered cells
hypersensitive to cisplatin treatment (Fig. 3C). Importantly,
and consistent with a role for the entire yeast PP4cs complex
in cisplatin sensitivity, deletion of YBL046W also elicited cis-
platin hypersensitivity. Interestingly, deletion of TIP41 yielded
an intermediate phenotype, exhibiting more sensitivity than a
wild type strain yet less sensitivity than the PSY2, PPH3, or
YBL046W deletants. Strains deleted for the PPH3-related
PPH22 or PPZ2 phosphatases displayed cisplatin sensitivity
similar to the parental strain in this screen. To control for
spurious results due to secondary mutations, we repeated the
experiment with a haploid deletion set and obtained identical
results (Fig. 3D). Thus, the yeast PP4 complex containing
Pph3, Ybl046w, and Psy2 plays a crucial role in viability
following cisplatin-induced DNA damage. Tip41 may play a
role as a modulator or facilitator perhaps by making the PP4
complex more available to substrate(s) following DNA dam-
age treatment.
Because Psy2, Pph3, and Ybl046w interacted with Spt4
and Spt5 in the TAP tag pull-down experiments and Spt4 was
implicated in the shutdown of Pol II-mediated transcription
following DNA damage (possibly via dephosphorylation of Pol
II Ser-5; Ref. 39), we reasoned that the involvement of the
PP4cs proteins in cisplatin resistance may be effected
TABLE II
Yeast protein interactions detected by mass spectrometry
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FIG. 3. Comparison of yeast and human PP4C interaction maps and cisplatin sensitivity of individual yeast deletion strains. A and B,
schematic organization of the multiprotein complexes recovered and identified by TAP tagging and mass spectrometry. Human data are also
shown in Fig. 1 and Table I; yeast data are extracted from Table II. Arrows denote directionality of the interaction (bait 3 prey) and are
color-coded as in Fig. 1. Colored nodes represent proteins used as bait in the TAP tagging procedure, whereas gray nodes represent proteins
that were not analyzed further. The beige diamond encompasses the PP4CPP4R2PP4R3hTip41 complex conserved from yeast to mammals.
C and D, cisplatin sensitivity of yeast strains harboring deletions for PP4cs complex components. Diploid (C) or haploid (D) S. cerevisiae
A PP4 Complex Involved in Cisplatin Sensitivity
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through SPT4 and SPT5. Therefore, homozygous diploid
SPT5 deletant and haploid SPT4 and SPT5 deletion strains
were tested for cisplatin sensitivity. In the absence of cispla-
tin, both strains grew slightly slower than the parental strain.
However, none of the SPT4/5 strains exhibited significant
hypersensitization to cisplatin (Fig. 3, C and D). Thus, SPT4
and SPT5 are not likely to be key mediators of the cisplatin
sensitivity caused by PP4cs deletion.
Psy2 Interacts with Rad53—In an attempt to elucidate how
PP4cs and Tip41 are connected to the DNA damage repair
machinery, we turned to a yeast two-hybrid strategy. Psy2
was previously reported to interact with Rad53 in the yeast
two-hybrid assay (Rad53 was used as bait; Ref. 13). We
attempted to verify this interaction using the reverse config-
uration with Rad53 cloned into a prey vector and Psy2 ex-
pressed from a bait vector. In addition, we tested pairwise
interactions among all of the components of our yeast PP4
complex and explored putative interactions with other com-
ponents of the DNA damage machinery. A total of 31 non-
redundant prey-containing yeast strains were mated in dupli-
cate to strains expressing Psy2, Ybl046w, Pph3, Tip41, and
Rad53 from the bait vector. Although a previous study utilized
Rad53 as bait, our own bait strains harboring Rad53 mated
inefficiently, and two-hybrid interactions could not be tested
for this strain. The other bait strains were tested in a 96-well
format, and the growth of colonies on media lacking histidine
was monitored. By plating the yeast on selection media con-
taining varying amounts of 3-aminotriazole (a stoichiometric
inhibitor of His3p activity), background levels could be effi-
ciently controlled such that growth of negative controls (e.g.
vector alone) served as a base line to score positives. As
previously reported, bidirectional interactions were detected
between Psy2 and Ybl046w (Fig. 4, A and B). In addition,
Tip41 (bait) interacted with Pph3 (prey), Pph21, Pph22 (Fig.
4A), Sit4, and Ppg1 (not shown). We also detected a previ-
ously unreported bidirectional interaction between Pph3 and
Ybl046w. Consistent with our TAP tag data, Psy2 strongly
interacted with Spt4 and Spt5 in the two-hybrid assay. Finally
a strong signal was also observed between Psy2 (bait) and
Rad53 (prey). No signal was detected for Rad53 with any of
the other baits tested. Additionally no signal was detected
between any of the baits tested and strains containing prey
vectors expressing other proteins involved in DNA damage
(not shown). These data suggest that the yeast PP4cs com-
plex is connected to the DNA damage machinery via an
interaction between Psy2 (PP4R3) and Rad53.
PP4R3 Is a Functional Homolog of Psy2—To determine
whether the yeast and human PP4cs are functionally equiva-
lent in the cisplatin sensitivity assay, we reintroduced a FLAG-
tagged galactose-inducible Psy2 or mammalian PP4R3 (or
vector alone) into the psy2 diploid strain. We then performed
cisplatin sensitivity assays as above. As expected, the psy2
strain (transformed with vector alone) was much more sensi-
tive to cisplatin treatment than the parental strain (trans-
formed with vector alone; Fig. 5A), although the magnitude of
this effect was less pronounced on the synthetic defined
media used for this assay than on YPD media as used in Fig.
4. psy2 strains transformed with FLAG-Psy2 (two independ-
ent transformants tested) exhibited a level of cisplatin sensi-
tivity similar to the parental strain (Fig. 5A). Strikingly expres-
sion of FLAG-tagged mammalian PP4R3 also reverted the
cisplatin hypersensitivity of a psy2 strain, indicating that
Psy2 and PP4R3 are functionally equivalent in mediating re-
sistance to cisplatin.
To determine whether human PP4R3 can establish the
same two-hybrid contacts with the yeast prey proteins as
Psy2, we mated a yeast bait strain expressing human PP4R3
to our prey array. Although we did not detect interactions with
Ybl046w, Spt4, or Spt5, PP4R3 strongly interacted with yeast
Rad53 (this was, in fact, the only interaction we detected; Fig.
5B). It thus appears that an interaction between PP4R3/Psy2
and the DNA damage machinery has been evolutionarily
conserved.
Cisplatin Hypersensitivity of PP4R3 Mutants in Higher Eu-
karyotes—To investigate whether a reduction in PP4R3 activ-
ity renders a multicellular organism hypersensitive to cisplatin,
we assayed animals harboring mutations in the Drosophila
falafel (flfl) gene, which encodes the fly homolog of the
PP4R3/Psy2 protein (Fig. 1C). Two ethyl methanesulfonate-
induced mutant alleles, flfl2 and flfl3 (see “Experimental Pro-
cedures”), were identified in a reversion assay for an enhancer
and promoter-mediated flfl gain-of-function phenotype.2 Al-
though flies homozygous for either mutation (flfl2/flfl2 or flfl3/
flfl3) were inviable, 30% of animals possessing the heteroal-
lelic combination flfl2/flfl3 reached adulthood and displayed a
statistically significant reduction in size as compared with
their wild type counterparts (weight reduction of 23% in
females and 12% in males).
Mutant first instar flfl2/flfl3 larvae were placed onto standard
fly food supplemented with increasing concentrations of cis-
platin (see “Experimental Procedures”), and emerging adult
flies were counted 3 days after eclosion. (The survival of
mutant flfl2/flfl3 animals is compromised even in the absence
of cisplatin, so these data were normalized to the survival of
flfl mutants in the absence of the drug.) Survival curves for
flfl2/flfl3 mutants and control animals grown on increasing
2 M. Zarske and E. Hafen, manuscript in preparation.
deletion mutants were grown to OD  0.4 and then treated with 1 mM cisplatin (or DMSO vehicle alone) for 4 h. Serial 10-fold dilutions were
plated onto YPD, and growth was monitored 36 h post-treatment. Pph22 is a yeast homolog of the PP2A catalytic subunit, whereas Ppz2 is
a homolog of the human PP1 catalytic subunit. rev1 was used here as a positive control.
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FIG. 4. Psy2p interacts with Rad53p. Coding sequences for Psy2p, Ybl046w, Pph3p, and Tip41p were cloned into the yeast two-hybrid bait
vector pOBD-2, and the constructs were transfected into the pJ69-4a strain. A miniarray of “prey” in pOAD/pJ69-4, extracted from a larger
collection described previously (13), was supplemented with a collection of cDNAs coding for Psy2, Ybl046w, Pph3, Tip41, and Rad53 in
pOAD/pJ69-4 and generated in parallel to the bait. The final prey array consisted of the following proteins: Spt4, Rad6, Rev7, Mrc1, Ybl046w,
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concentrations of cisplatin are shown in Fig. 5C. Female flfl2/
flfl3 mutant flies displayed reduced survival at 0.4 M cisplatin
compared with wild type flies (Fig. 5C). No flfl2/flfl3 individuals
survived when exposed to 0.8 or 1.2 M cisplatin, whereas
some wild type animals emerged (identical results were ob-
served with male flfl mutant animals; data not shown). These
results suggest that falafel (PP4reg3) function in higher eu-
karyotes is required for resistance to cisplatin treatment and
provide further evidence for a critical and evolutionarily con-
served role of this PP4C-interacting partner in the response to
DNA damage.
DISCUSSION
Here, using an iterative TAP tagging/mass spectrometry
approach, we report that the mammalian PP4 catalytic sub-
unit is a component of several different mutually exclusive
subcomplexes: one containing PP4R1, another containing
alpha4 and the TRiC/CCT complex, and a third (PP4cs) con-
taining PP4R2 and a novel protein that we termed PP4R3. The
PP4cs complex is evolutionarily conserved and in yeast is
composed of the Pph3, Ybl046w, and Psy2 proteins. The
conservation in S. cerevisiae suggested a role for PP4cs in
resistance to cytotoxic agents: genome-wide screens of the
yeast deletion collection with the DNA-damaging agents cis-
platin, oxaliplatin, mitomycin C, and methyl methanesulfate
have highlighted the importance of both PPH3 and PSY2 in
survival following exposure to these agents (10, 38). We dem-
onstrated that yeast strains deleted for YBL046W (PP4R2) are
hypersensitive to cisplatin to the same extent as strains de-
leted for either PPH3 or PSY2. The mammalian ortholog of
Psy2, PP4R3, could substitute for the yeast protein in cisplatin
sensitivity assays, suggesting that the mammalian complex
plays a similar role. Furthermore in Drosophila, mutation of the
falafel gene, the ortholog of Psy2, led to increased cisplatin
sensitivity.
How might the PP4CPP4R2PP4R3 complex be linked to
the DNA damage response? A previous yeast two-hybrid
screen for Rad53-interacting partners yielded Psy2 (13). We
confirmed this observation and demonstrated that the inter-
action is independent of Rad53 kinase activity (data not
shown). Rad53 (or CHK2 in humans) is a critical component in
a DNA damage checkpoint response conserved from yeast to
humans (human ortholog CHK2; Refs. 40 and 41). We were
not able to detect Rad53-Psy2 or human CHK2-PP4R3 inter-
actions by pull-down assay, suggesting that these interac-
tions are transient or easily disrupted through our purification
protocol or that the interactions may be substoichiometric.
Rad18, Rrd1, Rad10, Rad2, Pho85, Ppg1, Luc7, Pph3, Rrd2, Tip41, Pph22, Pph21, Ynr069c, Ahc1, Hol1, Psy2, Rad53, Rev1, Rad1, Spt5,
Rad26, Rad9, Rev3, Mec1, Sit4, and Mrp144. Bait and prey strains were mated, and growth on selective medium (lacking histidine and
containing various amounts of 3-aminotriazole) was monitored. A, representative results for each mating. Positive results are framed in red. B,
summary of the interactions detected by the yeast two-hybrid method in this and other studies. Proteins used as bait are denoted by colored
nodes. Red arrows indicate novel interactions reported for the first time in this study; green arrows indicate interactions detected in this study
as in previous reports; and the blue arrow represents an interaction reported in the literature but not tested here.
FIG. 5. PP4R3 from higher eukaryotes is involved in cisplatin
sensitivity. A, mammalian PP4R3 functionally replaces PSY2 in the
cisplatin sensitivity assay. Yeast Psy2 or mammalian PP4R3 cDNAs
were cloned into the galactose-inducible pESC-ura vector and trans-
formed into the diploid yeast strain lacking PSY2. Individual clones
were selected. Expression of the recombinant cDNAs was driven
through growth on galactose for 8 h prior to cisplatin treatment (4 h).
A serial 10-fold dilution series was plated onto minimal medium
lacking uracil but containing galactose to maintain expression.
Growth was monitored 48 h post-treatment. B, mammalian PP4R3
interacts with yeast Rad53. A yeast two-hybrid assay using human
PP4R3 as bait was performed as in Fig. 5 in duplicate. C, flies lacking
functional PP4R3 (flfl) are hypersensitive to cisplatin. Survival of flfl
heterozygous (control, MKRS/flfl2, or MKRS/flfl3) and flfl2/flfl3 het-
eroallelic mutant female flies following cisplatin treatment. Numbers
of surviving flies at various concentrations of cisplatin were normal-
ized to the numbers of untreated animals. Similar results were ob-
tained with male flies. Experiments were performed in triplicate at all
concentrations with 100 flies per concentration.
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Other links between PP4cs and DNA damage also exist.
Yeast PP4cs associates with Spt4 and Spt5, transcription
elongation factor proteins linked to DNA damage-induced Pol
II dephosphorylation at Ser-5, and subsequent transcriptional
shutdown (39). However, deletion of Spt4 or Spt5 did not
result in hypersensitivity to cisplatin, indicating that the
PP4cs-Spt4-Spt5 interaction is not sufficient to explain the
cisplatin sensitivity phenotype.
Psy2 was also reported previously to genetically and phys-
ically interact with Wss1 and Tof1, two proteins presumed to
play a role in the stabilization of stalled replication forks (42).
In human cells, additional links between PP4C and/or the
PP4cs complex and cisplatin-induced DNA damage may
exist. For instance, cisplatin-induced NF-B activation ap-
pears to be mediated, at least in part, by PP4C-mediated
dephosphorylation of NF-B p65 at Thr-435 (43). The pre-
cise contribution of each of these pathways to the cisplatin
hypersensitivity phenotype of the PP4cs deletants remains
to be assessed.
Cisplatin and related platinum compounds such as carbo-
platin are effective against many types of solid tumors, includ-
ing cervical, ovarian, head-and-neck, and non-small cell lung
cancers (for a review, see Ref. 44). Cisplatin analogs have also
proven particularly effective against testicular cancer for
which the overall cure rate exceeds 90% (for a review, see
Ref. 12). However, intrinsic or acquired resistance to cisplatin
analogs is frequently encountered, significantly limiting the
application of this class of drugs (12). Resistance may be
attributed to several factors, including decreased drug accu-
mulation, increased cellular detoxification, enhanced DNA re-
pair, tolerance to platinum-induced DNA damage, and alter-
ations in signal transduction pathways (11). Cisplatin
resistance is thus a major hurdle in cancer therapies, and a
primary goal in designing new platinum-based anticancer
agents has been to circumvent this problem (45).
The sensitization to cisplatin of S. cerevisiae deleted for any
of the PP4cs members suggests that inactivation of the hu-
man PP4cs components during cisplatin treatment may sen-
sitize cisplatin-resistant tumor cells to the drug. In support of
this possibility, two different cell lines selected for cisplatin
resistance through long term cisplatin treatment demon-
strated a striking reversal to a sensitive phenotype when
co-treated with low doses of demethylcantharidin or okadaic
acid, two PP2A inhibitors (46, 47). PP4C is also sensitive to
these compounds (48) and was likely inhibited in these stud-
ies. Novel platinum-based compounds comprised of two moi-
eties, the platinum group and demethylcantharidin, elicited
sensitivity of these cisplatin-resistant cell lines only when the
compounds exhibited activity toward PP2A (46, 47). Based on
the shared sensitivity of PP2AC and PP4C to cantharidin-
based compounds, PP4C is also likely targeted by these
compounds. A drug that targets the assembly of PP4cs,
perhaps by preventing PP4R2 from binding to PP4C or
PP4R3, could thus potentially synergize with cisplatin while
having fewer side effects than drugs inhibiting all PP2A-type
subunits.
Finally a different type of anticancer compound, rapamycin,
was also demonstrated to enhance cisplatin sensitivity in cell
and animal models (e.g. Ref. 49). Rapamycin actions are
conserved from yeast to humans and appear to involve mod-
ulation of PP2A-type phosphatase activity through Tap42 (al-
pha4) and Tip41 (at least in yeast). Rapamycin analogs are
used in the clinic to prevent graft rejection and as anticancer
agents (for reviews, see Refs. 50 and 51). Recently the syn-
ergy between cisplatin and rapamycin was demonstrated to
be attributable to changes in the levels of the p21 protein
because of a modest general decrease in translation brought
about by rapamycin (52). Whether PP4cs plays a role in the
control of translation and the regulation of p21 levels remains
to be investigated.
Further delineation of the interacting partners and supramo-
lecular architecture of the PP2A-type phosphatases should
greatly assist us in deciphering the roles that each of these
important proteins plays in various cellular processes. Given
that these enzymes play critical roles in DNA repair and tumor
promotion (4), a more intimate understanding of their regula-
tion and function should provide us with greater treatment
options for various types of cancers.
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